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The aim of this study was to identify, isolate and characterise the protective
antigens present on the surface of Pasteurella haemolytica, serotype A1. A specific
serotype antigen was identified by crossed immunoelectrophoresis (CIE) in a hot
phenol-water extract (PWE) of P. haemolytica A1 cells. This preparation protected
mice challenged with the homologous serotype. However, this protection and also the
serotype-specific antigenicity of the PWE was reduced by treatment with sodium
periodate but not proteinase K or heat, indicating that the protective antigen was
carbohydrate in nature. The composition of PWE consisted of carbohydrate with some
protein and lipid. The sugar analyses revealed the presence of mannose, galactose,
glucose, two heptoses, glucosamime and galactosamine. The additional presence of
ketodeoxyoctonic acid suggested that lipopolysaccharide was the major component of PWE.
Partial acid hydrolysis and subsequent separation of the products on Sephadex G50
indicated that the LPS may be of the rough type. However, two antigens which were
identified in the PWE by CIE could not be separated from each other to allow individual
analyses of both.
The PWE and sodium salicylate extracts (SSE) antigens of P. haemolytica A2 and A6
were also investigated. The PWE of both serotypes were found to have similar
compositions to that of A1 PWE, especially the sugar composition determined by gas
chromatography GC where identical sugars were present, although in different
proportions. A strong serotype-specific antigen was observed in A6 PWE when analysed
in CIE but the reaction with A2 PWE was weak. The PWE of A6 protected against
homologous and a heterologous A1 challenge indicating some sharing of antigens within
the carbohydrate component of A1 and A6 but no consistent protection was observed with
any inactivated A2 vaccine although a combination of concentrated SSE and heat killed
organisms did show protection on one occasion. Solid protection was observed in mice
which had survived an LD,-q dose of A2 and had then been rechallenged.
Strains of P. haemolytica not typable by the indirect haemagglutination test (IHA)
isolated from both sheep and cattle were investigated using the immunological methods
applied to A1. These strains were shown to belong to the A biotype and were groupable
on the basis of specific antigenicity in agarose gel diffusion and CIE. A counter
current immunoelectrophoresis (CCIE)method was developed to detect these antigens. Ten
serogroups were identified in 31 strains by CCIE and these groups contained both cattle
and sheep strains. Protection was evident in mice when SSE antigens of these strains
were used as vaccines but a high level of cross protection was evident between IHA
negative serogroups. Representative strains of 2 IHA negative serogroups, shown to be
of high and low virulence for mice, were not found to be pathogenic for sheep.
A 'sandwich' enzyme-linked immunosorbent assay (ELISA) using rabbit IgG as an
antigen trapping layer was developed to measure antibody in the sera of sheep and mice
to serotype-specific antigens of P. haemolytica.
A modified ELISA test and the IHA test were used to follow the development of
serum antibodies in sheep with an experimental, chronic pasteurellosis. There was a
specific serum antibody response to P. haemolytica A2.
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GENERAL INTRODUCTION
Pneumonia in sheep is the cause of major loss to the sheep
farming industry of Great Britain and an idea of its importance
is given in a survey conducted by the Ministry of Agriculture,
Fisheries and Food (MAFF 1964) in which it was found that 82% of
all carcases refered to Veterinary Investigation Centres showed
evidence of pneumonia. There is no reason to believe that the
situation has changed much since then and a Veterinary
Investigation Diagnosis analysis report for the years 1976-77
showed that pasteurellosis is the pneumonia found most
frequently in sheep. The organisms implicated in the disease
are Pasteurella haemolytica and Pasteurella multocida with the
former being by far the more significant (Gilmour, 1978a).
Evidence by various investigators has ■indicated that
Pasteurella species are also the main causative organisms of
pneumonia in sheep throughout the world. Hamdy et al (1959).
found that pneumonia in slaughtered lamb was associated with
P.multocida in 15 out of 51 cases and P.haemolytica in 9 out of
51 cases. In an investigation of enzootic pneumonia in South
Africa, Van der Veen and Zumpt (1967) recovered P.haemolytica
from 13 out of 36 outbreaks and P.multocida from six. A 3 year
study of perinatal lambs mortality in Western Australia by
Dennis (1974) indicated that P.haemolytica was the main cause of
pneumonia. Alley (1975) in a study of 5-10 month old lambs at a
New Zealand slaughterhouse isolated P.haemolytica in pure
culture from 45% of all cases and in association with
Branhamella cattarhalis from a further 14%.
In all these studies a number of other bacteria were found
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including Escherichia coli, Staphylococcus species,
Streptococcus species, Pseudomonas species, and Fusobacterium
necrophorum. These were thought to be of minor importance
although Stevenson (1974), working in Canada, reported cases of
pneumonia in sheep due to infection with Streptococcus
zooepidemicus which he was able to reproduce experimentally.
Pneumonic pasteurellosis is not restricted to sheep but is
also a major problem in the cattle industry. Losses in the
U.S.A. due to "shipping fever", as the disease is sometimes
known in North America, were estimated by McKercher (1978) at 76
million dollars in 1972. The involvement of P.haemolytica in
the cattle disease has been well documented and excellent
reviews are available in the literature (Yates, 1982; Carter,
1967; Gilmour, 1978b).
This thesis concentrates on P.haemolytica as the chief cause
of ovine pneumonic pasteurellosis.
Control of the disease is likely to be best achieved by the
use of vaccines against P.haemolytica and recent work by Gilmour
et al (1979) has shown that vaccines prepared from extracts of
bacterial cells do protect sheep against experimentally produced
pneumonic pasturellosis. A more detailed knowledge of the
important antigens involved in stimulating protection could lead
to improvement in the production and efficiency of existing
vaccines. The aim of this thesis was to attempt the isolation
and characterisation of the surface antigens of P.haemolytica.
The first part of the literature review discusses the
literature associated with P.haemolytica and pneumonic
pasteurellosis, the second part is concerned with the structure
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and chemistry of the Gram-negative cell wall and the final part
with the use of bacterial surface antigens as vaccine
components.
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Pasteurella haemolytica and pneumonic pasteurellosis
Characteristics of Pasteurella haemolytica
P■haemolytica has been the subject of intense investigation
since Jones (1921) first described a short Gram-negative, non
motile, capsulate cocco-bacillus isolated in a slaughterhouse
survey. In 1932 Newsom and Cross isolated a similar organism
from a pneumonic sheep lung and gave it the name we now
associate with the bacterium.
P.haemolytica is a small Gram-negative pleomorphic rod
showing marked bipolar staining when freshly isolated from
animal tissue. It is aerobic and facultatively anaerobic,
oxidase and catalase positive and ferments sugars by
fermentation,giving small amounts of acid but no gas.
It can be easily distinguished from other members of the
genus Pasteurella and especially P.multocida, by the
characteristics shown in Table 1.
Strains of P.haemolytica can be classified into two biotypes
and at least fifteen serotypes. This aspect of P.haemolytica
has been the subject of reviews by Biberstein (1978) and Gilmour
(1978a;1980).
Biotype: Smith (1959b;1961) investigated the biochemical and
cultural characteristics of isolates of P.haemolytica. This
resulted in the division of P.haemolytica into two biotypes, A
and T, which denoted arabinose fermentation and trehalose
fermentation respectively. Smith also showed that the biotypes
differed in their sensitivity to penicillin, with biotype A
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Table 1
Differentiation of P.haemolytica from other Pasteurella species.
1. P.haemolytica causes weak haemolysis on 7% sheep blood agar
plates. A layered plate with a nutrient agar underlayer
and blood agar overlayer facilities the observation of this
haemolysis, P.multocida is not haemolytic.
2. P.haemolytica does not produce indole whereas P.multocida
does.
3. P.haemolytica will grow on MacConkey agar while P.multocida
will not.
4. P.haemolytica does not produce urease while P.ureae and
P.pneumotropica do.
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being more susceptible. This has been confirmed in subsequent
studies by Biberstein and Kirkham (1979), who showed that
biotype A strains also had increased in vitro susceptibility to
ampicillin, cephalothin, chloramphenicol, tetracycline,
erythromycin and nitrofurantoin. Olmos and Biberstein (1979)
showed that there were differences in the resistance to dyes
apparent between the biotypes. T strains grew in brain heart
infusion broth containing basic fuchsin (0.2 ug ml--'-) while A
strains did not.
Taxonomic studies by Smith and Thai (1965) on the A and T
biotypes led them to propose that they could be considered as
different species and the differences noted in nucleic acid
homologies (Biberstein and Francis, 1968) and in polypeptide
content as measured on polyacrylamide gels (Thompson and Mould,
1975) gives support to this proposal.
Serotype: Biberstein et al (1960) developed an indirect
haemagglutination (IHA) test to serotype strains of
P.haemolytica and identified 10 serotypes. In 1962, an
investigation into the relationship of A and T biotypes to the
serotypes (Biberstein and Gills, 1962) disclosed, in the sample
studied, a consistent association between serotypes and
biotypes. Subsequently, five additional serotypes, have been
added (Biberstein and Gills, 1962; Biberstein and Thompson,1966;
Pegram, 1979; Fraser et al, 1982b) so that at present 15
serotypes are recognised. Biotype A comprises
1,2,5,6,7,8,9,11,12,13 and 14 and Biotype T 3,4,10 and 15. The
serotype antigen is presumed to be a surface antigen which is
either polysaccharide (Cameron 1966) or lipopolysaccharide in
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nature (Carter 1967). A number of strains which are untypable
by the IHA test have been isolated from both healthy and
diseased sheep. These generally belong to the A biotype and
their negative reaction in the IHA test has been ascribed by
Aarsleff et al (1970) to a lack of the soluble antigen
responsible for serotyping.
Strains of P.haemolytica can also be serotyped by the rapid
plate agglutination method (RPA) described by Frank and Wessman
(1978) where direct agglutination of the bacterial cells can be
carried out on a microscope slide. Recently Frank (1980) tested
10 untypable strains using this method and discovered that they
fell into three distinct serogroups. He proposed that that
these untypable strains lack the necessary soluble antigen for
the RPA. He did not feel that the existence of these serogroups
undermined the theory put forward by Aarsleff et a_l (1970) that
untypable strains were traditional serotypes lacking the soluble
surface antigen.
The distribution of biotypes and serotypes is of
epidemiological interest and surveys carried out by Thompson et
al (1977) and Fraser et al (1982a) on P.haemolytica strains
isolated from field cases showed that during the years 1974-77 A
biotypes comprised 52% of all strains serotyped while between
1978-81 56.5% of all strains were A biotypes. In both surveys
A2 was the serotype most frequently isolated; 33% of all
serotypes in 1974-77 and 38% in 1978-81. T biotypes were
isolated from 42% of all cases in 1974-77 and from 33.5% in
1981. However the T distribution was complicated by the
discovery of T15 midway through the timespan of the later
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survey. Fraser and his colleagues also noted that over the
period of the two surveys the rise in
frequency of T15 from 0 to 30% of T strains tested coincided
with a dramatic drop in the incidence of T3 from 38.5% to 9.4%.
They suggested that some strains previously identified as T3
were in fact T15 as the strains possess a common antigen which
leads to a cross reaction in the IHA test.
A13 and A14 were not included in the second survey but were
isolated from a few cases, mainly exotic animals. The extension
of the serotype range did not reduce the frequency of untypable
strains and these strains did in fact increase in frequency from
6-11%. Gilmour (1980) suggests that the untypable group may
harbour more type strains which have not as yet been detected.
Pasteurellosis in sheep
Smith (1961) showed that the disease in sheep caused by
P.haemolytica fell into two distinct syndromes each of which is
generally associated with one of the two biotypes.
Disease caused by biotype A: Montgomerie et al (1938)
described this form of disease as an enzootic pneumonia and it
has since been shown to affect sheep of all ages. However, in
lambs under two months old a more systemic form may occur
(•Gilmour, 1980 ). Morbidity and mortality can be upto 10% of the
flock but sheep which recover can remain chronically unthrifty.
Stress factors would seem to play an important part in the
disease and such factors as temperature , dipping, castrating
and dosing for treatment of helminthiasis have all been
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postulated as predisposing the animals to disease (Gilmour
1978) .
Viral infection prior to pasteurellosis has been put forward
as a possible predisposing factor and such viruses as para
influenzae virus type 3 (PI3) and respiratory syncytial virus
(RSV) have been implicated. Serological and experimental
evidence obtained by Davies et al^ (1981) in New Zealand and
Sharp et aj. (1978) in the U.K. lend weight to this argument.
Gilmour and Brotherston (1963) first described a sub-acute
form of the disease in which there is now known to be a close
association of P.haemolytica biotype A strains with Mycoplasma
ovipneumoniae in lung lesions. Jones et. al (1979) have shown
that sub-acute disease can be reproduced by the inoculation of
homogenated lung lesions from affected animals which have been
shown to contain only P.haemolytica and M.ovipneumoniae.
Bacteriological confirmation of A type pasteurellosis is
usually obtained when an A biotype strain is recovered,
generally in pure culture, from exudates or lung lesions in
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numbers approaching 1 X 10 colony forming units (cfu) per g of
lung. Recovery of P.haemolytica from other organs such as the
liver, spleen, kidney, lymph nodes or heart blood is possible
when young lambs or very acute cases are examined. Gilmour et
al (1982) have shown that in the sub acute form of the disease
P.haemolytica can be recovered from the lesions up to six
weeks after infection.
Disease caused by biotype T: A rapidly fatal septicaemic
disease in lambs, associated with P.haemolytica was first
described by Stamp et a^l (1955) in Scotland and then later by
10
Biberstein and Kennedy (1959) in the United States. Smith
(1959b) subsequently identified the strains involved in the
disease described by Stamp as T biotypes. Dyson et al (1981)
suggested that this disease be termed a systemic disease as it
was doubtful that the bacteria underwent a true septicaemic
phase with rapid multiplication in the blood.
This form of the disease affects lambs 5-12 months old,
usually in the autumn and is coincidental with husbandry changes
such as movement to improved pasture or feeding on rape and
turnips. Although mortality from this disease is generally low
it may reach 20% of the sheep at risk.
P.haemolytica T biotype strains are present in all body
organs in large numbers and in pure culture if death has been
fairly recent (Gilmour, 1978). The T biotype disease has a
complex aetiology and will not form any part of this thesis
which will concern itself solely with A biotype strains.
Control of the disease: Although P.haemolytica is readily
susceptible to antibiotics (Thompson, 1973) it is generally
accepted that vaccination probably offers the most effective
means of control.
One of the earliest reports of successful vaccination was
that of Dungal (1931) in Iceland, where he described the
vaccination of sheep with either 1ml of a live 12 hour broth
culture or 1ml of a phenolised 12 hour culture given
subcutaneously. Although this protected 66 out of 70 sheep
against subsequent challenge with the homologous strain the work
was never repeated successfully.
In 1957 Stevens described the vaccination of sheep with a
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formalinised autologous culture given subcutaneously. This
treatment was effective in stopping losses in 14 outbreaks.
Although few controls were included the results were thought to
be encouraging.
Cameron (1966) claimed to have demonstrated successful
immunization of sheep by vaccinating with whole cells,
polysaccharide or proteins of P.haemolytica and showing passive
protection of mice given serum from the vaccinated sheep.
However, he states in a subsequent report (1970) that it was
impossible to infect laboratory animals consistently and
effectively which casts doubt on the earlier report.
After using an autogenous killed cell vaccine, Van der Veen
and Zumpt (1967) reported that losses in the flock given the
vaccine were reduced from 15-20% to 1-2%.
12
Experimental reproduction of pneumonic pasteurellosis
One of the major difficulties confronting workers
investigating pasteurellosis was the successful experimental
reproduction of the disease. P.haemolytica is ubiquitous in its
relationship with sheep and isolates can be recovered from the
respiratory tract of a high proportion of normal sheep. Gilmour
et al (1974) in a study into the prevalance of P.haemolytica in
sheep tonsils reported that 95% of all tonsils and 64% of all
nasopharynxes examined contained P.haemolytica. The A and T
biotypes differed in their distribution between these two sites
with 65% of all isolates from tonsils and 6% of isolates from
the nasopharynx being T biotype strains. This was in general
agreement with an earlier study by Biberstein and Thompson
(1966) who reported that 85.4% of all P.haemolytica isolates
recovered from the nasopharyx of normal sheep were of the A
biotype while only 2.2% were of the T biotype. In both these
studies a random assortment of serotypes was encountered.
Studies by Al Sultan (1982) have shown that colonization of the
respiratory tract occurs quickly after birth.
Dungworth and Cordy (1962) using chlamydiae alone in an
intra-tracheal challenge found P.haemolytica in the lung lesion
indicating the opportunistic nature of the bacterium. Biberstein
et al (1967) challenged sheep with P.haemolytica by an
intubation method. This resulted in lesions similar to natural
field cases but did not cause death. When combined with
chlamydiae increased numbers of animals had lesions suggesting
synergy in the aetiology of the disease. An unsuccesful
attempt to produce experimental pneumonia using PI3 and
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P.haemolytica A5 in combination led Biberstein to conclude that
PI3 was not significantly involved in the disease.
Gilmour and co-workers (1975) produced pneumonic
pasteurellosis identical to that seen under natural conditions
by exposing specific pathogen free (SPF) lambs to an aerosol of
P.haemolytica serotype Al. This resulted in 40% of the lambs
developing pasteurellosis. Subsequent experiments showed that
if the bacterial aerosol was preceded one week earlier by an
intra-tracheal challenge with PI3 virus the percentage of
infected animals rose to 90% (Sharp et al, 1978).
This system of experimentally produced pasteurellosis allowed
the testing of vaccines in a controlled environment and Gilmour
et al (1979) reported successful immunization of SPF lambs with
extracts of P.haemolytica cells obtained by treatment with
sodium salicylate. Protection was stated to be serotype
specific as a challenge with a serotype not included in the
vaccine resulted in failure of the vaccine to confer protection.
Laboratory animal models for the disease
In parallel with the search for an effective experimental
method for the reproduction of pasteurellosis in sheep
researchers were also investigating possible laboratory animal
models. The attraction of the latter lies in less costly
experiments and in the availability of greater numbers of
animals.
However, P.haemolytica is relatively non-pathogenic for
laboratory animals unless high numbers of bacteria are used and
thus increase the likelihood of endotoxic shock.
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Smith (1959c) described two successful methods for infecting
mice with P.haemolytica. One was an intra-cerebral inoculation
of the organism suspended in casein hydrolysate solution. The
organism multiplied and caused death but there was variation in
individual susceptibility to the infection. A modification of
this method where inoculation of a starch-saline solution which
caused brain trauma, was followed by intra-venous inoculation of
P.haemolytica, gave 100% mortality. However this was dependent
on a suitable dose of P.haemolytica. The other method described
was a challenge by the intra-peritoneal route with a suspension
of the bacteria in mucin. This caused death following the
development of septicaemia after 48 hours. The number of
bacteria required for successful challenge was less than that
causing endotoxic shock and the challenge seemed reproducible.
Smith used this model to demonstrate passive protection and
later active immunization of mice against challenge (Smith
1959a).
This model was applied to the investigation of a role played
by "capsular" and somatic antigens in immunity by Biberstein and
Thompson (1965). The major influence seemed to reside in the
"capsular" antigen with somatic antigens being of minor
importance. Knight et al (1969) using the same model could not
repeat the work and found anomalies in their results, one of
these being that greater immunity was conferred by antigenically
unrelated serotypes.
The problem of inconsistent results was encountered by
Cameron and Smit, (1970) while trying to reproduce an
intraperitoneal (i.p.) challenge with an aqueous suspension of
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organisms that he had described earlier (Cameron 1966). He
concluded that he was unable to challenge mice consistently
using this method.
A different approach was attempted by Rushton (1978) who
c c. 7 fi
inoculated mice, under anaesthesia, with 10° ,D to 10 cfu of
P.haemolytica. This caused a non-fatal pneumonia after three
days and it was claimed that the model was quick, easy, cheap
and "provided an opportunity for studying P.haemolytica in the
lung without the development of extensive changes and subsequent
death".
In an investigation of mouse models for P.haemolytica Evans
(1979) showed that the pneumonia seen by Rushton was due to
toxicity and not to multiplication as the same effect could be
obtained by the inoculation of killed cells.
Evans and Wells (1979a) described a modification of Smith's
original ip model where after challenge with P.haemolytica
suspended in mucin, the multiplication of the bacteria was
measured by counting the number of bacteria in the liver of the
mouse. This method seemed to be more reliable than the simple
death or survival criteria used by previous researchers and
experiments with sodium salicylate extract (SSE) vaccines of
P.haemolytica gave similar results to those found by Gilmour et
al (1979) in sheep, except that no protection was offered
against P.haemolytica serotype A2 challenge.
Mucin has been used to enhance the virulence of organisms
which are weakly or non-pathogenic when injected into mice on
their own (Olitzki,1948). The reasons for this enhancement are
not fully understood although some specific effects have been
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suggested. One of these is that there is a simple protective
role due to the viscosity of the mucin suspension and other work
with Neisseria meningitidis has shown that the presence of iron
in mucin is an important factor (Calver et al,1976). A1 Sultan
(1982) found that when iron is given intravenously some hours
before a suspension of P.haemolytica in mucin is given ip then
the LD5q is reduced significantly below that obtained for
mucin alone. This indicates the importance of iron in the
virulence of P.haemolytica for mice.
The use of SSE of P. haemolytica described by Gilmour et a_l
(1979) was prompted by the observation that existing commercial
vaccines were of questionable efficacy in preventing
pasteurellosis (Gilmour, 1980)oflow potency and limited serotype
range and indicated that there was a need for an improved, low
dose volume, potent, multi-serotype vaccine against
pasteurellosis.
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The Gram-negative cell envelope.
Treatment with sodium salicylate is thought to strip the
outer coat from the bacterium as the antigen responsible for IHA
activity is present in the preparation (Gilmour, 1980).
The envelope of Gram-negative bacteria is a complex structure
and has been the subject of numerous reviews (Costerton, 1974,
Rogers et al, 1981). The vast majority of reports describe the
structure found in the Enterobacteriaceae. The morphology of
the envelope can be determined by physical and chemical methods
and can easily be visualised by electron microscopy (Costerton,
1979). Physical methods necessitate breakage of the cell and
this can be done by mechanical means, by sonic disintigration or
by treatment in a presure cell. This is usually followed by
differential centrifugation. An alternative is enzymatic lysis
but this may denature or completely destroy the structures under
investigation. Electron microscopy offers a variety of
procedures but these are fairly restricted in their power to
analyse the morphology allowing only visual examination.
Scanning electron microscopy (SEM) can be used to look at
surfaces of intact bacteria while transmission electron
microscopy (TEM) allows a greater, much closer and detailed
observation of thin sections of the cell envelope to be made. It
is from TEM studies that valuable information on the structure
on the cell wall has been obtained. Freeze etching has been
used to look at the fine detail of the cell wall, especially at
the layered composition of this structure with its two membranes
sandwiching a denser staining layer.
Electron microscopy shows the Gram-negative cell wall to be
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composed of an inner trilamellar cytoplasmic membrane enclosed
by a dense staining peptidoglyican band, which is in turn
enclosed by an outer trilamellar membrane. There may also be a
further layer of loosely attached material. In addition,
certain appendages such as flagella, fimbriae or pili may be
present. Between the inner and outer membrane a gap known as
the periplasmic space is found which has an important function
in the Gram-negative bacterium, keeping enzymes and other cell
products in close proximity to the cell. The Gram-negative
envelope is represented diagramatically in Figure 1.
Cytoplasmic membrane
This can be obtained by the method of Miura and Mizushima
(1968, 1969) which was later modified by Osborn et al (1972) who
used ethylene diamine tetra acetic acid (EDTA) and lysozyme in
combination to disrupt the outer membrane and break down the
peptidoglycan. This released spheroplasts which were lysed and
the outer membrane and cytoplasmic membrane separated by sucrose
density centrifugation.
The cytoplasmic membrane is approximately 7.5nm in width and
its structure is a bilayer of phospholipid with proteins
intimately associated with it. Approximately 40-70% of the
membrane is made up of protein with lipid accounting for 10-35%.
This membrane is similar to the plasma membrane of eukaryotic
cells in that the membrane lipids consist mainly of phosphatides
but differs in that they contain no sterols (except for certain
mycoplasmas). The protein in this membrane may account for up to
20% of the total protein of a bacterium (Leive and Davis, 1980).
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Figure 1








The membrane provides a osmotic barrier for the bacterial
cell and the proteins in the membrane are mainly enzymatic in
nature although some may provide sructural functions. The
enzymatic processes include the specific transport systems,
respiratory chain system, lipid biosynthetic processes, wall
biosynthesis , DNA replicase and exoenzymes not yet released' to
the exterior (periplasmic space).
Peptidoqlycan layer (rigid layer)
The dense layer seen in EM, the peptidoglycan or rigid layer,
was first isolated by Weidel et al (1960) using NaOH and sodium
dodecyl sulphate (SDS) to disrupt the cells and phenol to remove
lipid and protein components. The insoluble material remaining
after this was treated again with SDS to remove any residual
soluble material. The resultant material, about 10% of the cell
mass, contained all the constituents of the peptidoglycan
complex. If proteases were used the covalently bound proteins
were removed leaving only the backbone components. The unique
nature of the marine pseudomonad B16 enabled the outer membrane
to be separated from the peptidoglycan by NaCl+SDS+trypsin
(Forsberg et al, 1970).
Peptidoglycan is found in all prokaryotic organisms and can
be regarded as an indicator for this group. There is a
difference in the amount of peptidoglycan contained in the cell
walls of Gram-positive and Gram-negative bacteria. In
Gram-positive bacteria the peptidoglycan layer is 15-50nm thick
while in Gram-negative bacteria the peptidoglycan is almost a
monolayer 3-8nm thick.
The composition of this layer is more uniform in
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Gram-negative bacteria than it is in Gram-positive bacteria with
all Gram-negative bacteria investigated so far having
peptidoglycan composed of a glycan chain with peptide
substituents. The glycan chain, composed of alternating units
of N-acetyl glucosamine and N-acetyl muramic acid, has a peptide
chain attached to it through the 3 carbon of the N-acetyl
muramic acid. This peptide chain contains D and L isomers of
amino acid residues and it is the cross-linking of these chains
which gives the structure its mesh like appearance and rigidity.
This rigidity is necessary for cell shape and also as an
anchoring point for the layers external to it (Ghuysen, 1968).
Outer membrane.
The layer immediately external to the peptidoglycan is the
outer membrane. Studies on this layer have concentrated mainly
on those found within the Enterobacteriaceae especially those of
E.coli and Salmonella typhimurium.
The major difficulty encountered when isolating outer
membrane is the separation of this membrane from the other
layers in the envelope. The method of Osborn et al, 1972 has
already been described in the section dealing with cytoplasmic
membrane.
The finding that Triton X100 solubilizes cytoplasmic membrane
(De Pamphlis and Adler, 1971) was used by Schnaitman to
isolate outer membrane from E.coli (1971). A much more rapid
method was devised by Wolf-Watz et al (1973) working with E.coli
After treatment with lysozyme and EDTA, MgC^ ribonuclease and
deoxyribonuclease are added. Following centrifugation at
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48,0002 the PH lowered to pH5 and agglutination occurs giving
rise to a precipitate which can then be deposited and washed
with distilled water.Poxton and Brown (1979) described a
convenient method for the extraction of outer membrane
components from Bacteriodes fragilis involving the use of lOmM
EDTA and sonication followed by centrifugation of the cells to
leave outer membrane components in the supernate.
The outer membrane is composed of three main constituents;
phospholipid, protein and lipopolysaccharide. These are
arranged as shown in Figure 1. Basically the structure is a
lipid bilayer with proteins embedded in it and these proteins
can be either located in one half of the bilayer or traverse the
whole membrane. The distribution of these components within the
outer membrane is interesting and Nikaido and Nakae (1979)
calculated that the outer surface of the membrane is 59% protein
and 41% LPS while the inner surface has a composition of 53%
phospholipid and 47% protein.
Phospholipids: The phospholipids in the outer membrane of
Enterobacteriaciae are apparently identical to those in the
cytoplasmic membrane and thus contain mostly phosphatidyl
ethanolamine, some phosphatidyl glycerol and very small amounts
of cardiolipin (Osborn et a_l, 1972). This similarity is more
easily understood in the light of findings by Jones and Osborn
(1977) that phospholipids move rapidly between outer and inner
membranes.
Proteins: The proteins of the outer membrane have been the
subject of intense study and a number of reviews are in the
literature (Nikaido and Nakae 1979; DiRienzo et al, 1978; Rogers
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et al, 1981). The investigation of protein components of the
outer membrane was advanced rapidly by the application of sodium
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE)
to the problem of visualising and resolving the proteins. Work
by Ames (1974) and Bragg and Hou (1972) showed that between 30
and 60 protein bands could be identified in the outer membranes
of E.coli and S.typhimurium of which 4 or 5 appeared to be major
components. Although the greater part of the information on
outer membranes has been obtained from these two organisms the
result of investigation into other species such as
Ps.aeruginosa, and N.gonorrhoeaehave shown similarities in that
4-5 major proteins are always present. (Booth and Curtis, 1977,
Heckels, 1977).
The major proteins in the outer membrane of E.coli have been
isolated and studied and will be described briefly.
The matrix proteins have a molecular weight of approximately
36.5K and are thought to be the constituents of "porins"- pores
in the membrane allowing passage of substances from the outside
into the cell (Nakae, 1976). They are also implicated as phage
receptors.
The Tol G protein, 27-48K, is trypsin sensitive and heat
modifiable in that its appearance in SDS-PAGE changes after
heating at 50°C.
The lipoprotein, first described by Braun and Rehn (1969) has
a lower molecular weight than the two previously described
proteins at 7K but it is probably the most abundant protein in
the outer membrane. This protein is thought to anchor the outer
membrane as it is covalently bound to the peptidoglycan.
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Minor proteins, numbering around 10-20, vary in quantity
according to growth conditions and would appear to be involved
with the uptake of nutrients.
Lipopolysaccharide (LPS): The third component of the outer
membrane is LPS. As its descriptive name indicates it is a
complex consisting primarily of polysaccharide with a
significant amount of lipid attached to, or associated with it.
The LPS is a specific component of the outer membrane and
work by Muhlradt and Golecki (1975) has shown that this molecule
is located exclusively on the outer surface of the outer
membrane of S.typhimurium. In the specific case of
S.typhimurium, Smit et al (1975) calculated that there are
approximately 2.5xl06 molecules of LPS per cell and this
occupies about 45% of the outer surface.
The LPS of the Gram-negative bacterium is the endotoxin and
because of interest in the biological effects of this molecule
its chemistry, structure and function have been extensively
researched (Landy and Braun, 1964; Kass and Wolf, 1973; Rowley,
1971; Westphal, 1975; Kabir,1978; Wilkinson, 1977; Orskov et al,
1977; Reaveley and Burge, 1972 and Wright and Kanegasaki, 1971).
The accepted general structure for LPS is that found in the
Enterobacteriaceae and depicted by Luderitz et al (1971).
0 specific side chain - core region - Lipid A.
The molecule is composed of three covalently linked segments
each with its distinctive composition, biosynthesis and
biological function. The side chain is the serologically
25
dominant part of the molecule responsible for its O-antigenic
specificity and consisting of repeating oligosaccharides.
R-form lipopolysaccharides are deficient in the side chain and
are present in rough strains. The core region contains sugars
not found elsewhere in the bacterium including a 3-keto
deoxyoctonic acid and an aldoheptose. The core is linked to
lipid A which also contains distinctive components such as
glucosamine and 3-hydroxy alkanoic acids. In contrast to the
variety that exists in "0" side chain structure within a genus
the core and lipid A are quite conserved (Luderitz et al, 1966).
The entire lipopolysaccharide molecule is thought to have a
molecular weight somewhere between 1x10® and 20x10® (Kabir et
al, 1978) and the reason for the wide ranging limits are two
fold. The first is that lipopolysaccharides are amphipathic
molecules containing both hydrophilic (polysaccharide) regions
and hydrophobic (Lipid A) regions and when suspended in aqueous
solution they tend to form aggregates (micelles), probably due
to hydrophobic forces. The second is that the "0" side chain
oligosaccharide has been shown to be heterogeneous in length in
salmonellae (Nowotny,1966) and E.coli (Morrison and Leive,1975).
The amphipathic nature of the molecule is evident in its
orientation in the membrane with the lipid A intercalating with
the lipid and the "0" antigen chain projecting out of the cell.
As with outer membrane proteins studies on the
Enterobacteriaceae lipopolysaccharides have provided the vast
majority of the published reports.
A number of methods have been used for the extraction of
lipopolysaccharides most of which involve the treatment of the
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bacterial cells with organic reagents such as trichloroacetic
(Boivin and Mesrobeanu, 1933) aqueous pyridine (Goebel et al,
1945) and aqueous ether (Fukushi et al, 1964). However in
addition to the lipopolysaccharide all of these methods also
remove other cell wall components such as phospholipids,
lipoprotein and protein. The most common method used for
preparing lipopolysaccharides is the phenol-water method of
Palmer and Gerlough (1940) which was later modified by Westphal
et al (1952). This procedure involving extraction at
68°C with phenol-water (45:55v/v)gives relatively pure
lipopolysaccharides which can then be centrifuged out of
solution. Galanos et al (1969) modified this procedure still
further to allow the extraction of rough lipopolysaccharide
which, due to their loss of "0" side chains, are less
hydrophilic. This extraction is carried out at room temperature
with a mixture of phenol/chloroform/ether.
A method for isolating lipopolysaccharide which did not use
organic reagent was described by Galanos et a_l (1975) where
electrodialysis produced a soluble form of lipid A.
Figure 2 shows the schematic representaions of various types
of lipopolysaccharide preparations (figure from Bradley, 1979).
Most structural studies on lipopolysaccharides have involved
degradation of LPS by partial acid hydrolysis with 1% acetic
acid (Schmidt et^ al., 1969 ) followed by separation on Sephadex
G50 which in the case of 'smooth' lipopolysaccharide results in
3 distinct fractions: "0" antigen, core and KDO. The
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Figure 2
Schematic representations of various types of
lipopolysaccharide preparations. 0, somatic
antigens; C, heterooligosaccharide core; L, Lipid A;
m, mitogenic peptide; + , metal cations and
polyamines. (taken from Bradley, 1979).
Boivin
0 0 0
Id + Id + Id
0 + □ ♦ □
free Lipid A
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combination of gas chromatography and mass spectrometry allowed
a more detailed examination of composition and structure of the
"0" antigen side chain and it is now known that common hexoses
(L-rhamnose, L-fucose ) and hexosamines, (D-glucosamine,
D-galactosamine), are widely distributed in bacterial
lipopolysaccharides while pentoses (arabinose, ribose, xylose
and uronic acids (glucuronic, galacturonic) are less frequent. A
large number of unusual sugars are detailed by Wilkinson (1977)
and includes such sugars as 3,6-dideoxy D-galactose
(abequose),3,6-dideoxy mannose (tyvelose) and 3,6-dideoxy
L-galactose (colitose) which are present in the LPS of
salmonellae and in some Yersinia species.
In the "0" antigen side chains there is potentially great
variety in the arrangement of the substituent sugars which can
be linear or branched in the structure. This gives
correspondingly great variety in the antigenic nature of the
molecule which is probably an important function of the "0"
antigen side chain. Within a single genus this can give a
remarkable number of different serotypes (Orskov et al, 1977).
The core regions are attached to the repeating
oligosaccharide of the "0" antigen side chain and contain
hexoses (glucose, galactose) , heptose (L-glycero, D-manno
heptose) keto-deoxyoctonic acid and amino sugars such as
N-acetyl glucosamine. Phosphates and phosphatidyl ethanolamine
are also found in the core.
In Salmonella species the core grouping is highly conserved
with only one core composition throughout the genus while in
E.coli and Shigella species a number of different arrangements
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are found (Wilkinson, 1977). The genus Bacteroides differs from
this general structure for Gram-negatives in that they do not
contain heptose or keto-deoxyoctonic acid which are generally
regarded as specific markers for lipopolysaccharide (Wilkinson
1977). Ketodeoxyoctonic acid and heptose have been detected by
Schmerr and Rebers (1979) in P.multocida indicating that the
lipopolysaccharide is probably similar to those in the
Enterobacteriaceae.
Lipid A is connected to the polysaccharide regions by an acid
labile link with keto-deoxyoctonic acid, and can be isolated as
the insoluble product after mild acid hydrolysis with 1% acetic
acid. In salmonellae the back bone of Lipid A is a B 1,6-linked
disaccharide of glucosamine. The bulk of the lipid A structure
is composed of fatty acids which are attached to the glucosamine
via ester and amide linkages . B-hydroxy acids are found in
Lipid A but are not present in other cellular lipids making them
useful markers for this molecule. However, not every
Gram-negative organism contains these acids and Nikaido and
Nakae (1979) indicate that Brucella species are reported not to
have any. Phosphorylation in Lipid A is thought to be
responsible for the aggregation of monomeric units into larger
molecules, 4-5 units in size (Luderitz et al, 1973).
Lipopolysaccharide is a complex molecule having numerous
biological effects most of which can be assigned to the Lipid A
portion. These include pyrogenicity, lethal toxicity, bone
marrow necrosis and leukopoenia. The polysaccharide regions,
especially the "0" antigen side chains help to protect the
bacterium both physically and immunologically. The long chains
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inhibit phagocytosis and act like a picket fence while the vast
number of possible configurations allows the bacterium to avoid
the host immune system.
Capsule
Many Gram-negative bacteria produce an external layer
composed of extracellular polysaccharide. This may take the
form of a discrete capsule or may appear as a loosely attached
slime layer which is easily lost into the culture media. The
removal of capsule, however, usually requires vigorous shaking
or treatment with alkali.
Capsules can be visualised by light microscopy using the thin
indian ink method Duguid (1951) or the congo red, lactophenol
blue method of Maneval (1941). As most capsules are negatively
charged they may be stained with ruthenium red (Howard and
Gourlay,1974) or labelled with cationic ferritin (Weiss et
al, 1979) and examined by electron microscopy.
The composition of exopolysaccharide is usually simpler than
that of lipopolysaccharide with neutral hexoses such as
D-glucose, D-galactose and D-mannose frequently present. Methyl
pentoses (6 deoxy hexoses) such as L-fucose and L-rhamnose and
polyols, (ribitol and glycerol) are also frequently identified.
Uronic acids contribute towards the negative charge often found
in exopolysaccharides.
Pentoses, heptoses and octonic acids are rarely found in
capsules. However, non sugar components are found and
phosphate, acyl groups, pyruvate, formate and succinate have
been described (Sutherland, 1977).
The exopolysaccharides can be divided into two main groups:
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1, homopolysaccharides and 2, heteropolysaccharides
1.Homopolysaccharides are composed of one sugar and are usually
very long chain molecules. Cellulose, levans (fructose
polymer) and glucans (glucose polymer) are examples of this
type. Linkage differences within glucose residues gives rise
to different glucans and l->6, l->3 and Bl->2 linkages are
found. Less frequently encountered is the bacterial cellulose
(B l->4) which is found in Acetobacter xylinum. Levans have
been isolated from Xanthomonas, Aerobacter and Acetobacter
species.
Another type of homopolysaccharide is the sialic acid polymer
(N-acetylneuraminic acid) found in some E. coli strains and
Neisseria meningitidis (references cited in Sutherland, 1977).
2.Heteropolysaccharides are more complex structures composed of
2-4 monosaccharides and frequently containing uronic acid. The
use of paper and gas chromatography was a great advance in the
analyses of these structures. Some Klebsiella capsules are
well defined and components such as pyruvate, glucuronic acid,
rhamnose, fucose, mannose, glucose, galactose and O-acetyl
groups have been found in them. It has also been shown that
different strains in one serotype may have different capsule
structures (references cited in Sutherland, 1977).
Hyaluronic acid, a heteropolymer of N-acetyl glucosamine and
glucuronic acid is a component of both prokaryotic and
eukaryotic cells.
The capsule is very hydrated being only 1-2% polysaccharide
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and probably functions as a moisture and ion trapping layer
around cells as well as an inhibitor of phagocytosis.
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Bacterial cell surface antigens
The envelope is the part of the Gram-negative bacterium which
interacts directly with the host and because of this the
components of the envelope contribute an important antigenic
stimulus to the host. The antigenicity (the reactivity with
antibodies) and the immunogenicity (the capacity to induce the
formation of antibodies in mammals) of the surface components
are subjects of great interest to bacteriologists looking at the
structure and function of the bacterial cell surface as well as
its role in pathogenesis.
A clear indication of the complex antigen mosaic presented by
the Gram-negative bacterium is given by the large number of
precipitin lines present when envelopes are examined by crossed
immunoelectophoresis (CIE). This involves two dimensional
elecrophoresis which separates antigens by their charge in the
first dimension then visualises them by precipitation against
specific antiserum in the second dimension (Weeke, 1973b). When
the envelope of E.coli was examined by this method at least 25
immunoprecipitates were visible in the outer membrane portion
(Smyth et a_l, 1978 ). The LPS and Braun lipoprotein were
identified as the major antigens. More recently Bhasin and
Lapointe-Shaw (1980) have shown that when P.multocida envelopes
are examined in CIE at least 19 antigens can be counted. No
attempt was made to identify individual immunoprecipitates.
In an examination of the outer membrane of N.meningitidis
group B 7 different precipitin lines were observed, among which
the capsular and LPS immunoprecipitates could be distinguished
(Hoff and Frasch, 1979).
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Polysaccharides are antigenic components of the envelope and
the capsular ("K") or LPS ("0" and "R") antigens are the ones
mainly responsible for the immunological individuality of the
Gram-negative bacterium. These two types of antigen can
occur in the same cell and the immunological response can be
governed by the interaction of these two. Good reviews on
polysaccharide antigenicity have been published (Jann and
Westphal, 1975; Jann and Jann, 1977; and Orskov et a_l, 1977).
As many of these components are very antigenic they tend to
be the dominant surface antigen and the large clasification
schemes for Salmonella species and E.coli are based on the
agglutination reactions of the antigens with specifically
absorbed antisera (Kauffman, 1954; Orskov et al, 1977).
The IHA test for serotyping P.haemolytica isolates is thought
to depend on a soluble capsular antigen (Biberstein et al,1960),
and more recently Frank and Wessman (1978) have shown that the
species can also be serotyped by a plate agglutination test
which suggests that the serotyping antigen is a polysaccharide
and present on the surface of the bacterium.
The enzyme - linked immunosorbent assay (ELISA) developed by
Engvall and Perlmann (1972) although primarily for measuring
antibodies has also been used to examine the surface antigens of
Gram-negative bacteria. Poxton (1979) has shown that
Bacteroides species are related through the antigens present in
EDTA extracts of the cell envelopes when these are tested in an
ELISA, and the method has been applied to the detection and
quantitation of the capsular antigen of H.influenzae type b
(Crosson et al, 1978).
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Other serological methods have been employed to analyse the
antigens of bacterial cell surfaces including agar gel
diffusion for P.multocida antigens (Penn and Nagy, 1976), simple
immunoelectroporesis LPS and proteins of Yersinia enterocolitica
(Ogata et a_l, 1972) and radio-immune assay on H.influenzae type
b outer membrane proteins (Hansen et a_l 1981).
The immunogenicity of the cell surface antigens has been
studied most carefully as it is a property which may be
important in conferring protection against infection. Although
bacterial polysaccharides are often very antigenic their
immunogenicity is dependent on such things as molecular weight,
the dose of polysaccharides given and their interaction with the
immunological mechanism of the host (Jann and Jann, 1977).
The type of problem which can be encountered is well
documented for the work carried out on Neisseria meningitidis.
Serogroup specificity of N.meningitidis is dependent on the
capsular polysaccharide antigen. The capsular antigens of
groups A,B and C have been isolated and purified and tested as
vaccines. The antigens for groups A and C have been
used successfully in vaccines but in group B the capsular
polysaccharide is not the antigen important in protection
(Goldschneider et al, 1969). It has since been shown that in
the B group the outer membrane protein of 41,000 molecular
weight is involved in protection (Steele et al, 1977).
The studies on P.haemolytica have yielded conflicting results
as to the important antigens involved in protection. As stated
earlier in this review, Biberstein and Thompson (1965)
concluded that both surface antigens and capsular antigens were
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involved but that the capsular antigen was more important.
Knight et al (1969) subsequently repeated the work but found
that immunity did not correlate with capsular type. Cameron
(1966) reported that both protein and polysaccharide antigens
were implicated in the passive protection of mice against
challenge. More recently both Gilmour et al (1979) and Evans
(1979) have shown that SSE extracts, presumably containing
surface material have been protective in both sheep and mice.
Protein antigens have been shown to protect against E.coli B
infection in mice (Taplits, 1979) and Lam et al (1980) working
on H.influenzae type b demonstrated that even after antisera had
been absorbed with capsular antigen the antisera still passively
protected. This indicated that other antigens were involved.
The proteins which have been described as porins in the outer
membrane have also been used in vaccines. The porins of
Salmonella typhimurium were protective against challenge with
the organism (Kuusi, 1979) and LPS was shown not to be necessary
for protection.
As the potency of an antigen as an immunogen can be lost on
isolation and purification it can prove difficult to assess the
immunogenicity in pure form. An elegant answer to this problem
was provided by Diena et al (1979). An E.coli hybrid expressing
Salmonella typhi somatic antigens 9 and 12 and a derivative
expressing these two plus the capsular antigen Vi were compared
with the parent S.typhi strain against challenge with
S,typhimurium. The hybrid expressing only somatic antigens was
the more effective of the two hybrids but was not as good as the
parent strain. It is interesting that the inclusion of the Vi
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antigen did not improve the protection.
Penn and Nagy (1976) have shown that P.multocida capsular
antigens stimulated mouse-protecting antibodies in cattle. The
difficulties related to immunogenicity were illustrated here as
the polysaccharide did not stimulate antibodies in rabbits but
was effective in cattle.
The foregoing section on immunogenicity serves to emphasize
the complex interaction of bacterial surface antigens and the
host's immune system. It suggests that a simple relationship
between one antigen and protection is an infrequent event and





The serotype strains of P.haemolytica used in this
study were taken from the stock prototype strain collection kept
at the Moredun Research Institute (MRI). .These strains were
stored at -70°C in No.2 nutrient broth (Oxoid
Ltd.,Basingstoke,Hampshire). Strains of serotypes A1,A2,A6,A7
and A9 were all recovered from cases of sheep pneumonia.
Strains of P.haemolytica referred to the MRI for serotyping
but which failed to react in the IHA test were designated
untypable strains.These were subcultured into 50 ml of nutrient
broth and grown for 18 h at 37°C without agitation after which 1
ml aliquots were dispensed into 2 ml vials and stored at -70°C
till required.
Culture conditions: Unless otherwise stated the bacteria were
removed from -70°C storage,thawed and plated out on 7% sheep
blood agar plates which were then incubated at 37°C for
18h.Single colonies were picked from these plates and inoculated
into 50 ml nutrient broths which were incubated at 37°C for
18h.If required this was used as a seed broth for larger
volumes.Large quantities of bacterial cells for extraction were
produced by inoculating 1.5L volumes of nutrient broth with 15ml
of seed broth.These were incubated at 37°C for 6 or 18 h on an
orbital shaker(LH Engineering,Stoke Poges,Bucks.).Bacteria were




Sodium salicylate extract(SSE): Cells of P.haemolytica were
extracted with 1M sodium salicylate.Cells from 31 of nutrient
broth culture incubated at 37°C for 6h on an orbital shaker,were
harvested by centrifugation at 4200£ for 45 min on an MSE
Coolspin centrifuge(MSE,Crawley,Sussex).The cells were
resuspended in 300ml of 1M sodium salicylate, shaken vigorously
for 3h at 37°C and then centrifuged at 20000g for 30 minutes to
remove the cells.The supernate was further clarified by
centrifugation at 40000c[ after which it was concentrated by
ultrafiltration in an Amicon 200ml cell containing an XM 100A
membrane(Amicon,Lexington, USA) under 12 pounds per square inch
(psi) compressed air pressure.The concentration was stopped when
the volume in the cell reached 30 ml.The concentrate was removed
and dialysed against two changes of phosphate buffered
saline(PBS,0.02M sodium phosphate,0.03M sodium chloride,pH 7.6)
and two changes of distilled water.The dialysed extract was
dispensed in 5ml volumes and lyophilsed till required.
Ethylene diamine tetra acetic acid (EDTA) extract: P.haemolytica
cells grown in nutrient broth for 18h at 37° were harvested by
centrifugation at 4200gr for 45 min,washed twice in PBS and then
lyophilised.Five grammes dry weight of cells were then
resuspended in 50ml of lOmM EDTA in buffer and shaken vigorously
at 45°C for 30 minutes.The bacterial cells were then sheared by
passing the suspension twice through a 23 gauge needle.The cells
were removed by centrifugation at 12000£.The supernate was
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dialysed against two changes of distilled water for 24h then
lyophilised.
Saline extract: P haemolytica cells grown on blood agar plates
for 18h at 37°C were harvested by flooding the plate with 5ml of
PBS and gently scraping the surface of the agar with a bent
sealed pasteur pipette.This suspension was washed once in PBS
,resuspended in 5ml PBS and 0.5 ml volumes used to seed 10 six
inch diameter glass petri dishes containing 60ml of 1% galactose
agar.These plates were incubated for 18h at 37°C.The cells were
harvested in 2.5% saline using the method described above.The
suspension was then homogenised on an MSE mixer for 5 minutes at
full speed after which the cells were removed by centrifugation
at 30002 on a bench centrifuge.The supernate was filtered
through a 0.45um Millipore filter(Millipore,London).The
resultant translucent supernate was precipitated with four
volumes of cold acetone (-20° C) and left overnight in the ice
box of the refrigerator.The precipate was washed once in acetone
then lyophilised till required.
Phenol water extract(PWE): The method described by Westphal et
al (1952) was used to extract dried cells of P.haemolytica.Cells
grown in nutrient broth for 18h at 37° C were harvested by
centrifugation at 4200£ for 45 min, washed twice in distilled
water,then lyophilised.Dried cells were resuspended in 50ml of
distilled water and mixed with an equal volume of 90% (w/w)
phenol at 68°C.The mixture was shaken for 10 min at 68°C, cooled
quickly in an ice bath before centrifugation at 8000£ for 20 min
to deposit the cells.The phases of the mixture were separated
after cooling and centrifugation, the upper aqueous layer was
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removed ,without disturbing the interface,and dialysed against
running water for 24h before lyophilisation.SSE's of
P.haemolytica serotypes were further extracted with hot phenol
water by mixing equal volumes of phenol and SSE in aqueous
suspension (2. 5mg ml"-'-) at 68 °C and proceeding in the same manner
as that described for whole cells.
Heated culture extract(HE): P haemolytica cells,grown on 7%
sheep blood agar for 18h at 37°C,were harvested and resuspended
in 1ml of PBS.The suspension was heated at 56°C for
45min,centrifuged at 115002 for 10 min and the supernate stored
at -20°C.
Heat killed organisms(HKO): P haemolytica cells from 1 litre
nutrient broth culture incubated at 37°C fo 18h were harvested
by centrifugation at 4200£,washed once in PBS,and finally
resuspended in 10 ml PBS.A 0.1ml aliquot was removed for viable
counting and the remaining 9.9ml heated at 56°C for lh.Another
0.1ml aliquot was taken to check for sterility before the
suspension was lyophilised.
Sequential saline and phenol-water extraction of cells grown
on galactose agar: P.haemolytica Al cells grown on 3 petri
dishes of 1% galactose agar for 18h were treated as described
by Penn and Nagy (1976) .Cells were harvested in 2.5%
saline,agitated on a wrist action shaker (Stuart
Scientific, Croydon ) for 30min and the cells removed by
centrifugation at 3000£.The supernate was dialysed against
running tap water for 24h before lyophilisation.This was
regarded as the saline(pg)extract.The cells recovered at
centrifugation were extracted with hot phenol-water as described
for PWE.
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Treatment of Al PWE.
1)Sodium periodate (NaI04): PWE (2mg) was resuspended in 2ml of
50mM NaI04 in acetate buffer pH 5.This was left in the dark at
RT for 18h then dialysed against running tap water for 24h.
2)Proteinase K: Proteinase K (Sigma Chemical CoPoole,Dorset)
was added to Al PWE to give a final concentration of lmg ml-"'"
for PWE and lOug ml proteinase K in PBS (pH7.4) .This was
incubated at RT for 24h ,stopped by heating at 70°C for 30min
and then dialysed against running tap water for 24h.
3)Heat: Al PWE at lmg ml-^" was autoclaved at 120°C at 15 psi
for 20 min.The sample was dialysed against running tap water for
24h.
4)Partial hydrolysis: PWE (lOug) was hydrolysed with 1% acetic
acid at 100°C for 90 mins in a sealed test tube and the
resulting precipitate was removed by centrifugation at 50000^
for 10 mins. The supernate was rotary evaporated to dryness and
resuspended in 1ml distilled water. The precipitate (presumed
to be Lipid A) was washed once then freeze dried.
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Sera
Rabbits: New Zealand white rabbits were hyperimmunised with
repeated doses of formalin killed cells of P.haemolytica.
Rabbits were immunised according to the schedule in Table 2.
One week after the final dose the rabbits were bled from
the ear vein and the sera tested by the IHA test.If the titre
was satisfactory/usually >1 in 128 then the rabbit was
exsanguinated by cardiac puncture.If the titre was
unsatisfactory then the rabbit was given a further two 3ml doses
of live organisms i.v..This was always the case with serotype
A2.If this failed to raise the titre of the antiserum then the
attempt to immunise was stopped.
Rabbit IgG was prepared by fractionation on protein
A-Sepharose CL-4B(Pharmacia,(Great Britain)Ltd.,Hounslow
/Middlesex) by the method of Goding (1976) followed by dialysis
against PBS.The IgG was dispensed into 2 ml aliquots and stored
at -20°C.
Sheep.Antisera to serotypes A1,A6 and A7 were obtained from
specific pathogen free (SPF) lambs vaccinated with individual
SSEs(l.lmg ml for Al and A6 and 5. 5mg ml for A7) in
alhydrogel/oil as described by Wells et al (1979).Antisera to
serotypes A2 and A9 were obtained from SPF lambs which had been
vaccinated with A2 or A9 SSE then challenged with the homologous
serotype using the aerosol method described by Gilmour et al
(1979)
Serology
Indirect haemagglutination (IHA) test: For antibodies
against P.haemolytica,serum samples were tested by the method
described by Shreeve et al_ (1972). Antigen was prepared from a
nutrient broth culture of P.haemolytica incubated at
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Table 2 Hyperimmunisation schedule for the production of
hyperimmune antisera against P haemolytica serotypes in rabbits.
Day Dose












37°C for 18h.The culture was heated at 56°C for 45 minutes after
which bovine RBC,fixed in 1% glutaraldehyde(Shirai et
al,1975),were added to a final concentration of 0.5% and
incubated at 37°C for lh.The RBCs were washed three times in
formolised phosphate buffered saline(FBS)(0.3% formalin),and
resuspended at 0.5% in the same solution.Doubling dilutions of
test sera were made in FBS in U bottomed microtitration
plates(Cookes Engineering Company,Alexandria,Virginia,USA).Equal
volumes (0.025ml)of sensitised RBCs were added to each well and
left for 2h at room temperature.The titre of the sera was the
highest dilution at which the RBCs were agglutinated.
For antigen the samples to be tested were diluted in FBS in
ten fold dilutions from 1 in 10 to 1 in 100,000 in 2ml volumes.
Glutaraldehyde fixed RBCs were sensitised by adding 0.2 ml of a
5% washed suspension to the sample.The tubes were incubated at
37°C for 30 min,the cells washed three times in FBS and then
resuspended to their original volume.An homologous rabbit
antiserum at a previously determined optimal dilution,was
dispensed in 0.025ml volumes into the wells of a microtitre
plate .After the addition of 0.025ml of sensitised RBC
suspensions to the appropriate wells the plate was left at RT
for 2h before examination for haemagglutination.Positive and
negative controls were included and the highest dilution of
sample which produced haemagglutination was the IHA titre of the
sample.
Enzyme linked immunosorbent assay (ELISA): The technique was a
modification (Burrells et al,1978) of that described by Engvall
and Perlmann (1972). P.haemolytica antigen in 0.05M
46
carbonate/bicarbonate (CB) buffer pH 9.6,was used to coat the
wells of a polystyrene microtitre plate (type 129A,Dynatech
Laboratories Ltd,Billinghurst,Sussex).Individual wells were
filled with 200ul of antigen solution and the plates were held
at 4°C overnight.Plates were then washed three times with PBS
containing 0.05% Tween 20 (PBS/Tween),shaking out excess fluid
between each wash.Standard and test sera were not pre-treated
prior to testing and dilutions of these in PBS/Tween containing
0.02% sodium azide were added in 200ul volumes to the wells of
antigen coated plates which were incubated at RT for 3h.Serum
dilutions were removed from the wells,the plates washed three
times with PBS/Tween and 200ul of pig anti-sheep IgG conjugated
with alkaline phosphatase diluted in PBS/Tween added to the
wells.After incubation for 3h at RT the plates were emptied and
washed.Enzyme substrate (p-nitro phenyl phosphate,Sigma Chemical
Co. ,Poole,Dorset)at a concentration of lmg ml--'- in 10%
diethanolamine buffer,pH9.8,containing 0.5M magnesium chloride
was added to the plates in 200ul volumes.After lh at RT the
reaction was stopped by the addition of 3M sodium
hydroxide.Results were recorded as optical densities at 405 nm
(A 405)and were determined using a "Titertek multiskan"
multichannel spectrophotometer (Flow Laboratories, Irvine,
Ayrshire).With this test it has been found that A405 readings
below 0.1 are generally unreliable(personal observation)and this
A405 has been arbitrally adopted as the negative baseline for
the ELISAs reported in this thesis.
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Double agar gel diffusion: The technique was essentially that
described by Ouchterlony (1948).Agarose (1%) in 25%
barbital/TRIS/glycine buffer pH 8.8(Weeke,1973a) was poured to a
thickness of 2mm on the required size of glass plate or Gelbond
(FMC Corporation,Marine Colloids Division,Bio-Products,
Rockland,Me,USA).Six 2mm diameter wells were arranged
circumferentially around a central 2mm well at a distance of
10mm.Antigens and antisera were added to the appropriate wells
in 8ul volumes and left at 4° C.The plates were examined at 24h
intervals up to 72h and the precipitin pattern if present was
noted.
Fused rocket Immunoelectrophoresis(FRIE): The method used was
that described by Svendson(1973).Strips of Gelbond,8x4cm,were
covered with a 2mm thickness of 1% agarose in 25% BTG buffer
containing antisera at the required concentration. Wells,2mm,in
diameter were punched in two parallel but offset rows. Antigen
samples were added to the wells and left to diffuse for lh at
RT,before electrophoresing into the antibody containing gel at
20 volts for 18h.The gels were pressed,washed and then stained
with Coomassie blue as described by Weeke (1973a).
Counter current Immunoelectrophoresis(CCIE): Strips of
Gelbond,8x8cm,were covered with a 2mm thickness of 1% agarose in
25% BTG buffer.Wells,2mm in diameter,were punched 5mm apart with
10 mm between parallel rows.Antigen and absorbed antisera were
loaded in 8ul volumes into alternate rows.Electrophoresis was
12v cm--'- with the antiserum row placed nearest to the
anode.After lh the gels were examined and precipitin lines
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noted.If required the gels were pressed,washed and then stained
with Coomassie blue.
Crossed Immunoelectrophoresis(CIE): The procedure was
essentially that described by Weeke (1973b). a)First
dimension.Samples were applied in wells punched in 1% agarose in
25% BTG buffer(four wells on an 80x80x1.5 mm glass plate).Buffer
was used undiluted (ionic strength 0.08) in the electrode
resevoirs but in gels and in sample buffer it was diluted 1 in 4
with distilled water.Electrophoresis was carried out at 12.5v
cm--*- for 45 min. After the first-dimension electrophoresis the
gel was divided into four slabs,each corresponding to one well,
b)Second dimension.Each of the four first-dimension slabs was
then transferred to the edge of a 50x50 mm square of Gelbond
film and the remaining part of the film was filled with 1%
agarose contaning antiserum at a previously determined optimal
dilution for each antiserum.After electrophoresis for 18h at 4v
cm-^ the gel was pressed,washed and stained with Coomassie blue.
The CIE procedure was modified to include an antibody
containing intermediate gel.After the antibody containing gel of
the second dimension had set,a 1cm slice across the
gel,including the join between first and second dimension
gels,was removed.This gap was then filled with 1% agarose,with




Preparative agarose gel electrophoresis:Agarose(1% in 25% BTG
buffer) was poured to a depth of 2 mm on an 80x80x1.5 mm glass
plate.A 1cm slice was removed 1cm from one edge and this space
filled with 1% agarose containing A1 PWE (lmg ml~^).At a
distance of 1cm from this insertion another 1cm slice was
removed and replaced with 1% agarose containing rabbit antiserum
raised against A9 cells.A schematic diagram of the plate
arrangement is shown in Figure 3.The gel was electrophoresed as
for the second dimension of CIE.A strip of dialysis tubing was
placed between the agarose gel and the wick at the anodic end to
prevent the unprecipitated antigen running into the wick.After
eletrophoresis the agarose gel on the anodic side of the
antiserum loaded gel was removed and freeze dried.The freeze
dried material was crushed then washed three times in distilled
water.The supernates from the washings were pooled and this
together with the residual freeze dried agarose were stored at
-20 °C.
Preparation of immunosorbent column: The IgG fraction of a
rabbit antiserum to P.haemolytica A9 was coupled to 10.5ml of
swollen CNBr-activated Sepharose 4B (Pharmacia) by the method
recommended by Pharmacia in "Affinity Chromatography,Principles
and Methods".The immunoabsorbent was packed in a column 10x1cm
and equilibrated with 2-3 volumes of 0.1M phosphate buffer,pH
7.0 containing 0.5M NaCl and 0.5% Tween 80 (starting buffer).Al
PWE (5mg ml-"1-) in starting buffer was applied to the column in a
lml volume and washed with 30ml of starting buffer.Ten 3ml
fractions were collected.The flow was reversed and any bound
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Figure 3
Schematic representation of the agarose gel for
separation of A1 PWE antigens. Ag, A1 PWE antigen;
As, rabbit antiserum to A9 whole cells; B, agarose






material was eluted with carbonate/bicarbonate buffer,pH9.6, in
ethylene glycol (50:50 vol/vol).Ten 3ml fractions were again
collected after which the column was washed with starting buffer
to equilibrate before storage at 4°C.
Paper chromatography: Samples were hydrolysed in 2M HC1 at
100°C for 2h and dried several times
in vacuo over NaOH pellets and phosphorus pentoxide.The
hydrolysates were resuspended in 0.1ml distilled water and
together with standards were added in lOul volumes to the
paper.This was allowed to run overnight in a descending
chromatographic system with butan-l-ol/pyridine/water (6:4:3;by
volume)as solvent on Whatman's No. 1 paper.Reducing sugars were
stained by the alkaline silver nitrate method of Trevelyan et al
(1950)
Column chromatography: Samples were chromatographed on
Sephadex G 50 (Pharmacia,Milton Keynes,Bucks,U.K.) column with
distilled water as the mobile phase.The sample (1ml) was washed
carefully into the top of the column and run through with a flow
rate of 1ml per 5 min.Fractions (1ml) were collected using an
LKB Ultrorac 11 fraction collector (LKB,Bromma,Sweden).
Gas chromatography (GC): For the analysis of sugar
composition,dry hydrolysates of samples were converted to
alditol acetates by a method modified from that of Lindberg et
al (1978).The hydrolysate (l-20mg) was dissolved in 1ml of
distilled water and lOmg sodium borohydride was added.After lh
at 20°C the borohydride was destroyed by the addition of a few
drops of glacial acetic acid.The sample was dried by rotary
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evaporation and borate as methyl borate was removed by three
distillations with methanol.The dry alditols were acetylated in
lml pyridine/acetic anhydride(1:1fv/v)at 100°C for Ih.Excess
reagents were removed by several co-distillations with toluene
in a rotary evaporator and the alditol acetates taken up in
chloroform.Samples were examined on columns of 3% OV 225 on
Gas-chrom Q in a Pye-Unicam model 104 gas chromatograph,with the
temperature controlled between 190° C and 210°C rising by 2°C
min-^" .Alditol acetates of known sugars were run as standards
either separate from or co-injected with the test sample.
Other analytical techniques:Phosphorus was estimated by the
method of Chen et a_l (1956);sugars, as glucose equivalents, by
the method of Dubois et al(1956);protein by the method of
Lowry(1951);heptoses and keto-deoxyoctonic acid (KDO) by the
method of Osborn (1963);fatty acids by the method of Duncombe
(1963); sialic acid by the method of Cassidy et al_ (1966) and
uronic acids by the method of Dische (1947).
Laboratory animal techniques
Mice; Unless otherwise stated,mice used in experiments were
of the C57 black strain,bred at the MRI.The mice were of both
sexes and were 4-6 weeks old at the the start of
experimentation.
Inoculations; 1)Subcutaneous(s.c.) inoculations into mice
were performed without anaesthesia.Mice were injected under the
loose skin of the groin using a 25 gauge needle.When more than
one injection per mouse was required they were given in opposite
sides of the groin. 2)Intraperitoneal(i.p.) injections were
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also given without anaesthesia using a 25 gauge needle.The
injection was into the abdomen,slightly to the left of the
umbilicus.
Determination of for P.haemolytica: The method used was
essentially that used by Evans and Wells(1979a).Bacteria from a
50ml nutrient broth culture,incubated at 37° C for 18h were
harvested by centrifugation at 1000c[ for 15 min in a bench
centrifuge.The bacteria were resuspended in 10ml of PBS ,a
series of ten fold dilutions made and a viable count was
performed by the method of Miles et al(1938).The undiluted
suspensions and required dilutions were incorporated into a 5%
suspension of hog gastric mucin,pH 7.2(ICN Pharmaceuticals
Inc,Plainview,New York,USA.),at a ratio of one part bacterial
suspension to four parts mucin.Groups of 5 mice were inoculated
i.p. with 0.5ml of each dilution and the number of deaths per
group recorded up to 48h after challenge.The Ld^q was
calculated by the method of Reed and Muench(1938).
Mouse model of P.haemolytica infection: The model described
by Evans and Wells(1979a) was adopted.Groups of ten mice were
inoculated i.p. with at least 2 LD^gS of the P.haemolytica
isolate required in hog gastric mucin .After 6h the mice were
killed by cervical dislocation and the livers removed
aseptically.These were then individually macerated with 9ml of
peptone water (Oxoid) in a Colworth stomacher (Seward, London)
Serial ten-fold dilutions in peptone water were plated out for
counting of viable cells by the method of Miles et a_l
(1938).The mean viable count and standard deviation for each
group was calculated and expressed as log^g cfu.
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Vaccines: Aqueous suspensions of the prepared antigens were
either emulsified in equal volumes of complete Freund's
Adjuvant(CFA) or absorbed onto 0.2% alhydrogel (Miles
Laboratories Ltd,Stoke Poges,Slough)Antigen,water and Alhydrogel
(5:2:4) were mixed and allowed to precipitate.This preparation
was then emulsified in an equal volume of Bayol (Esso )
containing 10% Arlacel A (Sigma).
Vaccination and challenge of mice: Ten mice were each given
two doses of 0.1ml of vaccine s.c. with 14 days between the two
inoculations.Fourteen days after the second inoculation these
mice and a group of uninoculated control mice were challenged
i.p. as described in the mouse infection model.After 6h the mice
were killed and viable counts performed on whole liver
suspensions.The counts from vaccinated and control animals were
statistically analysed using the Mann-Whitney Ranking Test
(Snedecor and Cochrane,1967).In early experiments a group of ten
uninoculated control mice were killed immediately after
challenge and the liver counts obtained were used as a base line
count for the challenge.However,as the results of a number of
experiments indicated that this value varied very little from
1x10^ this group was ommitted from later experiments.
Specific pathogen free (SPF) lamb model for P.haemolytica
infection: The method used was that described by Sharp et al
(1978).Four week old SPF lambs were allocated randomly into two
groups of four which were housed in separate isolation
rooms.Nasal swabs taken before challenge did not contain
P.haemolytica.The lambs were infected with 8ml intratracheally
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and 2ml intranasally of a suspension of parainfluenza virus type
3 (PI3) strain 92/425 (10^*^ TCID 50 per 0.2ml).Seven days
later one group of lambs was exposed for 15min to an aerosol
4 -1
which contained 4.6x10 cfu 1 of P.haemolytica isolate UT18(IHA
negative serogroup II).The second group was similarly infected
with an aerosol of isolate UT2 (IHA negative serogroup V) at a
4 -1
concentration of 7.0x10 cfu 1 . The lambs were examined





The identification and isolation of a protective antigen from
P.haemolytica serotype Al.
The antigens responsible for conferring protection against
certain A biotype serotypes of P.haemolytica are known to be
contained in extracts prepared by sodium salicylate treatment of
cells from these serotypes (Gilmour et aJ., 1979 and 1983). These
extracts are presumed to contain surface components and they
include the serotype - specific antigen as sheep vaccinated with
this extract in adjuvant produce high levels of antibody against
the serotype antigen (Wells et al 1979). In addition, Gilmour
et al (1979) have shown that protection is conferred on lambs
vaccinated with SSE from serotypes Al, A2 and A6 when challenged
with Al and A6 but these lambs are susceptible to challenge with
A9, a serotype not included in the vaccine. Thus the immunity
is considered to be serotype-specific.
Identification of the specific antigen or antigens involved
in protection would help in understanding the immunology of the
disease. It should be possible by means of a range of different
purification procedures and with the help of immunochemical
techniques to identify and isolate the relevant antigens.
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SECTION 1.1
The Immunochemical analyses of extracts of P.haemolytica.
A1 cells.
The protein and carbohydrate compositions of SSE and EDTA
extract, saline extract and PWE are shown in Table 1.1. SSE,
EDTA and saline preparations were similar in composition with
their protein to carbohydrate ratio ranging from 5.01 to 9.65
while the ratio for the PWE was substantially different at 0.31.
Crossed Immunoelectrophoresis (CIE). The antigenic profiles
obtained for each preparation run against antiserum to A1 whole
cell raised in rabbits are shown in Figure la-d. SSE (1.1a) gave
one major peak which is almost a double peak with a strong
cathodic line (close to origin) and a tapering anodic line. The
EDTA preparation (1.1b) shows at least three and perhaps four
different antigens: i)A fast running antigen producing a weak
staining precipitin arc, ii)one antigen producing a strong
staining precipitin, iii) one antigen producing a weak staining
double precipitin arc close to the origin. The saline extract
(1.1c) produced one very strongly staining complete precipitin
arc while PWE reaction (l.ld) shows a strongly staining, large
peaked precipitin arc running in front of a very weak staining
double humped arc which is very close to the origin. The
profiles obtained when PWE antigen was run in tandem with the
other preparations are shown in Fig. 1.2. When run with SSE
(1.2a) the single peak of the SSE fused with the fast running
strongly staining precipitate of PWE, demonstrating that both
antigens are identical. Slow moving antigen of PWE was
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unaffected. The profile obtained with EDTA, extract and PWE,
with the latter in the leading well in the tandem, is shown in
Fig. 1.2b. The fusion of the two heavy staining peaks indicated
their identity but the fast moving antigen of EDTA i, is
unaffected. The EDTA iii antigen is identifiable by its
double-humped precipitation but the slow moving precipitin arc
of the PWE has disappeared. It is possible that these two
antigens have fused resulting in one double humped precipitin
arc. The tandem run of PWE with the saline extract is shown in
Figure 1.2c. The main precipitin arcs of both preparations
fused to confirm identity while the minor slow moving precipitin
arc of PWE is seen directly below the saline precipitin arc.
The PWE antigen was also run in gels containing an
intermediate gel loaded with antiserum against individual
heterologous serotypes.
The results of the gels run with antiserum to A2, A6, A7 and
A9 respectively are shown in Fig 1.3. The control gel did not
have antiserum in the intermediate gel and the PWE antigen ran
through this to precipitate in the main gel which contained
homologous antiserum to A1 (Figure 1.3a). When the intermediate
gel did contain antiserum to individual heterologous serotypes
then the slow moving antigen close to the origin precipitated in
the intermediate gel. The faster moving heavy staining peak was
unimpared and precipitated in the main gel.
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TABLE 1.1
The protein and carbohydrate composition of extracts of
P.haemolytica Al. (expressed as a percentage of total dry
weight)
PREPARATION PROTEIN CARBOHYDRATE PROTEIN/CARBOHYDRATE
RATIO
SSE 57.9 6.0 9.65
EDTA extract 36.1 7.2 5.01
saline extract 45.8 6.1 7.51
PWE 6.3 20.1 0.31
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Figure 1.1
Crossed Immunoelectrophoresis of a)Al SSE (40ug) b)Al
EDTA extract (40ug) c)Al saline extract (40ug) and
d)Al PWE (lOug) run against rabbit antiserum to A1
whole cells. The origins for these and all





Crossed Immunoelectrophoresis of Al PWE (lOug) when
run in tandem with a)Al SSE (40ug), b)Al EDTA (40ug)
and c)Al saline extract (40ug), against 130ul of




Crossed Immunoelectrophoresis of Al PWE (lOug) run
against lOOul of rabbit antiserum to Al whole cells
with the incorporation of an intermediate gel
containing a)no antiserum or 30ul of rabbit antiserum




The immunogenicity of extracts of P.haemolytica A1 cells
The immunogenicity of A1SSE in mice has been described by
Evans and Wells (1979) and this model offers a means of
assessing the protective capacity of the preparations.
Mice, vaccinated with A1SSE, EDTA extract, saline extract, PWE
and heat killed organisms (HKO) all at a concentration of 0.58
ug ml-^ dry weight were challenged with P. haemolytica Al as
described in Materials and Methods.
The results are summarised in Table 1.2. All mice vaccinated
with extracts or HKO had significantly lower liver counts than
did the unvaccinated control group. Only in the control group
did the bacteria multiply as shown by increased numbers of cfu
after 6h compared to these obtained immediately after challenge.
(4.6 to 6.1 (Log^g values)). There is some indication that the
degree of protection conferred by the different preparations,
although not significant, is not the same, as the mean liver
counts vary from 3.1±0.8 for the saline extract to 3.96±1.2 for
PWE.
The results from section 1.1 indicated that a
serotype-specific antigen was present in all the preparations
and that PWE was apparently the simplest chemically and
antigenically. This experiment showed that PWE can confer
protection in mice and therefore that the protective antigen is
present in this extract. Analysis of this extract would seem to




Colony forming units of P.haemolytica A1 in the liver of control
mice and mice vaccinated with P.haemolytica Al antigens after
challenge.
VACCINE CHALLENGE DOSE1 COUNT1 IN LIVER AFTER P2
Oh 6h
SSE 6.32 4.6±0 . 5 3.50±1.0 <0.001
EDTA extract 6.32 4 . 6 ± 0 . 5 3.30±1. 0 <0.001
Saline extract 6.32 4.6+0.5 3.10 ±0 . 8 <0.001
PWE 6.32 4.6±0 . 5 3.96+1.2 <0.001
HKO 6.32 4.6+0.5 3.60±0 . 6 <0.001
Control 6.32 4.6±0 . 5 6.10±0.3
1. Count expressed as Log ■j^Q values




The effect on the antigenicity of A1 PWE when treated
with sodium periodate, proteinase K or heat.
The antigen which confers protection on mice against challenge
with P.haemolytica Al is present in PWE and this extract has
been shown to contain protein and carbohydrate in the ratio 0.31
to 1. Treatment of PWE with reagents to destroy either the
protein or carbohydrate components and the challenge of mice
vaccinated with these treated PWE's might indicate which
component is important in stimulating immunity.
Al PWE was prepared and aliquots treated with sodium
periodate, proteinase K or heated at 115°C for 15 minutes as
described in Materials and Methods. Untreated PWE and PWE
treated as described above were incorporated into vaccines with
FCA to a final concentration of 375ug ml-"'" of vaccine. The
vaccination and challenge of mice has already been described.
The antigenicity of PWE before and after treatment as measured
by the IHA test is shown in Table 1.3. Only treatment with
periodate removed the IHA titre. The other treatments had no
effect.
The gel patterns obtained when the four samples were run in
CIE against homologous antiserum are shown in figure 1.4 (a-d).
The samples were run through an intermediate gel containing
antiserum against A9 whole cells (Fig 1.4 e-h). The patterns
are approximately similar for all four samples with a strong
cathodic line and an anodic line fading and tapering. However,
the periodate treated sample is different from the other three
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when run through the heterologous antiserum as the
cross-reacting antigen is not present (Fig 1.4g).
The effectiveness of the samples in stimulating protection was
determined in the mouse model . The results are shown in Table
1.4.
The periodate treated PWE did not give protection while the
other three preparations did. The order of protective efficacy,
as indicated by the Mann-Whitney Ranking Test was untreated PWE
> proteinase K treated PWE > heat treated PWE.
It can be concluded from this experiment that the IHA antigen
and the protective antigen are periodate sensitive and therefore
a carbohydrate component of PWE is an important antigen in the
protection of mice against challenge with P.haemolytica.
67
Table 1.3
IHA titre of Al PWE before and after treatment with sodium







Colony forming units of P.haemolytica in the livers of mice
vaccinated with Al PWE treated with proteinase K, sodium
periodate or heat after challenge with P.haemolytica Al.
VACCINE TREATMENT LIVER COUNT 6h p. i . (Log-j^Qcf u ) P1
PWE None 2.76+0.2 .001
PWE Proteinase K 3.19±1.0 .005
PWE Sodium periodate 3 . 59±1.1 NS
PWE Heat 3 . 54±1. 4 .001
None - 4.50±1.3
1. P= significance when compared with the control group count in




Crossed Immunoelectrophoresis of Al PWE preparations
(lOug) run against 130ul of rabbit raised against Al
whole cells; a)untreated; b)proteinase K treated;
c)sodium periodate treated and d)heat (115°C)
treated. The same samples were also run with an
intermediate gel containing 30ul rabbit antiserum to
A9 whole cells; e)untreated; f)proteinase K treated;




SSE of P.haemolytica Al has been shown by Gilmour et al (1979,
1983) to protect against challenge with P.haemolytica Al in
sheep but no work has been carried out on the antigens
responsible for this protection. The results of this
preliminary investigation into the antigenicity of P.haemolytica
Al showed that the SSE, EDTA saline extracts and PWE contained a
serotype-specific antigen.
Crossed Immunoelectrophoresis examinations of the structure
and antigenic composition of other bacteria such as E.coli
(Smyth et al, 1978), P.multocida (Bhasin and Lapointe-Shaw,
1980) N.meningitidis (Hoff and Frasch, 1979) and Bacteroides
vulgatus (Poxton and Ip, 1981) have indicated the usefulness of
CIE in identifying and characterising antigens. However, it has
highlighted the antigenic complexity of the bacterial cell. The
results of the CIE on extracts of P.haemolytica cells show the
presence of a distinct serotype antigen in all preparations.
The lack of reaction with heterologous antisera is strong
evidence that this antigen is the serotype antigen. The number
of different antigens present in the extracts was low compared
to that reported for E,coli (Smyth et al, 1978) in which at
least 25 immunoprecipitates were observed in outer membrane
preparations and for the related organism, P.multocida in which
19 envelope antigens were observed (Bhasin and Lapointe-Shaw,
1980). The paucity of reactions with P.haemolytica extracts may
be due to the immunodominance of the serotype antigen which is
obscuring the reactions of weaker antigens.
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A reason for this observation may lie in the few passages that
this strain has been subjected to in the laboratory from the
time it was isolated from a field case of pneumonic
pasteurellosis. Poxton (personal communication) has found that
fresh clinical isolates of Gram-positive bacteria have a simpler
antigenic profile than the same organisms after subsequent
laboratory passage. Costerton et al (1981) has suggested that
this may occur because the glycocalyx (a polysaccharide layer
external to the LPS) present in vivo is lost on passage in vitro
as the media would preferentially allow the growth of mutants
not producing an energy demanding glycocalyx. Another
explanation of this may be that the sodium salicylate denatures
the other antigens. However, very little is known of the action
of sodium salicylate on the bacterial cells and the only other
bacterial cells treated with this salt were those of Yersinia
(Pasteurella) pestis (Amies, 1952). Amies suggested that it
acted to disrupt the outer layers.
The result of section 1.2 showed that the antigen (or
antigens) responsible for mouse protection are present in all
the extracts. PWE was shown to be predominantly polysaccharide
in nature compared to the protein-rich composition of EDTA, SSE
and saline preparations and the importance of polysaccharide
antigen was demonstrated by the abrogation of protective
immunity after treatment of PWE with sodium periodate. This
finding together with the coincidental loss of IHA activity of
the sample indicated that the antigens responsible for
protection and serotype specificites are related and may be
identical.
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It is interesting that PWE was probably the least effective
immunogen but a possible explanation of this may lie in its
predominantly polysaccharide composition. Karch and Nixdorff
(1981) have shown that antibody-producing cells of mice gave an
increased response to the LPS of Proteus mirabilis when it was
combined with an outer membrane compared to that of LPS alone. A
similar finding was reported for E.coli by Ahlstedt and
Lindholm (1977) who found that a small molecular weight protein
was associated with the immune response to LPS. Removal of the
protein reduced the response to the LPS antigen while
coinjection of LPS with the protein, either linked or separate,
restored the level of the response. It may be that the LPS of
P.haemolytica also requires some close association with proteins
to enhance its protective immunogenicity. The protein could be
acting as an antigenic carrier and the response to the LPS
connected with a response of T-helper cells to the protein. When
T-cells recognise and respond to the carrier determinants they
help B-lymphocytes specific for the hapten (LPS), to develop
into antibody forming cells (Roitt, 1980).
The results of previous studies present conflicting evidence
as to the antigens important in protection. Biberstein and
Thompson (1965) found that in mice vaccinated with whole cells,
the serotype antigen was the major influence on protection with
so-called somatic antigens playing a lesser role. However,
Knight et a_l (1969), also working with mice presented
contradictory results indicating that strains unrelated in IHA
serotype or somatic antigenicity cross protected. More recently
Tadayon and Lauerman (1981) have reported that an extract of
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P.haemolytica, prepared by treatment of the cells with
potassium thiocyanate (KSCN) was effective in protecting mice
and hamsters against homologous challenge whereas an LPS
preparation did not. However, neither the serotype used nor the
challenge method was detailed so it is difficult to gauge the
significance of their findings.
Phenol-water treatment is generally regarded as a method for
extracting LPS from Gram-negative bacteria and it is therefore
likely that it has the same effect on P.haemolytica. Two
distinct antigens are present in PWE when visualised in CIE, one
a serotype-specific antigen producing a strong precipitin arc
the other producing a weak precipitin line in the form of a
double humped peak close to the origin, was common to all
serotypes tested. The main antigen seems to comprise two
closely spaced lines, which is similar to the pattern obtained
for N.meningitidis LPS by Hoff and Frasch (1979) who suggested
that microheterogeneities in the molecule might be responsible.
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SECTION 2.
The characterisation of the protective antigen of P.haemolytica
Al.
Components of both a phenol-water or sodium salicylate
extract of cells of P.haemolytica have been shown to protect
against challenge with the homologous serotype (Section 1.2).
The hot phenol water extraction procedure used to produce the
PWE is generally recognised as a preparative procedure for
Gram-negative LPS (Westphal et al, 1952) and as the results of
Section 1 implied that a polysaccharide antigen was important in
protection, then the LPS is possibly the protective antigen.
A combination of chromatographical and traditional chemical
analytical techniques should help to elucidate the composition
of the P.haemolytica Al polysaccharide antigen.
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SECTION 2.1
The analyses of the polysaccharide antigens of P.haemolytica
Al.
Lipopolysaccharide preparations of many Gram-negative bacteria
can be hydrolysed with 1% acetic acid to break the link between
lipid A and the core polysaccharide/ antigenic "0" chain and the
components can be isolated by centrifugation and chromatography
(Schmidt et al, 1969; Fensom and Meadow, 1970). The "0" antigen
obtained by this method can then be fractionated and analysed.
This section describes the the isolation, fractionation and
analyses of the presumptive polysaccharide of P.haemolytica Al
PWE. PWE (10 mg), hydrolysed with 1% acetic acid as described
in Materials and Methods, and untreated PWE were chromatographed
on a Sephadex G50 column. The fractions were analysed for
phosphate, protein and sugar content. They were also tested for
antigenicity by fused-rocket immunoelectrophoresis (FRIE). The
sandwich enzyme-linked immunosorbent assay (ELISA) described in
Section 3 was also used to measure antigenicity in column
fractions. Sheep antiserum raised against Al SSE was used at a
dilution of 1 in 500 as the detecting antiserum. PWE was
analysed for heptose, KDO, uronic acids, fatty acids and
N-acetyl neuraminic acid by the methods given in Materials and
Methods.
Yield of PWE: From 2.8g dry weight of cells, 44mg of extract
were obtained (i.e. 1.6%).
Chemical analysis: The total sugar, phosphate, heptose,
protein, KDO and fatty acid content of PWE is shown in Table
2.1. No uronic acids or N-acetyl neuraminic acid were detected.
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Paper chromatography: The PWE showed spots corresponding to
standards of glucose, galactose, glucosamine, galactosomine and
ribose. There were no spots corresponding to glucuronic acid,
mannose, fucose, rhamnose or xylose.
Column chromatography: The elution patterns obtained when
samples of untreated or partially hydrolysed PWE were
chromatographed on Sephadex G-50 and the fractions were assayed
for total reducing sugar and free or total phosphate are shown
in Figure 2.1. When assayed for reducing sugar untreated PWE
was shown to elute from the column in fraction numbers (FN)
15-29 while partially hydrolysed PWE eluted at three distinct
peaks; i)FN 15-23 ii)31-40 and iii)41-45. The second peak (ii>
contained most material. The profile of phosphate elution for
partially hydrolysed PWE is approximately similar to that
obtained for reducing sugars and shows three peaks; 1)FN 17-25
2)29-35 3)41-45.
The sephadex G50 fractions obtained for untreated and
partially hydrolysed PWE were run in FRIE. The antigen antibody
reactions obtained are shown in Figure 2.2. The early
fractions, FN17-29, recovered from the separation of untreated
PWE had antigenic activity (Fig 2.2a and b) and these correspond
to the fractions showing measurable sugar content as
demonstrated in Figure 2.1. The early fractions of partially
hydrolysed PWE, FN 16,17 had slight antigenic activity (Fig 2.2c
and d) which correspond to the first eluted peaks seen for
partially hydrolysed PWE in Fig 2.1. However, the rockets as
shown in Figure 2.2c are very weakly stained when compared to
the reference sample at the left side of the gel. Only a small
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proportion of the total sugar content of partially hydrolysed
PWE is found in these early fractions. The greater proportion
is found in the later fractions which do not show any antigenic
activity. As partial acid hydrolysis may have affected the
precipitating properties of the antigen a "sandwich" ELISA was
also used to measure the antigenic content of the sample. The
results are summarised in Table 2.2. Only two pools, FNll-16
and 17-23 showed high antigenicity.
The results of reducing sugar assay, FRIE and ELISA for
untreated PWE and partially hydrolysed PWE are summarised in
Table 2.3.
Gas chromatography analysis: The following samples were
examined: untreated PWE, partially hydrolysed PWE, Lipid A and
pooled fractions from the major peak ii, obtained in the G50
separation of partially hydrolysed PWE. Traces showing the
profiles of alditol acetate derivations of hydrolysed samples
are reproduced in Figure 2.3. The sugars identified in each
sample and their molar ratios are tabulated in Table 2.4. The
two peaks falling between the hexose and amino sugar derivatives
were provisionally identified as heptose derivatives. A sample
from each of the two peaks was collected by Dr. D.L. Mould at
Moredun Research Institute and was subjected to analysis by mass
spectrometry (MS) at the Rowett Research Institute by Dr. J.A.
Lomax. Both were identified as heptitol heptaacetates. PWE,
and Lipid A contain exactly the same components but with some
qualitative differences. Partially hydrolysed PWE and the major
product of partial acid hydrolysis, peak ii, contained glucose,
mannose, galactose and two heptoses.
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From these results it can be proposed that the phenol water
extract of P.haemolytica Al is composed mainly of
carbohydrate, a small proportion of lipid and an even smaller
proportion of protein. The PWE is sensitive to acid hydrolysis
and loses antigenicity after treatment. Two distinct peaks on
G.C. analysis proved to be heptoses.
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Table 2.1










The reducing sugar and phosphorus content (A490 and
A820 respectively) of fractions obtained after
separation of untreated Al PWE and partially
hydrolysed Al PWE on a Sephadex G50 column.
•—• = Untreated PWE




Fused rocket Immunoelectrophoresis of Sephadex G50
column fractions of a)untreated PWE, fractions 13-29;
b)untreated PWE, fractions 31-39, c)partially
hydrolysed PWE, fractions 11-28, d)partially
hydrolysed PWE, fractions 29-49, when run in 1%
agrose containing rabbit antiserum to Al whole cells.





The antigenicity in sandwich ELISA of Sephadex G50 column
fractions (A405 values given).
ABSORBANCE READINGS (A405) AT THE FOLLOWING
FRACTION POOL DILUTIONS OF ANTIGENS
10 100 1000
I-10 0 0 0
II- 16 0.9 0.56 0.1
17- 23 0.4 0.1 0.1
24- 35 0 0.12 0.08
36- 60 0 0 0
Untreated PWE 2.4 1.8 0.98
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Table 2.3
Summary of results of analyses on Sephadex G50 column fractions































ND = Not done.
+ = present
- = not present
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Figure 2.3
GC of alditol acetate derivatives of acid
hydrolysates ( 2M HC3.,, 100 °C 2h) of
P.haemolytica Al PWE preparations on columns of OV225
for detection of sugars. GC conditions: N2 20ml min
H220ml min ^ and air 525ml min temperature
programmed between 190°C and 210°C at 2°C
min ^.
a)untreated PWE; b)partially hydrolysed PWE c)pooled
fractions of peak II; d)Lipid A. The sugars present
are identified as follows: 1, mannose; 2, galactose;





The presence and molar ratios (sugar/glucose) of sugars in A1
PWE samples as detected gas chromatography. The sugars are
identified as follows: 1, mannose; 2, galactose; 3, glucose; 4,
heptose 1; 5, heptose 2; 6, glucosamine; 7, galactosamine.
SAMPLE SUGAR
1 2 3 4 5 6 7
PWE 0.08 0.83 1.0 0.83 1.3 0.6 0.83
Lipid A 0.04 0.8 1.0 0.7 0.6 0.2 0.23
Partially hydrolysed 0.08 1.0 1.0 0.7 0.8 0 0
PWE
Peak ii 0.06 0.6 1.0 0.7 0.73 0 0
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SECTION 2.2
The further characterisation of the PWE antigens of
P.haemolytica Al.
The results in section 1.1 have demonstrated that more than
one antigen existed within the PWE antigenic complex, as
measured with CIE. These antigens are carbohydrate in nature
and the evidence suggests a lipopolysaccharide composition.
However, it has been reported that capsules are present on
P.haemolytica (Biberstein and Thompson, 1965) and it may be that
one or more of the antigens present in the PWE are capsular in
nature.
Three different approaches were taken in attempting to
identify the antigens; differential isolation of the antigens
from the PWE by i)affinity chromatography, ii)elecrophoresis and
iii)the removal of surface material likely to be capsular in
nature before the cells were extracted with phenol water.
The methods have been described fully in Materials and
Methods.
i)Affinity chromatography; The gels obtained when fractions
of PWE from a CNBR sepharose 4B column with rabbit antisera to
A9 bound to it were tested in FRIE against antiserum to Al are
shown in Figure 2.4. The eluted fractions (Fig 2.4a) still
contained two antigens indicating that the cross-reacting
antigen had not been removed. The desorbed fractions (Fig 2.4b)
contained less antigen than the eluted fractions but again two
antigens are clearly seen, especially in fraction 5. This
suggested that the column was binding two antigens and not just
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the cross-reacting antigen. The antigenicity of the fractions
was assayed by the ELISA and the results are shown in Figure
2.5. The high A405 values shown by eluted fractions 2-4 against
antiserum to P.haemolytica A9 indicates that the eluant still
contained cross-reacting antigen.
ii)Electrophoretic separation: The supernate obtained after
washing of the agarose gel and the residual agarose were run in
rocket electrophoresis (Fig 2.6). A single antigen was
precipitated from both samples when run against homologous
rabbit antiserum whereas the reference preparation, PWE (5ug
rnl-^") showed that at least two distinct lines (Fig 2.6a). When
the same samples were run in a gel containing an intermediate
gel loaded with rabbit antiserum to A9 cells the supernate and
agarose preparations showed only one antigen which precipitated
in the main gel but the weaker staining antigen of the reference
sample was precipitated in the intermediate gel indicating its
cross-reactivity. The supernate and PWE were also tested in
ELISA and the results are shown in Table 2.5. The absence of
reactivity between the supernate and the antiserum to A9 (A405 <
0.1) compared to the reaction between A1 PWE and the same
antiserum (A405=l.1)confirms the purity of this antigen.
iii)Sequential treatment of Al cells: Saline extracts and
subsequent PWE of the same cells were tested in CIE as shown in
Figure 2.7. In both preparations two antigens were present,one
of which, the precipitin line nearest to the origin, was
precipitated in the intermediate gel containing antiserum to A9.
The antigenicity of both samples was also tested in ELISA (Fig
2.8). Both preparations had high antigenicity when reacted with
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antiserum against A1 SSE with the PWE being more antigenic.
When the same preparations were reacted with antiserum to A9 the
A405 values were substantially lower but again the antigenicity
of PWE was greater. However there does not seem to be any
convincing evidence that pre-treatment of P.haemolytica A1 cells




Fused rocket Immunoelectrophoresis of fractions
obtained after affinity chromatography of Al PWE on
immunosorbent column containing rabbit antibody to
A9. a)eluted fractions 11-10; b)desorbed
fractionsl-10. Al PWE (lOug) was included in each run




ELISA reactions of eluted ( O O ) and desorbed
( • • ) fractions obtained after affinity
chromatography of A1 PWE on an immunosorbent column
containing rabbit antibody to serotype A9 whole cells
when tested against a)sheep antiserum to Al whole






Fused rocket Immunoelectrophoresis of supernate (1)
residual agarose (2 ) and Al PWE ( 5mg rnl-^") ( 3) when
run against a)rabbit antiserum to Al whole cells and
b)rabbit antiserum to Al whole cells with an






Absorbance readings (A405) obtained from antigen isolated by
electrophoresis from A1 PWE when assayed in a sandwich ELISA
(For method see Materials and Methods).
SAMPLE ANTISERUM (A405) READING AT THE FOLLOWING
DILUTIONS OF ANTIGEN
10 50 100 200 1000
Supernate Anti Al 0.934 0.761 0.278 0.155 -
Supernate Anti A9 0.09 0.08 0.06 0.07 -
Al PWE Anti Al - - - - 2.5
Anti A9 - - - - 1.1
- = not done
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Figure 2.7
Crossed Immunoelectrophoresis of a)PWE extract and
b)PWE from A1 cells run against 130ul of rabbit
antiserum to Al whole cells. The samples were also
f
> run against an intermediate gel incorporating 30ul of




Titration of PWE and saline extract from galactose
agar grown cells of P.haemolytica Al by ELISA. These
antigens were reacted with a)sheep antiserum to
serotype Al and b)sheep antiserum to serotype A9.































The PWE of P.haemolytica A1 is predominantly carbohydrate in
composition with protein, fatty acids and phosphate associated
with it. The presence of heptose and KDO is good evidence for
assuming that lipopolysaccharide is present as these two
molecules are regarded as markers for this important component
of the outer membranes of the Gram-negative bacteria. The
proportion of sugar in PWE is similar to the proportion of sugar
in the LPS of other Gram-negative bacteria such as Vibrio
cholerae (Raziuddin, 1980) and Yersinia pseudotuberculosis
(Brubaker et al, 1973). However the amount of sugar present in
the LPS can vary substantially especially if rough mutants are
present (Poxton and Sutherland, 1976).
The molar ratios of the heptose and total sugars, (1:2.2,
moles heptose/moles total sugar) as determined by GC, show that
the heptoses constitute a major portion of the extract. The
heptose/total sugar ratios in the LPS of some other
Gram-negative bacteria are 1:2.4 for Yersinia pseudotuberculosis
(Brubaker et al, 1973), 1:5 for Vibrio cholerae (Raziuddin,
1980) and 1:7.7 for Klebsiella pneumoniae (aerogenes) (Poxton
and Sutherland, 1976).
As the proportion of heptose in Al PWE is almost in this range
it suggests that all the other sugars can be accounted for as
part of the LPS making the presence of capsular polysaccharide
unlikely. No pentoses, dideoxy sugars or uronic acids seem to
form part of the PWE. However, the results also indicate that
about 50% of the PWE could not be accounted for and it is
possible that capsular components could be in this.
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Partial acid hydrolysis of LPS from Gram-negative bacteria
such as E.coli (Schmidt et al, 1969) Klebsiella pneumoniae
(aerogenes) (Poxton and Sutherland, 1976), Vibrio cholerae
(Raziuddin, 1980) and Pseudomonas aeruginosa (Fensom and
Meadow , 1970) gave rise to fractions containing degraded
polysaccharide (water soluble), lipid A (chloroform soluble) and
interfacial material. When the degraded polysaccharide material
is chromotographed on a Sephadex G50 column two main peaks are
usually observed. The first peak, eluting just after the void
volume, contains the "0" antigen chain while the second peak
which is held back in the column corresponds with the core
polysaccharide. The results obtained with the PWE of
P.haemolytica Al did not follow this pattern. Only one major
peak was obtained after hydrolysis and the elution time
correlated with the core containing peak. The lack of
antigenicity in any of the fractions indicates that antigenicity
is destroyed by the treatment and this finding is associated
with the loss of amino sugars after partial acid hydrolysis.
This suggests that the LPS of P.haemolytica is a rough type
containing a core polysaccharide and perhaps a short "0" antigen
chain. This chain probably contains the two amino sugars and is
completely degraded after partial acid hydrolysis.
An interesting feature of PWE composition, as determined by
GC, was the presence of two distinct heptoses which are clearly
separated on the GC column but are indistiguishable when
analysed by mass spectrometry. These two heptoses cannot be
alpha and beta forms as these would run identically in the
column and therefore must be distinct heptoses. However,
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attempts to identify them by coinjection with known heptose
standards have proved unsuccessful. The genus Pasteurella is
closely related to the genus Yersinia and in this genus unusual
heptoses have been identified (Wilkinson,1977, Brubaker et al,
1973). It is possible that these two heptoses are
characteristic of P.haemolytica as they are also present in A2
and A6 PWE (see section 4).
Reports by Sjewczyk and Taylor (1980) and Jann and Jann (1983)
have indicated that the surface structures of S.typhi and E.coli
respectively, are more complex than were first thought. It is
now thought that individual components, such as KDO, previously
thought to be mainly of LPS origin can belong to more than one
type of molecule, either another LPS or a capsular polymer. If
this type of diversity occurs widely throughout other bacterial
genera then the difficulties facing any investigator are
considerably increased. It may be that the explanation for the
two distinct heptoses resides in the fact that there is a
multiplicity of different polysaccharide molecules on the
surface of P.haemolytica.
The question of purity is an important one and CIE analyses of
Al PWE shows that at least two antigens are present. The
possibility that one of these is a loosely bound capsular
polysaccharide is not substantiated by the finding that
extraction with saline removes approximately the same
proportions of the two antigens as does subsequent treatment
with hot phenol-water.
Gentry et al (1982) reported that the capsule of P.haemolytica
could be easily removed by phosphate buffered saline at 41°C.
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However this capsular material contained protein and
carbohydrate in a 5:4 ratio. If it is capsular material then it
may be a glycoprotein similar to that described for
Campylobacter fetus by Winter et al (1978).
Separation of the two antigens by immunological methods proved
unsuccessful. Although the cross-reacting antigen could be
clearly shown to precipitate with rabbit antiserum to A9 in an
agarose gel it proved impossible to bind it successfully to
antiserum or IgG bound to CNBr Sepharose 4B in an immunosorbent
affinity column. This may have been due to the mixture of
antigens in the solution or to leakage of the IgG from the
column. Schurig et a_l (1978 ) found that in a study of Brucella
abortus only two out of six identified antigens could be
isolated by affinity chromatography and these two were protein
antigens.
The attempt to isolate the antigens by selective precipitation
of the cross-reacting antigen in agarose gel loaded with
heterologous antiserum was more successful in that the
cross-reacting antigen was stopped in the intermediate gel and
purified serotype specific antigen could be collected. However,
insufficient amounts of the antigen could be collected to allow
successful GC analyses of the antigen. It would have been
useful to have been able to identify the components of this
antigen and use this information to postulate the possible
origin of the antigen in the outer membrane. Winter et al
(1978) described a microcapsule in Campylobacter fetus which is
a glycoprotein complexed with LPS. This is not removed with
saline but they postulate a requirement for cations, as EDTA
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removes microcapsule from the LPS. A similar arrangement could
be present on the surface of P.haemolytica Al.
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SECTION 3
The development and application of a serotype specific
enzyme-linked immunosorbent assay (ELISA) for the detection of
P.haemolytica antigens and antibodies.
Antibodies to P.haemolytica serotypes can be assayed by the
IHA test (Biberstein et al, 1960) and also by the ELISA method
described by Burrells et a_l (1978). The latter ELISA used SSE
as the antigen and was shown to be more sensitive than the IHA
test. However, the ELISA was not specific, in that it detected
antibody to heterologous serotypes and Evans (1979) found a high
degree of cross-reacting antibody in sera from rabbits and mice
immunised with single serotype SSE vaccines. The demonstration
that serotype-specific antigen can be purified by phenol-water
extraction of SSE (Section 1) suggested that the use of this
antigen in ELISA might improve the specificity of the test and




The demonstration of the type-specific antigenicity of
P.haemolytica Al PWE in the indirect enzyme linked immunosorbent
assay.
Inhibition of specific immune reactions has been shown to be
an effective indicator of the inhibitor's participation as an
antigen in the reaction. This has been described for E.coli "0"
antigen-typing schemes (Orskov et al, 1977) where absorption of
sera with different antigenic types allows the production of
monospecific sera which can then be used to identify that
antigenic determinant on strains of unknown antigenic status.
As Al PWE has been shown to contain the serotype antigen by
IHA and CIE (Section 1) it might therefore be worth testing it
as a more specific antigen in an ELISA system.
The ELISA method described by Burrells et al (1979), which
used SSE as the antigen, combined with various absorption
procedures on sheep anti Al serum, should indicate whether the
serotype specificity of Al PWE is acceptable as an antigen in
the ELISA system.
SSE's of P.haemolytica Al, A2, A6, A7, A9, T10 and UT6 and the
PWE of SSE of Al, A2, A6 and A9, were prepared as described in
Materials and Methods.
Antisera were raised in specific pathogen free (SPF) lambs by
immunising with Al SSE antigen as described in Materials and
Methods
Rabbit antisera were prepared as described in Materials and
Methods.
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Absorption of antisera - Sheep antiserum against Al SSE,
obtained from SPF lambs, was absorbed with heterologous SSE's
(2.5mg/ml) or Al PWE (5mg/ml) or both as described in Table 3.1.
The suspensions were mixed for 2h at 37°C then left overnight at
4°C. The precipitates were removed by centrifugation at
llOOOg for 5 min.
The ELISA method is described in Materials and Methods.
The A405 readings obtained with the four antiserum
preparations when titrated against Al and All SSE antigens are
shown in Figures 3.1 and 3.2 respectively. The effect of
absorption with heterologous SSE antigens was to reduce the A405
only slightly when reacted with Al SSE but to reduce
substantially the reaction against All SSE (titre of 1 in 30,000
and 1 in 3000 respectively). Absorption with Al PWE almost
halved the initial A405 of unabsorbed serum (0.57 and 1.0
respectively) when reacted against Al SSE but little effect was.
seen with All SSE. The combination of SSE's and Al PWE almost
removes completely the reactivity of the serum for Al SSE. The
same combination cannot be differentiated from serum absorbed
with heterologous SSE's when the reaction against All SSE was
examined.
The results confirmed the earlier findings with IHA and CIE
that Al PWE contains the type-specific antigen and that it is in
a fairly pure antigenic form as it does not decrease the
response of anti Al serum to the heterologous All SSE antigen
but does decrease the response to homologous antigen. It is




Mixtures used for absorption of antiserum to P.haemolytica Al
with heterologous SSE and homologous PWE.
SAMPLE SERUM SSE Al PWE PBS TOTAL DILUTION
VOLUME OF SERUM
0.1ml 0.2ml each of A2, - 4.7ml 6.0ml 1 in 60
A6,A7,A9,T10,UT6
0.1ml 0.2ml each of A2,
A6,A7,A9,T10,UT6 0.2ml 4.5ml 6.0ml 1 in 60
0.1ml - 0.2ml 5.7ml 6.0ml 1 in 60
0.1ml - - 5.9ml 6.0ml 1 in 60
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Figure 3.1
Absorbance at 405nm (A405) of dilutions of SPF lamb
antisera, raised against P.haemolytica Al reacted
with homologous Al SSE antigen in ELISA. The
antiserum was absorbed with heterologous SSE's (O)*





Absorbance at 405nm (A405) of dilutions of SPF lamb
antisera raised against P.haemolytica Al reacted with
heterologous All SSE in ELISA. The antiserum was
absorbed with heterologous SSE's (O), heterologous




Development of a serotype specific ELISA system for
P.haemolytica
The previous experiment demonstrated that Al PWE was a
potential candidate for a specific serotype antigen for use in
the ELISA system. The effectiveness of an ELISA depends on the
use of optimal concentrations of all reagents which have to be
determined before the test can be employed routinely. This
experiment describes the standardisation of the various
reagents.
The preparation of antigens, sheep and rabbit antisera,
rabbit IgG and the ELISA method have been described in Materials
and Methods.
Titration of Al PWE as an antigen: A1 PWE (lmg ml-"'") was
diluted from 1 in 10 to 1 in 10,000 in ten fold steps and
allowed to bind to wells for 18h at 4°C. The result, when the
ELISA was performed as in Materials and Methods, was negative.
No colour developed in any wells except for a control well where
conjugate and substrate were mixed indicating a reaction between
these two reagents. The sheep serum had previously been used
successfully in gel immunoelectophoresis and therefore
recognised Al PWE. It also contained IgG antibody to Al PWE as
it had reacted with the conjugate in the previous experiment
(3.1). A possible explanation for the result was the failure of
the antigen to bind to the plate.
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3.2.1. The use of whole rabbit antiserum as a trapping layer
in a "sandwich" ELISA
It has been reported that difficulties are sometimes
encountered when attempts are made to bind some bacterial
polysaccharide antigens to plastic for use in the ELISA system
(Russell et al, 1980). This can be overcome by using a sandwich
ELISA, where antiserum is bound to the plastic in an initial
step and this traps the antigen for the test. This has been
applied successfully by Barrett et al^ (1980 ) for the trapping of
pneumococcal antigens.
Rabbit antiserum against P.haemolytica Al whole cells was
diluted 1 in 50 in antigen buffer and added to all wells of an
ELISA plate. This was left for 18h at 4°C. After washing, Al
PWE (lmg ml ^) diluted from 1 in 50 to 1 in 800 in PBS/Tween 20
was added to the plate and the plate left at 20°C for 3h.
Subsequent steps were identical to those described in Materials
and Methods except that sheep antiserum to P.haemolytica A2 was
included in the antiserum step as a heterologous antiserum
control.
The result is shown in Table 3.2. The A405 for the
homologous reaction was very low (0.429-0.525) compared to the
expected result of 1.0 or greater. It is possible that, when
using whole serum, other serum components such as albumin bind
to the plastic wells more strongly than immunoglobulins. If
this is the explanation then a purified IgG fraction would be
expected to bind to the wells more effectively and thereby
increase the amount of antigen bound in the second step. The
absorbances obtained with the heterologous antiserum (A2)
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indicated that either the antigen was not totally specific or
that non-specific binding was occurring.
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Table 3.2
Absorbance readings at 405nm (A405) for ELISA reaction between
P.haemolytica A1 PWE with sheep anti A1 and A2 conjugates and a
rabbit antiserum against P.haemolytica A1 whole cells to trap
antigen.
SHEEP ANTISERUM A405 READINGS AT THE FOLLOWING DILUTIONS OF
Al PWE
50 100 200 400 800
Anti-Al
Anti-A2
0.429 0.540 0.525 0.547 0.479
0.214 0.234 0.217 0.178 0.170
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3.2.2. The Use of the IgG fraction from a rabbit antiserum to
P.haemolytica A1 as a trapping layer in a "sandwich" micro
ELISA
The initial step in ELISA, that of binding antigen to plastic
is little understood but it seems obvious that the purer the
preparation then the more likelihood there is of adequate
amounts of the antigen binding to the plastic. The use of a
purified IgG fraction of a rabbit antiserum to P.haemolytica Al
should allow the binding of a much greater amount of IgG than
would occur in the presence of other serum constituents.
The IgG fraction from a rabbit antiserum to P.haemolytica Al
whole cells (4.9mg ml-^) diluted in 1 in 100 in antigen buffer,
was added to all wells (i.e. 16ug IgG per well) and left at 4°C
for 18h.
Antigens A1,A2 and A6 PWE (all at lmg ml~^) were diluted in
doubling dilutions from 1 in 100 to 1 in 51,200 in PBS/Tween,
added to the plate and left at 4°C for 18h.
The remaining steps were identical to those given for the
ELISA in part 1 of this experiment.
The A405 reading obtained for the dilutions of Al PWE reacted
with homologous and heterologous antisera is displayed
graphically in Figure 3.3. Control wells exposed to the rabbit
IgG, antiserum conjugate and substrate but no antigen, did not
show colour development.
The results show that the homologous reaction is very strong
(A405 between 2 and 1.63) with no loss of antigen activity even
at the 1 in 51,200 dilution of antigen. The specificity of the
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reaction is confirmed by the
heterologous antigens (no A405
very low A405 obtained with the
above 0.15 for either A2 or A6).
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Figure 3.3
Absorbance at 405nm (A405) of various dilutions of
PWE antigens from P.haemolytica Al(0)r A2( • ), or
A6(B) reacted with the IgG fraction of a rabbit
antiserum and SPF lamb antisera, raised against Al,
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3.2.3 The checkerboard titration of IqG fractions of rabbit
antisera to A1, A2, A6 and A9 and prospective PWE antigens in a
"sandwich" ELISA
The demonstration of effective binding of A1 PWE by the IgG
fraction from a rabbit antiserum to A1 suggested that the same
system might be applied to other serotypes of P.haemolytica.
The optimum concentration of IgG and PWE for use in the test was
assessed by checkerboard titration. This was carried out as
follows; l)The IgG fractions of rabbit antisera to Al, A6 and A9
were diluted in antigen buffer from 1 in 500 to 1 in 8000 and
IgG fractions against A2 diluted from 1 in 100 to 1 in 1600.
After the addition of the dilutions to the wells the plates were
left at 4°C for 18h. 2)Ten fold dilutions of Al, A2, A6 and A9
PWE antigens (lmg ml--'-) from 1 in 100 to 1 in 100,000 in
PBS/Tween were added to the wells and left at 4°C for 18h.
3)Antisera raised in SPF lambs against each serotype were
diluted 1 in 500 with diluent and added to the appropriate
wells. The plates were left at RT for 3h. The remaining steps
were the same as described previously.
The titrations of rabbit IgG and PWE for Al, A6 and A9 are
shown in Tables 3.3, 3.4 and 3.5 respectively. The A2 reaction
did not give any colour development whereas the Al, A6 and A9
components did react and Table 3.6 shows the combination of
dilutions of IgG and PWE which give an A405 of around 1.0 for
each serotype. This A value was arbitrarily selected as a
convenient standard. With these dilutions it should be possible
to measure antibody to these three serotypes in the sera of
sheep. The failure of the A2 reaction may have been due to
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insufficient or low affinity IgG in the coating layer or to
insufficient binding of antigen or it may have been due to some
degradation of the A2 antigen by phenol-water treatment.
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Table 3.3
Checkerboard titration of anti-Al rabbit IgG and A1 PWE.
A405 READINGS AT THE FOLLOWING
DILUTIONS OF Al PWE DILUTIONS OF RABBIT IgG
500 1000 2000 4000 8000
100 2.25 2.0 2.0 1.25 0.75
1000 1.0 1.0 1.0 0.75 0.25
10000 0.25 0.25 0.25 0.00 0.00
100000 0.00 0.00 0.00 0.00 0.00
Table 3.4
Checkerboard titration of anti--A6 rabbit IgG and A6 PWE
DILUTIONS OF Al PWE
A405 READINGS AT THE
DILUTIONS OF RABBIT IgG
: FOLLOWING
500 1000 2000 4000 8000
100 1.4 1.4 1.2 0.8 0.00
1000 0.4 0.6 0.6 0.2 0.00
10000 0.4 0.4 0.4 0.0 0.00
100000 0.4 0 . 4 0.4 0.0 0 .00
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Table 3.5
Checkerboard titration of anti--A9 rabbit IgG and A 9 PWE
A405 READINGS AT THE FOLLOWING
DILUTIONS OF RABBIT IgG
DILUTION OF A9 PWE 500 1000 2000 4000 8000
100 1.8 1.6 1.4 1.2 0.6
1000 1.6 1.4 1.4 1.0 0.4
10000 1.2 1.0 1.0 0 . 8 0.4
100000 0.6 0.6 0.4 0.4 0.2
Table 3.6
Dilutions of IgG and PWE to be used in ELISA for P.haemolytica
serotypes Al, A6 and A9.
SEROTYPE DILUTION






The use of the micro ELISA to detect antibodies to specific
P.haemolytica serotypes in the sera of SPF lambs.
The micro ELISA for measurement of antibodies in sheep sera
to P.haemolytica, described by Burrells et a_l (1979), employed
SSE as the antigen but Evans (1979) showed that there was much
cross-reactivity between serotypes when this antigen was used in
in ELISA to measure antibody in mouse or rabbit sera to
different serotypes. The PWE used in the "sandwich" ELISA
should substantially decrease the cross-reactivity experienced
in earlier methods. The use of SPF lambs to raise serotype
specific antisera should overcome the problem of prior exposure
by experimental animals to a range of P,haemolytica serotypes.
Sera from two unvaccinated control lambs and from two groups
of 3 lambs vaccinated with either Al or A9 SSE taken before
vaccination and 6 weeks after vaccination were diluted 1 in 1000
for use in the ELISA. The micro ELISA used was that described
in experiment 3.2 with the Al and A9 reagents at optimum
dilutions. The sera were reacted against homologous and
heterologous antigens.
Table 3.7 shows the result obtained when antisera raised to
Al and A9 in SPF lambs were tested against homologous and
heterologous PWE antigens. Individual homologous values were
all greater than 0.69 whilst heterologous values were less than
0.23. Paired sera from the two unvaccinated lambs remained
negative to Al PWE, but showed some reaction to A9 PWE. This
reaction was also seen in the pre-vaccination sera of vaccinated
lambs.
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The results corroborate these found in experiment 3.2 in
which the sandwich ELISA, incorporating A1 PWE as antigen,
measured antibody to specific serotype antigens in the sera of
sheep. The criterion of specificity is that used by Russel et a_l
(1980) to measure antibody to pneumococcal antigen; i.e. the
lowest A405 in a homologous system (lamb3 serum = 0.691) was
more than three times greater than the highest heterologous A405
(lamb 2 serum = 0.225). The level of reactivity with A9 PWE of
both prevaccinated and control sera suggests that the lambs may
have been exposed to some cross-reacting antigen derived from an
organism other than P.haemolytica. Similar cross-reactions with
P.haemolytica Al antigens have been seen in IHA tests on the
sera of SPF lambs which had not experienced P.haemolytica




Values obtained from the reaction of antisera to type A1 or A9
with homologous and heterologous phenol-water extracted
antigens.
SPF VACCINES A405 VALUES
Lamb No. Al PWE A9 PWE
Pre-vac Post-vac Pre-vac Post-vac
1 Al SSE 0 1.065 0.097 0.122
2 0 1.087 0.132 1.225
3 0 0.691 0.126 0.154
4 A9 SSE 0 0.025 0.096 1.140
5 0 0 0.117 0.865
6 0 0.030 0.084 0.696
7 Not Vaccinated 0 0 0.086 0.151
8 0 0 0.117 0.130
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SECTION 3.4
The development of a micro ELISA to measure antibody to
P.haemolytica antigens in mouse serum.
The mouse model for P.haemolytica infection, described by
Evans and Wells (1979a) offers a method for the initial testing
of potential pasteurella vaccine components where the efficacy
of the antigen in providing protection against P.haemolytica
challenge can be assessed. However, the model is subject to
biological variation and the responses to challenge in any one
group of vaccinated animals can differ greatly. The detection
of antibodies against P.haemolytica in individual mouse serum
would allow assessment of the reaction of the mouse to the
antigens and possibly answer the question whether antibodies are
necessary for protection against challenge. This experiment
describes the development of an ELISA to measure antibody to
P.haemolytica in the sera of immunised and non-immunised mice.
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3.4.1 Titration of goat anti-mouse IgG, conjugated with
alkaline phosphatase, and sera from vaccinated mice.
Antisera were raised in three groups of C57 black mice by
subcutaneous inoculation of 0.1 ml of Al SSE (125 ug per dose)
or 0.1 ml of a PWE (50ug/dose) in CPA. These inoculations were
repeated 14 days after the initial dose. Fourteen days after
the second dose the mice were exsanguinated by cardiac puncture
and the sera from the five mice in each group were pooled. A
control group of 5 unvaccinated mice were killed and
exsanguinated at the same time and their sera pooled.
ELISA. The IgG fraction of a rabbit antiserum against Al
whole cells and Al PWE were added to wells in a micro ELISA
plate as previously described in experiment 3.2. Mouse
anti-sera and goat anti-mouse IgG conjugated with alkaline
phosphatase (Miles Laboratory, Slough, U.K.) were checkerboard
titrated; mouse serum was diluted in ten fold dilutions from 1
in 10 to 1 in 100000, added to micro ELISA plates and left for
3h at RT. Goat anti-mouse IgG conjugate diluted 1 in 50, 100,
400 and 800 was added to the wells and left for 3h at RT.
Substrate was reacted for lh before 3M NaOH was added to stop
the reaction. Absorbances were read as previously described.
The A405 measured for the reaction of mouse anti-Al PWE sera
and mouse anti-Al SSE sera are shown in Tables 3.8 and 3.9
respectively. No A405 readings were obtained for the control
pool of serum indicating that there was very low background
reaction in the test.
The results suggested a working dilution of 1 in 500 for
serum and 1 in 200 for conjugate which in both groups would give
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an A405 approaching the previously selected standard of 1.0.
The results also showed that A1 PWE does stimulate antibody
response in vaccinated mice.
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Table 3.8
Titration of mouse antiserum against P■haemolytica A1 PWE and
goat antiserum against mouse IgG conjugated with alkaline
phosphatase in an indirect "sandwich" micro ELISA against A1 PWE
antigen.
DILUTION OF ABSORBANCE (A405) READINGS AT THE FOLLOWING
CONJUGATE DILUTION OF SERUM
10 100 1000 10000 100000
50 o•CM 2.0 1.07 0.41 0.45
100 2.0 2.0 0.46 0.26 0.5
400 0.77 0.97 0.86 0.04 0.07
800 0.39 0.48 0.00 0.00 0.1
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Table 3.9
Titration of mouse antiserum against P.haemolytica A1 SSE and
goat antiserum against mouse IgG conjugated with alkaline
phosphatase in an indirect" sandwich" micro ELISA against A1 PWE
antigen.
DILUTION OF ABSORBANCE (A405) READINGS AT THE FOLLOWING
CONJUGATE DILUTION OF SERUM
10 100 1000 10000 100000
50 2.0 2.0 2.0 0.75 0.90
100 1.29 1.9 1.27 0.15 0.10
400 0.34 0.7 0.39 0.02 0.03
800 0.12 0.35 0.15 0.00 0.00
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3.4.2. Sequential measurement of antibodies to P.haemolytica
Al antigens in the blood of mice vaccinated with A1 PWE or SSE
The above titration in section 3.4.1 indicated that
antibodies to P.haemolytica Al could be measured in mouse serum
samples. However, for the sequential measurement of antibody in
individual mice it is difficult to remove sufficient volumes of
blood to allow the collection of enough serum.
The following experiment was designed to investigate whether
whole blood could be used directly in the ELISA.
Three groups of 5 mice treated in the same way as described
in the first part of this experiment (3.4.1) were killed and
50ul of blood, taken from the axilla of each mouse, were diluted
100 fold in PBS Tween. This assumed that a 1 in 100 dilution of
whole blood was equivalent to a 1 in 200 dilution of serum. In
the ELISA the IgG fraction of rabbit anti serum raised against
Al whole cells IgG, Al PWE and Al SSE antigens were added as
previously described. Mouse blood samples were diluted further
to 1 in 200 and 1 in 500 in PBS/Tween, added to the plates in
duplicate wells and left at RT for 3h. Conjugate was added at a
1 in 200 dilution and the plate incubated at RT for 3h.
Substrate was added to every well and the reaction stopped after
lh by the addition of 3M NaOH. The A405 readings were measured
as previously described.
The A405 readings obtained for two dilutions of blood taken
from vaccinated or unvaccinated mice reacted with Al PWE or SSE
are shown in Table 3.10.
The results show that antibodies to P.haemolytica can be
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measured in whole blood samples of mouse blood and that little
background activity is present although the A405 readings
obtained for mouse 15 (0.41 and 0.31) were high. It would also
appear that the response to A1 PWE vaccination was not as strong
as the response to A1SSE given only 2 out of 5 mice vaccinated
with PWE responded with A405 readings above 0.5 (numbers 7 and
9) whereas all mice vaccinated with SSE did respond to PWE with
A405 above 0.5.
The use of whole blood sampling should facilitate the




A405 readings obtained with dilutions of whole blood taken from
mice vaccinated with P.haemolytica A1 SSE or PWE reacted against
Al SSE or PWE antigens in an indirect "sandwich" ELISA .





1 Al SSE 200 1.92 1.87
Al SSE 500 1.33 1.19
2 Al SSE 200 1.23 1.17
Al SSE 500 0.55 0.92
3 Al SSE 200 1.70 1.1
Al SSE 500 0.74 0.68
4 Al SSE 200 1.97 1.23
Al SSE 500 1.46 1.00
5 Al SSE 200 1.35 1.14
Al SSE 500 0.50 0.66
6 Al PWE 200 1.11 0.30
Al PWE 500 0.40 0.08
7 Al PWE 200 1.09 0.60
Al PWE 500 0.32 0.23
8 Al PWE 200 0.35 0.23
Al PWE 500 0.18 0.08
9 Al PWE 200 0.96 1.02
Al PWE 500 0.36 0.49
10 Al PWE 200 1.18 0.39
Al PWE 500 0.58 0.16
11 UNVACCINATED 200 0 0.08
UNVACCINATED 500 0 0.07
12 UNVACCINATED 200 0 0
UNVACCINATED 500 0 0
13 UNVACCINATED 200 0.21 0.06
UNVACCINATED 500 0 0 .04
14 UNVACCINATED 200 0 0.07
UNVACCINATED 500 0 0.01
15 UNVACCINATED 200 0.02 0.41
UNVACCINATED 500 0 0.32
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SECTION 3.5
The use of ELISA to measure sequentially antibody to
P.haemolytica in the blood of mice vaccinated with A1 PWE and
SSE antigens and the correlation of those measurements with
protection against challenge with P.haemolytica Al.
PWE antigen of P.haemolytica Al has already been shown to
protect mice against homologous challenge (Section 1.2).
However, in those experiments not all mice in the vaccinated
groups were protected to the same degree against challenge
suggesting that individual mice had responded differently to
vaccination.
Measurement of antibody titres to P■haemolytica present after
vaccination and correlation of these with protection against
challenge should give some indication whether the above
explanation is correct.
Al SSE and Al PWE were emulsified in CFA to give a final
concentration of 62.5ug and 6ug per dose of vaccine
respectively.
Two groups of ten randomly allocated C57 black mice were
inoculated subcutaneous .ly with 0.1ml of SSE or PWE vaccine and
revaccinated 14 days later. Another group of ten mice were left
as unvaccinated controls. Fourteen days after the second
vaccination the mice were challenged with P.haemolytica Al as
described in Materials and Methods. The group results were
analysed statistically by the Mann Whitney Ranking Test. Samples
of mouse blood were obtained by pricking the tail vein and
withdrawing lOul of blood which were immediately diluted in 1ml
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of PBS/Tween. The mice were sampled before vaccination, at
revaccination and one day before challenge and the diluted blood
samples were stored at -20°C. Each mouse was individually
identified.
Antibodies to P.haemolytica A1 SSE and PWE were detected by
the following ELISA method. The plates were washed between
steps with PBS/Tween.
1)The IgG fraction of a rabbit anti serum raised against
P.haemolytica A1 whole cells was diluted 1 in 500 in antigen
buffer, added to the wells and left at 4°C for 18h.
2)A1 PWE at 1 in 1000 dilution and Al SSE at 1 in 500 dilution
in PBS/Tween were added to appropriate wells and left at 4°C for
18h.
3)Standard mouse sera pooled from a previous experiment (Exp
3.4.1 part 1) was doubly diluted in PBS/Tween from 1 in 100 to 1
in 12800 and added to columns 2 and 3 in the micro ELISA plate.
Test blood samples were diluted 1 in 2 giving a 1 in 200
dilution of the blood and added to duplicate wells for 3h at RT.
4)Goat anti-mouse IgG conjugated with alkaline phosphatasewas
diluted 1 in 200 in PBS/Tween, added to all wells and left at RT
for 3h.
5)Substrate, N-para nitro phenyl phosphate (lmg ml-1) was added
to all wells for lh at RT. The reaction was stopped by the
addition of 3M NaOH and the A405 readings taken as described
previously.
Calculation of results:
l)The A405 readings (A) were converted to log^Q values.
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2)The log A values of the standard serum dilutions were plotted
against the values of these dilutions to provide a
standard graph.
3)The titre of the standard serum was taken to be that dilution
which would give an A405 value of just greater than 0.1, as
negative control sera taken from SPF and gnotobiotic lambs
never exceeded this value.
4)The titres of the test sera are calculated from the formula,
Titre of test serum
Dilution of test serum
(200)
Dilution of standard
serum which would give





The correlation between the counts of P.haemolytica in the
liver and the serum antibody titres against A1 SSE and PWE
antigens for individual mice are given in Tables 3.11 and 3.12
respectively. All mice vaccinated with SSE or PWE showed rising
titres from the time of first vaccination to challenge against
both antigens. Taken as groups, all vaccinated mice were
protected against challenge to a significant level, P>0.001 for
both SSE and PWE vaccinated groups compared to the unvaccinated
control group. Unvaccinated control mice had no detectable
antibody to P.haemolytica although two mice in the group (24 and
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25) had low liver counts. The titres obtained against SSE were
generally higher than those against PWE no matter what the
vaccine. This probably reflects the greater variety of antigens
present in SSE although direct comparisons between values
obtained in the two ELISA's are difficult to interpret. The
average titres for each vaccinated group against PWE before
challenge and the protection obtained are not significantly
different.
This demonstrates that vaccination with a purified antigen,
PWE,at one tenth of the concentration of the SSE gives the same
antibody titre and protection as obtained with the SSE.
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Table 3.11
Antibody titres against A1 SSE determined by ELISA and viable
count of bacteria in the livers of mice challenged with
P.haemolytica A1.
MOUSE VACCINE ANTIBODY TITRE CHALLENGE LIVER COUNT
No STATUS SEROTYPE (cfu)1
DAY1 DAY14 DAY28
1 Al SSE - 215 1406 Al 3.8
2 Al SSE — — 3355 Al 2.7
3 Al SSE _ 204 1940 Al 2.7
4 Al SSE - - 949 Al 2.7
5 Al SSE - - 7709 Al 2.7
6 Al SSE - 413 15757 Al 3.3
7 Al SSE - 464 1805 Al 3.0
8 Al SSE - - 1303 Al 2.94
9 Al SSE - - 756 Al 3.57
10 Al SSE - 277 550 Al 2.7
11 Al PWE — 270 1295 Al 2.7
12 Al PWE - 267 1022 Al 2.7
13 Al PWE - 345 1756 Al 3.0
14 Al PWE - - 432 Al 2.7
15 Al PWE - 228 681 Al 2.7
16 Al PWE - - 1162 Al 3.0
17 Al PWE - 220 3539 Al 2.7
18 Al PWE - 217 2928 Al 2.7
19 Al PWE - - 325 Al 2.7
20 Al PWE — 212 649 Al 2.7
21 CONTROL — — — Al 6.11
22 CONTROL - - - Al 7.18
23 CONTROL - - - Al 6.18
24 CONTROL - - - Al 3.0
25 CONTROL - - - Al 3.76
26 CONTROL - - - Al 5.68
27 CONTROL - - - Al 6.68
28 CONTROL - - - Al 6.57
29 CONTROL - - - Al 7.08
30 CONTROL - - - Al 6.08
•COLONY FORMING UNITS (iog10 values) -
(2)-CHALLENGE DOSE = 5.2 X 106 cfu
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Table 3.12
Antibody titres against Al PWE determined by ELISA and viable
counts of bacteria in the livers of mice challenged with
•P. haemolytica Al.




1 Al SSE - 201 1034 Al 3.8
2 Al SSE - - 903 Al 2.7
3 Al SSE - - 1226 Al 2.7
4 Al SSE - - 599 Al 2.7
5 Al SSE - - 756 Al 2.7
6 Al SSE - 389 1811 Al 3.3
7 Al SSE - 401 1004 Al 3.0
8 Al SSE - - 400 Al 2.94
9 Al SSE - - 662 Al 3.57
10 Al SSE - 232 319 Al 2.7
11 Al PWE — 252 2358 Al 2.7
12 Al PWE - 269 329 Al 2.7
13 Al PWE - 299 425 Al 3.0
14 Al PWE - - 266 Al 2.7
15 Al PWE - - 455 Al 2.7
16 Al PWE - - 224 Al 3.0
17 Al PWE - - 1030 Al 2.7
18 Al PWE - - 7274 Al 2.7
19 Al PWE - - 219 Al 2.7
20 Al PWE - - 253 Al 2.7
21 CONTROL - - - Al 6.11
22 CONTROL - - - Al 7.18
23 CONTROL - - - Al 6 .18
24 CONTROL - - - Al 3.00
25 CONTROL - - - Al 3.76
26 CONTROL - - - Al 5.68
27 CONTROL - - - Al 6.68
28 CONTROL - - - Al 6.57
29 CONTROL - - - Al 7.08
30 CONTROL - - - Al 6.08
1. Log,„ values
2. Challenge dose =Log^Q 6
- = negative value
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SECTION 3.6
The development of an ELISA to measure antibody in sheep
serum to P.haemolytica A2 antigens.
P.haemolytica A2 is the serotype most frequently isolated
from ovine enzootic pneumonia (Fraser et al,1982a) and therefore
control of the disease depends on immunity to this serotype.
However, the A2 serotype is one of the least immunogenic of the
P.haemolytica serotypes and in rabbits the production of
antiserum for serotyping A2 strains has to be carried out with
live inoculation of bacterial cells (Fraser et al, 1982a). In
sheep there is no measurable antibody response in the IHA test
after vaccination with killed cells or SSE but there is a marked
response after challenge with live organisms (Dr. N.J.L.
Gilmour, personal communication).
The results of earlier experiments (Section 3.2) have shown
that the IgG binding layer (sandwich) technique was not
effective in binding A2 PWE to the wells of a micro ELISA plate.
This may have been due to the difficulty in producing high
titres of antibody against A2 in rabbits which would reduce the
effectiveness of any IgG fraction.
Dahlberg and Branefors (1980) have overcome the problem of
binding an LPS antigen from Haemophilus influenzae directly to
plastic by extending the time the antigen is in contact with the
plastic. Their method was applied to the A2 PWE antigen.
The standard antiserum used was a pool of conventional sheep
sera from animals shown to have a high titre in the IHA test
against A2 antigen.
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A2 PWE (Img ml-^) in doubling dilution from 1 in 50 to 1
in 6400 in antigen buffer was added to duplicate wells in a
micro ELISA plate and incubated at 37°C for 24h followed by
storage at 4°C for 7 days. After washing, the standard serum,
diluted 1 in 500, was added to the plate and left at RT for 3h.
The remaining steps were as described in Materials and Methods.
The dilution of antigen giving an A405 reading of 1.0 was a 1
in 200 dilution. By this method it should be possible to
measure the antibody levels to A2 PWE in the sera of sheep. The
dilution of PWE used is substantially lower than that used on
the A1 ELISA (1 in 1,000 dilution) but greater than that
calculated for A6 (1 in 100).
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SECTION 3.7
The measurement of antibody levels to P.haemolytica A2,by IHA
and ELISA, in the sera of sheep with experimental chronic
pasteurellosis.
Atypical or chronic pneumonia, caused by P.haemolytica in
conjunction with Mycoplasma ovipneumonia has been reproduced
experimentally (Jones et al, 1978) and because the sheep undergo
an active infection the antibody response should be measurable
during the course of this infection. The system also offers the
opportunity to compare the ELISA for A2, described in the
previous experiment, with the IHA test.
P.haemolytica A2 was grown in nutrient broth for 18h at
37°C. Twenty eight lambs, approximately 10 weeks old, were
obtained from a flock in which levels of infection with
potentially pathogenic respiratory organisms had been found to
be very low over 4 years of sampling. Nasal swabs taken from
the lambs on day 1 were free of P.haemolytica and mycoplasmas.
Eighteen lambs were inoculated intratracheally on day 1 with
6ml of a homogenate of pneumonic lung lesion obtained from the
£
abattoir (Jones et al, 1978). This homogenate contained 10
colour changing units (ecu) per 0.2ml of M.ovinpneumoniae and
2x10 cfu per 0.2ml of P.haemolytica A2 with no isolation of any
other micro-organism. The same animals were inoculated
intranasally on day 7 with 1ml of a culture of P.haemolytica A2
containing 4xl06 cfu ml-1. The remaining 10 control animals
were untreated throughout. All control lambs and 6 infected
lambs were slaughtered at 15.5 weeks post infection (wpi), and
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the surviving 8 infected lambs were slaughtered at 24.5 wpi,
when they had reached the same mean liveweight as the controls.
These procedures were carried out by Dr. G.E. Jones, Moredun
Research Institute.
All lambs were bled before challenge and at fortnightly
intervals thereafter.
Sera from sheep shown to have antibody to P.haemolytica A2 by
the IHA test in a previous experiment were pooled and stored in
aliquots at -20°C until used as a standard positive antiserum.
Antisera to P.haemolytica Al and A9 were prepared in SPF lambs
as described in Materials and Methods.
The IHA test is described in Materials and Methods.
The ELISA was carried out as follows;
1)Micro ELISA plates were coated with A2 PWE diluted 1 in 200 in
antigen buffer and inoculated at 37°C for 24h then held at 4°C
for 7 days.
2)Standard or test sera were added to all wells except those in
column 1 to which diluent only was added. Test sera were
diluted 1 in 2000 in PBS/Tween + 0.02% sodium azide before use.
The standard A2 antiserum was made up in doubling dilutions from
1 in 2,000 to 1 in 256,000. The Al and A9 antisera were diluted
in 1 in 2,000. Each sample was tested in duplicate and the
plates left at RT for 3h.
The remaining steps were those described in Materials and
Methods. Titres were calculated by the formula given in Section
3.5.
The ELISA results of the calculated mean serum titres against
P.haemolytica for infected and control animals are shown in
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Figure 3.4. Mean antibody titres against P.haemolytica in the
infected group reached their maximum at 8pwi but declined
quickly thereafter. The control animals showed no significant
rise in mean antibody titre over the duration of the experiment
and the titres with the standard antisera to A1 and A9 did not
exceed the control values.
The mean serum antibody titres of the infected and control
groups, measured in the IHA test, plotted against time are shown
in Figure 3.5. Antibody detected in this test increased quickly
to a titre of 1 in 48 at 4 pwi then declined sharply afterwards.
The mean serum antibody titres of the controls remained almost
constant at 1 in 2 throughout the experiment.
The results show that both tests detected antibodies to A2
but some differences are apparent. The IHA test demonstrated
maximum titres at 4 wpi while ELISA did not reach a maximum till
8 wpi. This probably reflects the measurement of different
antibodies in the tests as the IHA only registers those
antibodies reacting with the selected antigens on the red blood
cells surface while in the ELISA all antigens bound to the well
are available for reaction. It seems probable that both tests
are measuring the serotype specific antibodies as the inclusion
of heterologous serum in the ELISA did not give high titres and
did not register at all in the IHA. In the ELISA the background
level of reaction with control sera may be an indication of




Mean calculated serum antibody titres (Log^Q) against
P.haemolytica A2 as detected by ELISA for infected
group (+) and control group (□).
Figure 3.5
Mean serum antibody titre (Log2) against
P.haemolytica A2 as detected by IHA for infected




The ELISA technique has been successfully applied to the
measurement of antibodies to the antigens of Gram-negative
bacteria such as Brucella abortus (Carlsson et al, 1976),
Yersinia enterocolitica (Grippenberg et al, 1979), Haemophilus
influenzae type B (Crosson et al., 1978 ) and Bacteroides species
(Poxton, 1979). An ELISA to measure antibodies to P.haemolytica
SSE antigens was described by Burrells et al (1979) but the
complexity of the antigen made the test non-specific: a test set
up with one serotype SSE antigen would measure antibody in
antiserum to a heterologous serotype (Burrells, personal
communication). The ELISA system described here allows the
measurement of type-specific antibodies by using PWE antigens in
the ELISA.
The cross-reactivity in the ELISA developed by Burrells et al.
(1979) was demonstrated in the first experiment (section 3.1).
When antiserum to Al was absorbed with heterologous SSE antigens
the A405 was slightly reduced in comparison with an unabsorbed
control antiserum. Absorption of the antiserum with Al PWE
decreased the A405 by around 50% and when the antiserum was
absorbed with both heterologous SSE and PWE then the A405 fell
to just above zero indicating that the type specific antibodies
had been removed. Reaction of the same treated antisera with
All SSE showed that whereas absorption with heterologous SSE's
effected a substantial drop in the cross-reaction, absorption
with PWE had no effect. This demonstrated a type specificity in
PWE which agreed with the previous experiments with IHA and CIE.
(Section 1).
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Polysaccharide antigens, known to be type specific, have been
used in ELISA systems to detect the serotype specific antibodies
of such bacteria as Haemophilus influenzae type b (Crosson et
al, 1978), Yersinia enterocolitica (Grippenberg et al, 1979) and
Streptococcus pneumoniae(Barrett et al, 1980).
However, problems have been encountered in the binding of
polysaccharide antigens to plastic. The antigen binding
properties of plastic are little understood but the
manufacturers recognise the problems and produce plates by
different treatments which are claimed to endow the plastic with
different affinities for different antigens (e.g. the 129A and
129B plates from Dynatech). Another approach to the problem has
been to use the plastic's known strong affinity for protein
antigens. Russell et al (1980) and Barrett et al (1980) both
used capture technique to bind pneumococcal antigens and
replaced the polysaccharide with antiserum or an IgG fraction in
the initial step. Gray (1979) bound poly L-lysine to
polysaccharide antigen by a cross linking reagent, cyanuric
chloride, and used this hybrid antigen which bound directly to
the ELISA plate by virtue of its protein component.
Recently Ito et al (1980) has reported that the inclusion of
magnesium ions in the antigen buffer facilitates the binding of
rough endotoxin antigens of E♦coli and N.gonorrhoeae by some
unknown mechanism.
When initial studies showed that Al PWE was not going to bind
easily the possibility of using a sandwich technique with an
antibody capture layer was investigated.
Rabbit antibody to P.haemolytica Al whole cells was used and
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in the first attempt whole antiserum was bound to the plate. The
weakness of the subsequent colour development was attributed to
the competitive binding of the serum components. An IgG
fraction of rabbit antiserum is relatively easy to produce
on a Sepharose/protein A affinity column and this IgG
preparation worked effectively in binding PWE antigen. The
serotype specificity obtained with the sandwich ELISA was good
when A1 and A9 specificities were investigated and might be
applicable to other serotypes.
However, even with PWE a certain amount of cross-reactivity
existed. Pre-vaccination SPF lamb sera reacted with A9 PWE.
This may indicate a shared determinant with another organism,
perhaps in the LPS, as found between Salmonella
minnesota, Klebsiella pneumoniae and Proteus morganii' (McCabe,
1977) where common LPS core antigen is present.
The results described in Section 3.4 showed that the
sensitivity of the ELISA and the use of very small volumes of
sera allowed the sequential measurement of antibody from
individual mice to be performed. This in turn makes possible
the assessment of an individual mouse's response to vaccination
as well as the possible link between antibody titre and
protection.
The demonstration that A1 PWE can stimulate high titres of
circulating antibody shows that mice are responsive to the
serotype-specific antigen in this purer form. It also shows
that the protection seen on vaccination is not due to some
non-specific effect as that described by Evans and Wells
(1979b) but due to presence of specific antibody.
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Although ten times more SSE than PWE was incorporated into
the vaccines the titres obtained against PWE antigen and the
protection observed in the two vaccinated groups were
comparable, indicating that a substantially smaller dose of
purified antigen can elicit the same amount of protective
antibody than a larger dose of cruder material. This may have
consequences for the formulation of vaccines containing those
antigens.
The influence of biological variation between mice was not
noticable in the vaccinated groups where the protection and
antibody response was 100% but some indication of its effect is
seen in the counts obtained in the control group. The livers of
two control mice showed low counts after challenge. This could
be due to faulty inoculation or to a natural resistance in the
mice to challenge. However, it serves to emphasize the need for
large numbers in groups to reduce the distortion of results
which can occur in this type of experiment.
The solution to the problem of binding A2 PWE was not found
in a sandwich ELISA but in a prolonged binding step which means
that the time from start to completion of the ELISA is greatly
extended.
The comparison of the ELISA for A2 and the corresponding IHA
test showed that the antibodies measured in each case seemed to
be different as the peak antibody titres in both tests did not
correspond. However, the tests both detect specific serotype
antibody as shown by the low titres to heterologous sera in both
tests.
There is no precise information as to what class of antibody
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is responsible for immunity against Pasteurella haemolytica
infection, nor is there any defined minimal serum titre value
needed to establish immunity. However, a rise in titre against
the specific antigen of P.haemolytica A2 as demonstrated in
Section 3.7, indicates that the host is experiencing a current
infection with A2. This is in line with the findings of Gilmour
et al (1982) who showed that P.haemolytica can be recovered from
the lungs of sheep with experimentally induced chronic pneumonia
up to 11 weeks after infection. There may be some correlation
with peak titres of specific antibody at 8 wpi and the clearance
of the bacterium soon afterwards.
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SECTION 4.
The analysis of P.haemolytica A2 and A6 antigens
SECTION 4.1
The Serological analysis of P.haemolytica A2 and A6 antigens.
The SSE and PWE antigens of A2 were shown to contain the
serotype antigens of their respective serotypes by the IHA test.
The titres obtained for each antigen preparation are shown in
Table 4.1. The SSE and PWE of both serotypes were also run in
CIE against homologous antisera raised in sheep and rabbits.
When A2 SSE was run against homologous rabbit antisera at
least 9 weakly staining precipitin lines were observed (Fig
4.1a). The pattern obtained with A2 PWE run against rabbit
antisera (Fig 4.1b) shows only one very weakly staining
precipitin line.
Sheep sera were tried after difficulties in obtaining
consistently high-titre rabbit antisera were encountered. The
profiles obtained when antisera from SPF lambs were used are
shown in Figure 4.2a and 4.2b for SSE and PWE respectively.
These show more antigens for SSE than were found with rabbit
antisera but again the PWE antigen was only weakly reactive.
When A2 SSE was heated at 115°C for 15 min the profile
obtained (Fig 4.2c) showed some changes from that for the
untreated extract in that precipitin lines 1 and 2 disappeared.
The SSE and PWE antigens of A6 were also run in CIE against
antisera raised in sheep and rabbits. The profiles for A6 SSE
when run against rabbit antisera are shown (Fig 4.3). When
145
10.5ug of A6 SSE were tested against homologous antisera a
single precipitin line stretching from the origin almost to the
width of the gel was observed (Fig 4.3a). When the loading of
the SSE antigen was increased to 50ug, 4 lines were seen in the
gel with the strong staining precipitin line noted previously
becomimg more diffuse and distorted (Fig 4.3b). The
incorporation of an intermediate gel containing rabbit antisera
to Al whole cells resulted in the precipitation of the 3 minor
antigens of A6 SSE in the intermediate gel (Fig 4.3c). This
indicated the cross-reactivity of these antigens whereas the
strongly reacting antigen was not impeded. This demonstrated
its serotype specificity.
The converse situation, with antiserum to A6 in an
intermediate gel and Al SSE as antigen, did not give a similar
pattern, as the antiserum to A6 failed to precipitate any
antigens in the immediate gel (Fig 4.4). However, the
homologous- Al reaction with SSE at 50ug only gave one strongly
staining precipitin line. This was similar in size and shape to
that obtained for A6 SSE in Fig 4.3a.
When sheep antisera to A6 was used in CIE there was an
increase in the number of antigens precipitated (Fig 4.5a). At
least 9 precipitin lines are visible, but again one very
strongly staining line can be seen over much of the gel. When
antisera to Al was incorporated in the intermediate gel, 3
antigens were impeded in their progress (Fig 4.5b). These are
antigens 2,7 and 9. As with rabbit antisera the converse run
with Al SSE antigen and antisera to A6 in the intermediate gel
was carried out. This time two antigens not present in the
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homologous Al reaction were precipitated in the intermediate
gel.
The profiles obtained when A6 PWE was run in CIE against
homologous rabbit antiserum with and without an intermediate gel
containing antiserum to Al are shown in Figure 4.6. Two
precipitin lines can be seen in the homologous reaction with a
blank intermediate gel (Fig 4.6a). The major line extends from
the origin to beyond the middle of the gel and has a distinct
shoulder at the anodic side. The smaller line is present within
the area of the major line and is very close to the origin. This
smaller precipitin line was impeded in the intermediate gel when
antiserum to Al was incorporated into this gel.
The CIE profiles for A2 and A6 SSE are distinctly different
from that obtained for Al SSE as they demonstrate a complex
mixture of antigens not seen in the Al studies. However, with
PWE antigens the results with A6 were comparable to Al in that
two antigens were present one of which was cross-reactive with
antiserum to a heterologous serotype. The A2 PWE antigen was
less antigenic than either Al or A6 and appeared to consist of
one weakly staining precipitin line in CIE.
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Table 4.1
The IHA titres of SSE and PWE antigens of P.haemolytica A2 and
A6 when tested against homologous antisera.
SEROTYPE ANTIGEN IHA titre
A2 SSE (2.5mg ml-1) 1000
PWE (lmg ml-1) 1000
A6 SSE (2.5mg ml"1) 1000
PWE (lmg ml-1) 10,000
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Figure 4.1
Crossed Immunoelectrophoresis (CIE) of a)A2 SSE(40ug)
and b)A2 PWE(lOug) run against 130ul of rabbit






CIE of a)A2 SSE (40ug) and b)A2 PWE (lOug) and c)A2
SSE (40ug) heated at 115°C run against 130ul of SPF




CIE of a)A6 SSE (12.5ug) b)A6 SSE (50ug) run against
130ul of rabbit antisera to A6 whole cells and c)the
profile of A6 SSE (50ug)run against lOOul of antisera
to A6 and an intermediate gel containing 30ul of




CIE of A1 SSE (50ug) run into an agarose gel
containing 130ul of homologous rabbit antiserum with
an intermediate gel containing 30ul of rabbit




CIE of A6 SSE(12.5ug) run against lOOul of homologous
sheep antiserum to A6 with a)blank intermediate gel
and b)an intermediate gel containing 30ul sheep
antiserum to Al. c) CIE of Al SSE (50ug) run against
lOOul of homologous sheep antiserum to Al with an





CIE of A6 PWE (lOug) run against lOOul homologous
rabbit antiserum a)with a blank intermediate gel and





Further characterisation of the PWE antigens of P.haemolytica
A2 and A6.
The serotype specificity seen in A1 PWE is also present in A6
PWE and may also be present in A2 PWE. This suggests that the
basis of serotype differences might be discerned by the chemical
analyses already used on serotype Al when applied to A2 and A6.
The results of chemical analyses on A2 and A6 PWE are shown
in Table 4.2 and for comparison the corresponding results for Al
PWE are included. The results indicate that Al and A6 are
similar in composition with some slight quantitative
differences. A2 PWE has very little carbohydrate (2%) and this
may explain the failure to measure heptose content.
P.haemolytica A2 was subjected to partial hydrolysis
treatment with 1% acetic acid and the supernate from the
hydrolysis was chromatographed on Sephadex G50 as already
described for Al (Section 2.1). Fractions collected from the
column were assayed for total carbohydrate and the results are
shown graphically in Figure 4.7.
One major peak was observed between fractions 31 and 37. No
antigen was measurable by FRIE in the A2 PWE after partial
hydrolysis. The PWE's of A2 and A6 were analysed by GC and
copies of both traces are shown (Fig 4.8). These show that both
PWE's are very similar to each other and also similar to Al
(Section 2.1). Both contain mannose, galactose,glucose, two
heptoses, glucosamine and galactosamine in the molar ratios,
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1.3; 0.7; 1.0; 0.1; 0.2; 0.8; 0.4 and 0.7; 0.4; 1.0; 0.1; 0.09;
0.3; 0.1 for A2 and A6 respectively.
The fractions comprising the carbohydrate peak from the G50
separation of A2 PWE partial hydrolysate (fractions 31-39) were
pooled and analysed by G.C. A copy of the trace is shown in
Figure 4.8 and the presence of glucose, galactose and two
heptoses is clearly indicated. This is similar to the finding
for A1 peak II (Section 2.1).
Although quantitative differences are obviously present
between A2, A6 and A1 it would appear that they all have a
similar monosaccharide composition. The similar behaviour of
the partial hydrolysate of A2 PWE and Al PWE in FRIE and on
column chromatography reinforces the similarity in structure
that must exist between the serotypes.
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Table 4.2
Composition of PWE's prepared from Al, A2 and A6 (values are
expressed as percent of total dry weight).
COMPONENT SEROTYPE
Al A2 A6
Phosphorus 1 4.4 2.8
Protein 6.3 1.6 0.4
Carbohydrate 14.8 2 12.4
Fatty Acid 10.8 ND 5.8
Heptose 6.6 0 2.4
KDO 0.6 0.4 0.01
ND = Not Done
157
Figure 4.7
Elution profile of the aqueous portion of partially
hydrolysed A2 PWE on Sephadex G50. Fractions (50 X
3ml) were eluted with water and assayed for
carbohydrate by the phenol sulphuric acid method






GC of alditol acetate derivatives of acid
hydrolysates of P.haemolytica A2 and A6 PWE
preparations on columns of OV225 for the detection of
sugars. a)untreated A2 PWE; b)untreated A6 PWE;
c)The major sephadex G50 peak from partially
hydrolysed A2 PWE. The sugars present are identified
as follows: 1, mannose; 2, galactose; 3, glucose; 4,





The immunogenicity of P.haemolytica A2 antigens in mice.
P.haemolytica A2 is probably the most important serotype in
sheep pasteurellosis and protection against this serotype is
therefore crucial to the success of any vaccine. However, the
demonstration of protection by A2 SSE in sheep (Gilmour et al,
1983) has not been similarly demonstrated in mice and Evans
(1979) was unable to show protection in her studies in mice.
This failure may have been due to the wrong presentation of
the antigens and the following experiments were designed to
investigate the potency of different preparations of A2 antigens
in protecting against challenge.
In all vaccines except for that containing live cells the
antigens were absorbed onto aluminium hydroxide before
emulsification in oil as described in Materials and Methods.
Vaccines incorporating the SSE,EDTA and PWE antigens of A2
were tested in mice as described in Materials and Methods and
the results are shown in Table 4.3. No protection was evident
with EDTA or PWE preparation although A2 SSE at a concentration
of 280ug dry weight per dose gave significant protection
(P<.001).
A second experiment involved the inoculation of live A2
organisms. One group of 40 mice was challenged twice with an
LD50 of A2, the survivors were kept and 10 of these
re-challenged. A second group was given two s.c. doses of live
A2 organisms (1x10^ per dose) on the same schedule as that of
the other vaccines. These two groups were challenged along with
160
a third group vaccinated with A2 SSE at a concentration of 280ug
per dose. The results (Table 4.4) indicated that the LD50
survivors are protected against challenge (P=<.001) while the
other two groups are not.
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Table 4.3
Counts"'" of P .haemolyitca Al in the livers of unvaccinated
control mice and mice vaccinated with A2 SSE, EDTA or PWE
2
challenged with P.haemolytica A2 (strain S51)
VACCINE VACCINE
DOSE
MEAN COUNT IN LIVER
After 6h
P
A2 SSE (284ug) 4.6 ±1. 4 <.001
A2 EDTA (50ug) 6.2±2 . 0 NS
A2 PWE (50ug) 6.8±0 . 8 NS
Not Vaccinated - 6.9 ±0 . 9
1. Counts = cfu expressed as Log-^g values
2. Challenge dose (3.15 X 10^ cfu)
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Table 4.4
Counts"'" of P .haemolytica A2 in the livers of unvaccinated
control mice, mice vaccinated with A2 SSE or live A2 organisms
and mice surviving LD^q challenge. Challenge with
2
P.haemolytica A2 (strain FA2) .
GROUP Mean count in liver P
after 6h
A2 SSE Vaccine (284ug per dose) 5.83±1.2 NS
A2 live cells (lxlO^cfu per dose) 5.75±1.42 NS
LD50 survivors 3.04±0.99 <.001
1. Count - cfu expressed as l°g^0 values
2. Challenge dose = 1.75 X 105 cfu
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SECTION 4.4
The immunoqenicity of A6 antigens in mice.
The similarities noted between A6 and A1 antigens in the
immunochemical analysis results suggested that there may also be
similarities in the antigens required to stimulate protection in
mice. To test this hypothesis mice were vaccinated with the SSE
and PWE antigens of A6 and Al. The possibility of
cross-protection between PWE antigens was investigated by
heterologous challenge.
The antigens were made up in CFA and the dosages are given
with the results in Table 4.5.
The PWE antigens of both Al and A6 conferred significant
protection against homologous challenge (P=.01) and PWE of A6
also stimulated protection against heterologous challenge
(P=.05). The degree of protection with PWE seems to be less than




Viable counts of P.haemolytica Al or A6 in the livers of control
mice and mice vaccinated with SSE or PWE from P.haemolytica Al
or A6.
VACCINE CHALLENGE (DOSE) VIABLE COUNT (LOG1Q)
CONTROL VACCINATED
Al SSE Al (1.3X106 cf u ml"1) 6.68±1.7 3.4+0.91
Al PWE Al (1.3X106 cfu ml 1) 6.6811.7 4 . 911.8 2
A6 PWE Al (1.3X106 cfu ml"1) 6.6811.7 5.111.93
A6 SSE A6 (2.9X10 5 cf u ml"1) 7.4210.4 2.810.31
A6 PWE A6 (2.9X105 cfu ml"1) 7.4210.4 4.511.7 2
Al PWE A6 (2.9X105 cfu ml 1) 7.4210.4 6.710.9 4
1 = Significant at .001 level (Mann-Whitney ranking test)
2 = Significant at .01 level
3 = Significant at .05 level
4 = Not Significant
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DISCUSSION.
The results of CIE studies on P.haemolytica A2 and A6 SSE
preparations showed some differences from those obtained from Al
SSE. The most obvious was the presence of substantially more
precipitin arcs with A2 and A6 SSE, especially with sheep
antisera. In contrast to the findings with Al SSE, where a major
polysaccharide antigen predominated, the A2 SSE CIE profile
showed no such antigen. Heat treatment of A2 SSE altered the
profile of the 9 precipitin arcs indicating heat lability and
the probability of protein composition for some of these
antigens. With A6 however, the predominant antigen in the SSE
was also the major arc in the PWE and the serotype specific
antigen indicating that a similarity with the serotype antigen
of Al existed and that they are both polysaccharide in nature.
The PWE of A2 was only weakly antigenic although it did show a
mobility and an appearance in gels similar to the slow moving
double humped precipitin line seen with Al PWE (Fig. l.ld). This
is probably not the serotype antigen as it was precipitated by
antisera to A9 indicating that it was not serotype specific
(Fig. 1.3). It may be that the serotype specific antigen of A2
which has been shown to be present in PWE by IHA and ELISA
(section 3.6) is not precipitated in gels.
The comparison of the CIE results from the 3 serotypes Al, A2
and A6 suggests that the antigenic composition of the Al SSE is
simpler than that of A2 or A6 SSE and consists of only 3 or 4
different antigens. However, there may be antibody/antigen
reactions which are obscured by the strong reaction of the
serotype antigens as antigens not seen in the Al SSE homologous
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reaction were precipitated by antiserum to A6. The observation
that the antiserum to A1 precipitates antigens in the A6 SSE
showed that antibodies to antigens other than the serotype
antigen were present in the antiserum. This would seem to imply
that the serotype antigen of A1 obscures the reaction of other
antigens in CIE gels.
The differences seen in the gel profiles when sheep antisera
were used in place of rabbit antisera are possibly related to
the host specificity of P.haemolytica and the way that different
species perceive the chemical configuration of the antigens.
It is possible that rabbits and sheep respond to different
antigens, for example P.haemolytica A2 cells may contain
antigens which mimic sheep cellular antigens thus avoiding the
immune response of sheep. This has been shown to occur in the
polysaccharide K-antigens of E.coli K1 and N.meningitidis group
B where those antigens mimic antigens in human brain tissue
(Finne et al, 1983).
However, studies with A2 antigens indicated that it is
difficult to immunise mice against this organism. The result
with A2 SSE (Table 4.3) was not reproducible (Table 4.4) and the
variation seen in liver counts with this antigen suggests that
although some immunity is given it is not sufficient to protect
fully against challenge. The only effective procedure was to
challenge LD5q survivors and here the liver counts were
consistently low although it is possible that the protection
only reflects innate resistance in certain mice. However the
initial group of mice challenged contained 40 mice of which 18
survived an LD5q challenge and 10 of these a subsequent
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challenge in the mouse model. If this figure is consistent then
approximately 47% of all mice challenged should demonstrate
protection. This does not occur at this frequency with
unvaccinated control mice for A2 challenges or in other serotype
challenges, although frequently one mouse out of ten does not
succumb to challenge. Another possible explanation for the
apparent protection is that the i.p. challenge has stimulated a
non-specific protection.
It is interesting that a high titre antibody response in
sheep to A2 antigens is found only after infection as shown in
Section 3.7. High IHA and ELISA titres of antibodies to specific
serotype antigens of A2 were only obtained after infection of
sheep with live A2. In SPF lambs the highest antibody responses
also occur after challenge with live organisms (Gilmour,
personal communication).
It is known that protection against facultative intracellular
bacteria such as Salmonella and Brucella species is generally
better when living, attenuated vaccines are given rather than
killed organisms (Collins and Campbell, 1982) and the same
authors suggest that perhaps P.haemolytica is a facultative
intracellular bacteria. It is suggested that the improved
immunity associated with live vaccines arises from the continual
production of antigens, some of which may be unique "metabolic
antigens" which react with T lymphocytes. These in turn produce
lymphocytes to activate the macrophages which destroy the
bacteria which induced the initial response.
The possibility that killed antigens were not the same as
when in their native state was suggested by Gilmour et al (1983)
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to explain the need for both SSE and heat killed organisms in A2
vaccines. These authors proposed that the presentation and
quantity of the antigens were important in the induction of
immunity.
The resistance of mice vaccinated with A6 PWE to homologous
challenge is comparable to the Al finding (section 1.2) and
confirms that the PWE contains an antigen which confers
protection on some serotypes. As discussed earlier (section 1)
this is in agreement with the findings of Biberstein and
Thompson (1965) who concluded from studies on mouse protection
that the "capsular" (i.e. the serotype antigen) was more
important than the somatic antigens in stimulating protection.
The results of the mouse protection studies with Al and A6
antigens also demonstrate the possible cross-protective
properties of P.haemolytica PWE antigens. The cross-protection
observed was a one-way cross with A6 PWE conferring protection
against Al challenge. Evans (1979) did not observe
cross-protection in mice vaccinated with SSE antigens where
protection was serotype specific. The cross-protection evident
in A6 PWE vaccinated mice may be explained by the presence of
antigens in A6 PWE which are important in the protection of both
A6 and Al, while Al PWE lacks some of these antigens. Gilmour
(personal communication) has noted that Al and A6 sometimes
cross-react in the IHA test which is normally serotype-specific.
The antigens important in cross-protection may normally be
hidden by cell surface components, even in SSE, and are only
exposed when isolated in the PWE. McCabe et al (1977) reported
that a rough RE mutant of Salmonella minnesota, which possessed
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only KDO and Lipid A components of LPS, conferred more immunity
against challenge with Klebsiella pneumoniae and Proteus
morganii than did the parent strain. However, the homologous
protection with the mutant strain was less than that observed in
the parent strain^ The authors indicated that in addition to
possible disclosure of previously hidden antigens the mutation
to RE may also have produced other component changes in the
outer membrane of the bacterium.
Cross-protection was also observed in section 5 when the SSE
antigens of some group II IHA negative isolates of P.haemolytica
were shown to cross-protect against group I isolates (Section
5.4). However this cross-protection did not extend to the IHA
positive serotypes A1 and A2 so their potential as non-specific
immunisation agents is probably limited to the IHA negative
strains.
Mukkur (1977) demonstrated cross-protection between
P.haemolytica A1 and P.multocida type A when extracts prepared
by potassium thiocyanate treatment of A1 cells were used as
vaccines. It may be that other serotypes of P.haemolytica share
antigens with P.multocida and this could offer a means of
obtaining a common protective antigen.
The chemical analyses showed that the PWE antigens of Al and
A6 were very similar and although the sugar composition of A2
PWE's was similar to the other two the yield of carbohydrate was
low (approx 2%) compared to Al (14.8%) or A6 (12.4%). The sugar
composition of the PWE's were remarkably similar and as found
with Al, two distinct heptoses are present in A6 and A2. The
similarity between the serotypes was further emphasised by the
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composition of the pooled fractions from the Sephadex G50
chromatography of A2 PWE. This showed that A2 and Al PWE had
similar compositions. This finding suggests that the
differences seen in CIE are probably due to configurational
changes in the carbohydrate structure and are not due to the
presence of completely different components. A similar finding
was described by Hatten and Brodeur (1978). They found that
biotypes of Brucella abortus S19 strain could not be
differentiated on their elution from chromatography columns, or
chemical composition but could be differentiated in their
antigenicity on immunodiffusion studies.
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SECTION 5
The surface antigens of some IHA negative isolates of
P.haemolytica.
Up to the present time all isolates of P.haemolytica which do
not serotype with the 15 prototype antisera have been assigned
into a single group. The importance of this group is indicated
by the finding that approximately 11% of all isolates referred
to the MRI in the years 1978 to 1982 belonged to this group
(Fraser et al, 1982a). This is double the percentage from a
survey carried out a few years previously (Thompson et al,1977).
Biberstein et al (1960) and Aarsleff et al (1970) used type
specific antisera and agglutination tests and did not discover
any groupings within their IHA negative isolates; autoclaved
cells fom these isolates either reacted with more than one
antisera or failed to react at all. These workers have
speculated that the IHA negative isolates are members of the 15
IHA positive serotypes and this absence of reactivity in the IHA
test results from lack of soluble serotype antigen on the cell
surface.
However, recent work by Frank (1980) on ten IHA negative
isolates from cattle has shown that those isolates could be
grouped into 3 serotypes on the basis of their reactions in a
rapid plate agglutination (RPA) test. Frank proposed that these
serotypes are distinct from the established IHA positive
serotypes and because of this that all IHA negative isolates
should be examined for specific serotype antigens by the RPA
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test.
As the MRI provides a P.haemolytica serotyping service for
the U.K. a large number of IHA negative isolates have been
identified and stored. The serological techniques used in the
analyses of Al antigens were applied to the investigation of the
antigenicity of some of these IHA negative isolates and the
following experiments were carried out.
173
SECTION 5.1
The analysis of the surface antigens of IHA negative isolates
by rapid plate agglutination), agarose gel diffusion and
Immunoelectrophoresis.
Thirty one isolates of P.haemolytica which were referred to
the MRI for serotyping but which failed to react in the IHA test
were recovered from storage at -70°C. They were confirmed as
P.haemolytica by colonial morphology and on the basis of the
biochemical characteristics described by Biberstein (1978). They
were biotyped by their ability to ferment either arabinose or
trehalose (Biberstein, 1978). All IHA negative isolates tested
belonged to the A biotype.
Six isolates, UT5, 6, 7, 10, 18 and 19 (all ovine isolates)
were selected from the collection and antiserum to each
individual isolate was raised in rabbits by the
hyperimmunisation schedule given in Materials and Methods. The
cells of these six isolates were extracted with sodium
salicylate and this was further extracted with hot phenol-water
as described in Materials and Methods. The six isolates were
examined initially in the RPA test and subsequently with AGD and
CIE methods as described in Materials and Methods.
The six isolates were examined in the RPA with rabbit
antiserum and the results are shown in Table 5.1. These
indicated that two distinct serogroups were present, one group
containing UT5, 7, 18 and 19 and the second UT6 and 10.
However, when representative antisera from these two groups (UT6
and UT18) were absorbed with each other's cells and used to
examine the remaining isolates in the collection (Table 5.2) it
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was found that 7 isolates were agglutinated with antiserum to
UT6, 6 with antiserum to UT18, 3 isolates were agglutinated with
both antisera, one isolate autoagglutinated and the remaining 14
isolates were not agglutinated by either antiserum.
When the SSE antigens of the initial six isolates were tested
in AGD against homologous antiserum and antisera to the other 5
isolates the results confirmed the existence of the two groups
found in the RPA test. The patterns obtained when the six SSE
preparations were tested against antisera to UT6 or UT18 were
representative of the two groups and are shown (Fig 5.1.) Two
distinct precipitin lines were present in reactions between
antiserum and antigens of isolates in the same group. The was no
reaction visible between antiserum and antigens from different
groups. When PWE antigens were tested with the group
representative antisera, the two groups were again easily
distinguished although only one precipitin line was obtained in
the homologous reaction. (Fig 5.2).
The results indicated that antigens important in
distinguishing serogroups of IHA negative isolates could be
precipitated in gels with antiserum and that they were contained
in phenol-water extracts.
The pattern obtained when the SSE antigens of UT18 were run
against homologous antiserum in CIE is shown in Figure 5.3a. Two
antigens are clearly precipitated in the gel. The larger of the
two precipitin line stretches back to the origin and runs just
behind the smaller. Within the larger precipitin arc there
appears to be more than one antigen. When UT6 SSE antigens were
similarly examined one major precipitin line was observed with a
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possible second line present just in front at the anodic side
(Fig 5.3b). The specificity of these antigens for the group is
seen by the precipitation of UT18 SSE in an intermediate gel
containing antiserum to UT7 (Fig 5.3c) but not one containing
antiserum to UT6 (Fig 5.3d). The AGD result demonstrated that
the PWE contained the group-specific antigens and this was
confirmed when UT6 and UT18 PWE antigens were run in CIE. The
patterns obtained when UT6 and UT18 were tested with homologous
antisera are shown in Figure 5.4a and d respectively. Two
distinct antigens were precipitated in each case, and with UT18
PWE, these were very similar to those seen in the reaction with
the SSE of this strain (Fig. 5.3a). The incorporation of
heterologous antisera into intermediate gels did not impede the
antigens of UT6 or 18 and these precipitated in the homologous
gel (Fig. 5.4b and e). However, when UT6 PWE antigens were run
through an intermediate gel containing antiserum to UT10 the
antigens were precipitated in the intermediate gel (Fig. 5.4c).
Similar reactions occurred when UT18 PWE antigens were run
through intermediate gels containing antisera to one of the
following; UT5, 7 or 19. The reaction for UT5 is shown (Fig.
5.4f). The group-specificity of the antigens is therefore
confirmed by these results.
The cross-reactivity which has already been shown to exist
between the SSE's of different IHA positive serotypes (Section
4.1) was also shown to be present between an IHA positive
serotype and an IHA negative isolate. The SSE from UT5 was run
in CIE with an intermediate gel containing antiserum to A2 (Fig.
5.5). The gel shows that 4 distinct antigens react with
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antisera to A2 but not the group-specific antigen which
precipitates in the main gel containing antiserum to UT5.
When the PWE of the two groups were tested on AGD against
antisera to the IHA positive serotypes only one reacted.
Antiserum to All reacted strongly and specifically with the
antigens of UT6 and 10. This reaction was one-way and antiserum
to UT6, absorbed with UT18 cells, did not react with All
antigens in IHA, AGD or CIE. The reaction of antiserum to All
with UT6, UT10 and All antigens in AGD are shown in Figure 5.6a.
The homologous antigen is different from the heterologous
antigens as seen by the non-identity of the precipitin areas.
In addition, there is no observable reaction between antiserum
to UT6 and All antigen (Fig. 5.6b).
It would appear that the antiserum to All recognises an
antigen in the IHA negative group which is not present in the
homologous All extracts.
These results have demonstrated that group specific antigens
were present, presumably on the surface of the cells of IHA
negative isolates. The RPA was not reliable enough to group all
the isolates but AGD and CIE tests have shown that the group
specific antigens can be precipitated with specific homologous
antiserum. Furthermore the presence of these antigens in




The RPA reations of six IHA negative isolates of P. haemolyt ica.
CELLS RPA REACTION WITH THE FOLLOWING ANTISERA
UT6 UT10 UT5 UT7 UT18 UT19
UT6 + + - - - -
UT10 + + - - - -
UT5 - - + + + +
UT7 - - + + + +
UT18 _ - + + + +
UT19 - - + + + +
+ = Agglutination
- = No agglutination
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Table 5.2
The response of IHA negative isolates when tested with antisera
to UT6 and UT18 in the RPA test.
ISOLATE AGGLUTINATION WITH ISOLATE AGGLUTINATION WITH
ANTISERA TO ANTISERA TO
UT6 UT18 UT6 UT18
UT2 - - 28 - -
3 - - 29 + -
5 - + 30 + +
6 + - 31 + -
7 - + 33 - -
8 - + 34 + -
10 + - 35 - -
18 - + 36 - -
19 - + 37 - -
21 - - 38 - -
22 + + 39 - +
23 + + 40 - -
24 - - 42 - -
25 - - 43 + -
26 - - 44 + -
27 AA AA
+ = Agglutination
- = No agglutination
AA = Auto agglutination
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Figure 5.1
The agarose gel precipitin patterns obtained with
a)the antiserum to UT6 and b)the antiserum to UT18
diffused against the SSE antigens (40ug) of 1)UT5,
2)UT6, 3)UT7, 4)UT10, 5)UT18 an 6)UT19. The gel was




The agarose gel diffusion patterns obtained with
a)the antiserum to UT6 and b)the antiserum to UT18
diffused against the PWE antigens (lOug) of l)UT5f
2)UT6, 3)UT7, 4)UT10, 5)UT18 and 6)UT19. The gel was




Crossed Immunoelectrophoresis of UT18 SSE (40ug) run
against lOOul of homologous antiserum with an
intermediate gel containing a)no antiserum c)30ul of
antiserum to UT7 and d)30ul of antiserum to UT6. The
SSE of UT6 (40ug) was run against lOOul of homologous
antiserum with no antiserum in the intermediate gel




Crossed Immunoelectrophoresis of UT6 PWE (lOug)
against lOOul of antiserum to UT6 with the
incorporation of an intermediate gel containing a)no
antiserum, b)antiserum to UT18, c)antiserum to UT10.
UT18 PWE (lOug) run against lOOul of antiserum to
UT18 with the incorporation of an intermediate gel
containing d)no antiserum, e)antiserum (30ul) to
UT10, f)antiserum (30ul) to UT5. The boundaries
of the intermediate gels are shown by the dashed




Crossed Immunoelectrophoresis of UT5 SSE (40ug) run
against lOOul of rabbit antiserum to UT5 with the
incorporation of an intermediate gel containing a)no
antiserum, b)antiserum (30ul) to A2. The gel was




The agar gel diffusion patterns obatined with
a)antiserum to All and b)antiserum to UT6 diffused
against the PWE antigens of 1)UT5, 2)UT6, 3)UT7,





The serogrouping of IHA negative isolates of P.haemolytica
by countercurrent Immunoelectrophoresis.
The results obtained in the previous section showed that the
serogroup antigens of IHA negative isolates were demonstrable by
AGD and CIE. However, both of these tests are time consuming
and other disadvantages, such as the amount of antisera required
for CIE and the insensitivity of AGD, make them unsuitable as a
routine laboratory test for serogrouping large numbers of
isolates. Countercurrent Immunoelectrophoresis (CCIE) utilises
small volumes of reagents and as a result of electrophoresis is
a rapid and sensitive test. The potential of this method was
examined.
The CCIE method is described in Materials and Methods. The
SSE and PWE antigens of the six isolates were run against
antisera to UT6 and UT18. The patterns obtained again confirmed
the presence of two groups with no heterologous reactions
present. This demonstrated the suitability of the CCIE method
for serogrouping the isolates. However, as both SSE and PWE are
relatively complicated extracts to prepare , a better antigen
would be preferable. As heating P.haemolytica cells at
56°C released IHA antigen into solution (personal observation),
it was possible that heating IHA negative cells at 56°C for 45
min would have a similar effect. The supernate from this
procedure was used as antigen (HE antigen). The method is fully
detailed in Materials and Methods .
The HE antigens of the six isolates were examined by CCIE and
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it was found that the reactions were similar to those obtained
with SSE and PWE antigens. The antisera to the two
representative isolates UT6 and UT18 were then used to examine
all the other isolates in the collection. Three isolates, UT34,
43 and 44 reacted specifically with antiserum to UT6 and two
isolates, UT8 and UT39, with UT18. No other HE antigens
reacted. A further six isolates were selected from those which
did not react and were used to hyperimmunise rabbits. By the
continued use of this system of elimination and selection a
total of ten groups have been identified in the collection of 31
isolates. The isolates present in each group and their origin
are shown in Table 5.3.
An example of the precipitin line obtained with CCIE is shown
(Fig. 5.7). The rabbit antiserum to isolate UT23 (groupIV) was
absorbed with the cells of representative members of all other
serogroups and reacted with the HE antigens of various isolates.
It reactes specifically with UT23, UT30 and UT33. The
precipitin reaction comprises two closely spaced precipitin
lines.
The results of this experiment demonstrated that the 31 IHA
negative isolates can be serogrouped by CCIE using HE antigens.
There does not appear to be any correlation between the




The distribution of IHA negative isolates into serogroups
established by CCIE.
SEROGROUP ISOLATE No. ORIGIN1 TOTAL
OVINE BOVINE
I 6,10,34,43,44 3 2 5
II 5,7,8,18,19,39 6 0 6
III 3,21,22,24,25 1 4 5
IV 23,30,33 2 1 3
V 2,42 1 1 2
VI 26,28 2 0 2
VII 29,31,36,37 4 0 4
VIII 27 1 0 1
IX 35,40 1 1 2
X 38 1 0 1
1 - Origin = Species from which isolate was recovered.
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Figure 5.7
CCIE of antiserum to serogroup IV (a) reacted with
the HE antigens (h) of several IHA negative isolates.
The antiserum shows reactions with DUT23, 2)UT30 and
3)UT33.
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SECTION 5.3
The seroqrouping of North American IHA negative isolates of
P.haemolytica by CCIE and the correlation of these serogroups
with those found by RPA.
The ten IHA negative isolates of P.haemolytica examined by
Frank (1980) together with 3 rabbit RPA serotype antisera were
obtained from Dr. G. Frank, (National Animal Disease Centre,
Ames, Iowa, USA.). One isolate, 148-78, was lost in transit and
unfortunately this was the sole representative of Frank's group
3. The surviving 9 isolates were reconstituted in nutrient
broth , subcultured on 7% SBA and HE antigens prepared.
All the isolates obtained from Dr. Frank did not react with
homologous antisera nor with IHA typing sera in the IHA test.
The three RPA antisera did not react with the 15 prototype IHA
serotype antigens.
When the HE antigens of Franks's isolates and the antisera to
those isolates were tested in CCIE the results obtained were
identical to those reported by Frank (1980) for the RPA
reaction (Table 5.4).
At the time these examinations were carried out only antisera
to the first 5 of MRI's IHA negative serogroups were available
and none of these reacted with the HE antigens of Frank's
isolates in CCIE. However, when the representative strains of
the 10 groups were examined, it was found that UT35 (Group IX)
reacted with antiserum to isolate 282-76 (Table 5.5).
The results indicated that there is complete correlation
between CCIE and RPA methods in the serogrouping of Frank's
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isolates. As MRI Group IX is identical to Frank's group 2 it
means that Frank's other two groups can be added to the 10 from
MRI and the number of serogroups extended to 12.
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Table 5.4
Results of RPA and CCIE tests on Frank's IHA negative isolates
when reacted with antisera to Frank's three "serotypes".
ISOLATE RPA1 WITH ANTISERA TO CCIE WITH ANTISERA TO
194.76 282.76 148.78 194. 6 282.76 148.76
1. 171-85 + _ + -
2. 194-76 + - + -
3. 253-76 + - + -
4. 275-76 + - + -
5. 288-76 + - + -
6. 290-76 + - + -
7. 282-76 - + - +
8. 88-76 - + - +
9. 148-78 - + - +
1 - Frank's results (1980)
+ = Positive reaction
- = Negative reaction
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Table 5.5
The reaction of Moredun IHA negative serogroup HE antigens with
antisera to Frank's "serotypes" in CCIE.
CCIE HE ANTIGENS OF
ANTISERA TO MOREDUN FRANK'S
SEROGROUP SEROTYPES
I II III IV V VI VII IX X 194-76 282-76
194 - 76 _________ +
282 - 76 ____ ___ + _ _ +







The protective immunity of SSE preparations from IHA negative
isolates.
Immunity to some of the IHA positive serotypes of
P.haemolytica has been shown to be serotype specific (Gilmour et
al, 1979, 1983) and work described in this thesis confirms this
for P.haemolytica Al (section 1) and A6 (section 4). This
immunity in mice is conferred by a serotype-specific antigen.
If the IHA negative isolates are important in pathogenesis it
would be benificial to be aware of the possible immunising
properties of the serogroup antigens.
SSE was prepared from IHA negative isolates, UT5 and UT18
(groupll) and UT6 (group I), made into vaccines with aluminium
hydroxide and oil and tested in the mouse model for
P.haemolytica infection as described in Materials and Methods.
In the first experiment mice vaccinated with UT5 SSE (284ug
per dose) were challenged with UT5, UT7, UT18, UT19 (group II),
UT6, UT10 (group I) and serotype A2. The results are shown in
Table 5.6. These show that protection against all of group II
isolates except for UT19 is significant (P=0.001) and that
significant protection extends to challenge with group I
isolates (P=0.01). There was no protection against A2
challenge.
In a second experiment mice vaccinated with UT6 SSE or UT18 SSE
(56.8ug per dose of vaccine) were challenge with UT6, UT18 and
Al. The results are shown in Table 5.7. Both antigen
preparations gave protection against homologous challenge
(P=0.01 for UT6 and P=0.05 for UT18). The SSE antigen of UT18
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conferred protection against UT6 challenge (P=0.05) but UT6 SSE
did not confer protection against UT18 challenge. Neither
antigen protected against A1 challenge.
The results of the first experiment indicate that although
the serogroup antigens are involved in protection they are not
the sole antigens. The cross-protection seen between the
serogroups and the complete lack of protection to UT19 challenge
suggest that other antigens play a role in protection. The
second experiment, confined to two serogroups demonstrates again
that cross-protection is evident between the groups. However,
the cross-protection here is one way, group II antigens protect
against group I strains but not the converse. There is some
indication that UT6 is a weak pathogen in mice as the control
mice challenged with this isolate had a mean liver count of only
logio 4.04 cfu in the first experiment and log^g 3.79 cfu in the
second. These are the lowest counts in any of the challenges.
The cross-protection found between serogroups did not extend to




Counts'*" of P •haemolytica in the livers of unvaccinated control















UT5 (Group II) 5.83 6.37+1.5 2.7410.28 0.001
UT7 (Group II) 5.85 6.70±0.9 3.60+1.0 0.001
UT18(Group II) 6.1 6.8010.4 4.60+1.6 0.001
UT19(Group II) 6.28 6.70+0.3 5.50+1.6
3
NS
UT6 (Group I ) 6.3 4.04+1.26 2.76+0.2 0.01
UT10(Group I ) 6.6 7.9010.5 6.5011.7 0.01
A2 6.24 7.30+0.7 7.60+0.5 NS
1. Counts = cfu expressed as log^O values
2. P = vaccinated group compared with control group in Mann-
Whitney ranking test




Counts"'" of P.haemolytica in the livers of unvaccinated control
mice and mice vaccinated with UT6 or UT18 SSE after challenge
with homologous and heterologous P.haemolytica isolates.
VACCINE CHALLENGE CHALLENGE MEAN LIVER COUNT IN P
(56.8ug) ISOLATE DOSE (cfu)
CONTROL VACCINATED
GROUP GROUP
UT6 SSE UT6 (Group I ) 6.18 3.79 ±1.1 2.73±0.09 0.01
UT6 SSE UT18(Group II) 5.88 4.7 0 ±1. 6 4.70±1.36 NS
UT6 SSE Al 6.08 6.25 ±1. 7 7.38 ±0.50 NS
UT18 SSE UT6 (Group I ) 6.18 3.79±1.1 3.03±0.40 0.05
UT18 SSE UT18(Group II) 5.88 4.70±1. 6 2 . 80±0 . 9 0.05
UT18 SSE Al 6.08 6.25±1.7 6.1712.1 NS
1. Counts = cfu expressed as log10 values




The pathogenicity of IHA negative isolates for mice and SPF
lambs.
Although Biberstein et a_l (1960) and Aarslef et al (1970)
described agglutination studies with IHA negative isolates they
did not study the pathogenicity of the isolates.
As IHA negative islolates can be subdivided on the basis of
serogroup antigens it is possible that they also vary in their
pathogenicity. Their relative pathogenicity for mice can be
established by the mouse LD,-q test. However, as the mouse is
not the natural host a much more relevant assessment can be
carried out in sheep by the SPF lamb model for infection
developed at MRI by Sharp et al (1978).
The mouse LD,-q of a representative strain from each of nine
serogroups, I to IX, was measured using the method given in
Materials and Methods. The method of infection used in SPF
lambs has also been described in Methods and Materials.
The mouse results are given in Table 5.8. There are
marked differences in the virulence of the isolates. Isolate
UT2 is the most virulent (LD,-q=2.58x10^ cfu) with UT3 and UT5
slightly less virulent (LD^q=i.08xl06 cfu and 4.2x10^ cfu
7
respectively). All the rest have LD^q values of > 1x10 cfu.
On the basis of these results, which were the average of two
assessments, an isolate of high virulence, UT2, and an isolate
of lower virulence, UT18, were chosen to challenge SPF lambs.
After challenge of two groups of 4 SPF lambs no clinical,
pathological or bacteriological evidence of pasteurellosis was
found in the lungs. P.haemolytica isolates recovered from the
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upper respiratory tract of lambs in both groups were tested in
CCIE and found to correspond to the serogroup of the strains
administered in the aerosols.
Representative members of nine IHA negative serogroups have
been shown to differ in their virulence for mice. However, even
the most virulent of these, UT2, does not appear to be
pathogenic in the SPF lamb model for P.haemolytica infection.
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Table 5.8
Mouse LD,-q values for representative isolates of IHA negative
serogroups I to IX.
SEROGROUP ISOLATE ^SQ1
I UT6 6.21 X 10' cfu
II UT18 1.1 X 107 cfu
III UT3 1.7 X 106 cfu
IV UT3 0 3.1 X 107 cfu
V UT2 2.58 X 105 cfu
VI UT26 6.48 X 107 cfu
VII UT29 2.2 X 107 cfu
VIII UT27 6.2 X 107 cfu
IX UT35 2.2 X 106 cfu
1. LD,-q = Mean of two measurements.
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DISCUSSION
The first experiments showed that all of the IHA negative
strains belonged to the A biotype and that the 31 strains could
be separated into ten serogroups. These results are in broad
agreement with the findings of Frank (1980). He found that
three distinct serotypes could be identified with the RPA test
among ten isolates from the nasal cavities of cattle. Although
the initial RPA results of this study were promising , in that
two groups were discovered in six isolates, the test was not
satisfactory when applied to all the isolates in the collection.
This may have been due to cross-reacting antigens on the surface
of the IHA negative strains which have been described by
Biberstein et al_ (1960) and Aarslef et al (1970). Although
cross-absorption was carried out with the two initial groups it
may not have been effective in stopping agglutinating activity
with other isolates.
The dominance of the IHA serotype antigen in CIE has already
been demonstrated for IHA positive serotypes (Section 1.1 and
4.1) and a similar situation exists for IHA negative serogroup
antigens. Two specific antigens or at least antigens that do
not cross-react with heterologous antisera, are seen in CIE for
serogroups I and II. Although CIE was not carried out on
isolates from other groups the presence of distinct specific
precipitin lines, in homologous reactions in CCIE, would seem to
indicate that this observation with groups I and II holds for
all the serogroups. The presence of these antigens in PWE
suggests that they are similar to the serotype antigens of Al,
A2 and A6 (Section 1 and 4) and that they are probably the same
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type of molecule (i.e. a cell surface carbohydrate). However,
as the IHA negative strain antigens do not react in the IHA test
there must be important differences between these and the IHA
positive antigens. The cross-reaction of antiserum between All
and group I antigen is unusual as the HE antigen of All does not
seem to contain the cross-reactive antigen.
The general lack of cross-reactivity that the serogroup
antigens exhibit with IHA positive serotypes, with the exception
of All, strongly suggests that IHA negative isolates are in
groups distinct from the IHA positive serotypes. It has
previously been suggested that IHA-negative isolates were in
fact IHA positive serotypes which somehow lacked the soluble
serotype antigen (Biberstein et al, 1960). Although this
suggestion may explain the All-group I cross-reaction it does
not seem to hold for the other serogroups.
The demonstration that CCIE separated Frank's 9 strains
into the same serogroups that he found with RPA confirms his
results and shows the usefulness of CCIE. The placing of
Frank's isolate 282/76 in serogroup IX shows that some IHA
negative serogroups are found in both North America and in
Britain.
As 12 serogroups (10 at MRI and 2 in the USA) have now been
identified in only 41 isolates it would appear that there may be
as many if not more IHA negative serogroups as IHA positive
serotypes. This is interesting as IHA negative isolates only
account for 11% of all isolates referred for serotyping (Fraser
et al, 1982a).
The recovery of IHA-negative isolates from pneumonic lesions
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suggests that they are pathogenic for sheep but no experimental
evidence has yet been produced to substantiate this theory.
Virulence studies in mice indicated that isolate UT2 was highly
virulent compared to the rest although the (2.58xl05 cfu)
was similar to that recorded for IHA positive serotype Al
(2xl0^cfu) by Evans (1979). However, it was not pathogenic
for SPF lambs which have been used successfully for
demonstrating the pathogenicity of A biotype IHA positive
serotypes Al, A2, A6, A9 (Gilmour et al., 1979 ; Gilmour et al,
1983). This suggests that IHA negative isolates may have
reduced pathogenicity compared to the IHA positive isolates
although other IHA negative isolates should be tested before
coming to firm conclusion. Gilmour (personal communication) has
found that a T biotype, (serotype T10) isolate was not
pathogenic in this SPF lamb model and it may be that although
IHA negative and T biotype isolates are recovered from pneumonic
lesions they are not the primary P.haemolytica organism and are
present in conjunction with a more pathogenic A serotype.
The immunisation of mice with SSE from group I and group II
isolates showed that although protection was associated with the
serogroup antigen where UT6 SSE (group I) was used there was
some indication with UT5 and UT18 (group II) SSE's that
cross-protection against group I was present. The
cross-protection was probably due to factors other than the
serogroup antigen. The whole question of cross-protecting
antigens relating to IHA positive and IHA negative isolates is
discussed in Section 4. However another factor in apparent
cross-protecting may be the weak pathogenicity of the UT6
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isolate which has been discussed earlier (Section 5.4).
This aspect of mouse pathogenicity and its relationship to
possible pathogenicity in the sheep is one which raises
questions about the validity of the mouse model for
P.haemolytica studies. The converse situation existed for
serotype A2 where it had been impossible to demonstrate
protection in mice but protection with SSE and HKO has been
shown in sheep (Glimour et al, 1983). It may be that, although
the mouse model can be usefully employed to screen for possible
protective
antigens, it cannot be assumed that the same response to these
antigens will occur in sheep and vice versa. There is an
obvious need to establish a correlation between mouse and sheep
results to avert any possible misinterpretation. The mouse
ELISA described in section 3 may offer one avenue of future
interest as the titre of antibodies to specific antigens may
correlate with a degree of protection as has been already shown
for Neisseria meningitidis vaccines. Goldschneider et al (1969)
have demonstrated that the level circulating antibodies in
humans is proportional to the bactericidal effect of the sera
and hence its protective ability.
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GENERAL DISCUSSION
The primary aims of this study were to identify, isolate and
characterise the protective antigen or antigens of P.haemolytica
A1 and, if found, to ascertain whether antigens with similar
properties existed within the other A biotype serotypes. In the
course of this study the discovery of serotypes within the
untypable group of P.haemolytica isolates from cattle in the
USA was reported by Frank (1980). The techniques used in
examination of Al antigens were applied to those of the
untypable isolates recovered from both sheep and cattle in the
UK.
The general discussion collates information obtained during
the course of this study and suggestions are made for future
research which may provide additional useful data.
The importance of a phenol-water extracted carbohydrate
antigen from Al as a protective antigen was demonstrated in mice
and furthermore the same type of extract made from A6 cells
contained the protective antigen for this serotype. This is in
agreement with earlier work reported by Cameron (1966) who
showed that LPS antigen, obtained by phenol-water extraction of
whole cells, conferred protection. However, it is in
disagreement with the findings of Tadayon and Lauerman (1981)
who did not obtain protection in mice or hamsters with LPS but
found that a potassium thiocyanate (KSCN) extract was the most
effective. These workers did not give details of the serotype
or the challenge method used so it is difficult to assess the
results in relation to those presented here.
One of the aims of this thesis was to characterise the
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protective antigen and although the LPS has been identified and
shown to contain the serotype specific antigen it has not been
possible to relate the composition of the molecule to the
differences that are detected serologically between the
serotypes. Structural analyses using methylation of molecules
should be carried out to determine the basis for the serotype
differences. Methylation analysis has already been used to
determine the LPS structure of Yersinia pseudotuberculosis type
III (Gorshkova et al, 1980).
However, the CIE results indicated that more than one antigen
was present in the PWE of Al and it would be essential to
isolate the serotype antigen in a pure form before proceeding.
Although it was not possible to do this by affinity
chromatography other methods of separation, such as ion exchange
columns or isoelectric focussing, might be successful. The full
identification of the two heptoses present in the PWE of the
three serotypes was not achieved in this work although alditol
acetate derivatives from a number of different heptoses were
compared on GC with them. Further work on this may reveal
whether these heptoses are peculiar to P.haemolytica, and
whether they form part of the same molecule or number of
different molecules on the surface of P.haemolytica.
Previous studies on P.haemolytica LPS have concentrated on
the endotoxic aspects of this component. Keiss et al (1964)
working on a bovine isolate calculated that 25% of the total
cell dry weight was endotoxin. This was based on measurement of
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the dermotoxic effect in rabbits and the haemodynamic effect in
sheep and would appear to be exagerated.
A more recent report by Rimsay et al (1981) on serotype A7
showed that LPS extracted from P.haemolytica by the
phenol/chloroform/ether (PCE) method of Galanos et a^ (1969) for
rough LPS or the hot phenol-water method of Westphal et a_l
(1952) for smooth LPS accounted for 10% of the dry cell weight and
had different biological effects.The isolated polysaccharide
from the rough LPS was less endotoxic than smooth LPS but was
still able to induce non specific protection in mice against
challenge exposure with S.typhimurium.
The authors suggested that the polysaccharide from rough LPS
could possibly be used to stimulate non specific protection in
animals. However, no measurement of specific P.haemolytica
antigenicity was attempted and it is possible that the
polysaccharide of the rough LPS does share some antigenic
determinants with S.typhimurium or that the PCE treatment has
exposed core determinants which would otherwise have been hidden
in the smooth LPS.
The results of the mouse protection tests indicated that on
some occasions the protection afforded by the PWE was not as
strong as that given by SSE (Sections 1.2, 4.4). It is known
that some purified bacterial polysaccharides are notoriously
poor immunogens (Schneerson et al, 1980a) and this may explain
the apparent weaker immunogenicity of the PWE.
The use of an adjuvant may improve the immunogenicity and
Wells et al (1979) have shown that the serum antibody response
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to P.haemolytica Al SSE antigens is higher when the antigens are
first absorbed onto alhydrogel then emulsified in incomplete
Freund's adjuvant than when the antigens are emulsified in
complete Freund's adjuvant, incomplete adjuvant or absorbed onto
alhydrogel alone.
However a more interesting approach is that taken by Svenson
et a_l (1979 ) who prepared artificial S. typhimurium vaccines by
covalently linking "0" antigen polysaccharides to diphtheria
toxin or isolated porin proteins from S.typhimurium. These were
compared for protective efficacy with a third vaccine containing
only porins, against homologous S.typhimurium challenge in mice.
The vaccine containing "0" antigen linked to porins was the most
efective but porins alone were also protective. However, porins
are unlikely candidates for vaccine components as they are
difficult to prepare.
Experiments with the "0" antigen linked to a much more
readily accessible protein, bovine serum albumin, were performed
and also found to be successful (Jorbeck et al, 1981).
Schneerson et a_l (1980b) has reported that H.influenzae type b
polysaccharide antigen is a more effective immunogen when linked
to bovine serum albumin and suggests that this may be due to a
change from T independent to a T dependent antigen.
The protective property of the PWE antigen suggests that it
should be considered as a possible vaccine component for sheep
vaccines against pasteurellosis although the preparation
procedure might be too elaborate for commercial firms. However,
the trend displayed by companies involved in the production of
vaccines for animal health is towards multivalent vaccines
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comprising a number of different organisms. One of these
contains antigens giving immunity to seven different clostridial
related diseases and also the antigens from 8 serotypes of
P.haemolytica (Heptavac P, Hoechst U.K., Walton, Milton Keynes,
Bucks). If.this trend is continued then the requirement will be
for the refined antigens important in protection with all other
superfluous material removed. Under these circumstances the PWE
antigen may appear a more acceptable antigen and suggests that
its effectiveness in sheep should be examined .
The presence of other protective antigens cannot be ignored
and Cameron (1966) indicated that the protein as well as the
carbohydrate antigens were important in immunity. Biberstein
and Thompson (1965) concluded that other antigens apart from the
IHA antigen played a role in immunogenicity to A2. It may be
that the situation is similar to that found with N.meningitidis
where 3 main serogroups can be identified on the basis of their
capsular antigen. The capsular antigens of two of the groups, A
and C, are protective immunogens when challenged by their
respective serogroups but the B antigen does not confer
immunity. It has been shown that immunity to this group resides
in an outer membrane protein (Goldschneider, et a_l 1969). The
protein antigens of all the P.haemolytica serotypes should be
examined for possible protective immunogenicity.
The use of the Western blotting method (Towbin et al, 1979)
in the examination of bacterial antigens has been reported
(Virji et al, 1983) and the SDS-PAGE separation combined with
serological examination makes this a powerful tool in the
analysis of antigens. A detailed antigenic study of the
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antigens on the cell surface of P♦haemolytica could be
undertaken utilising a range of antisera from sheep which have
differing immune status. This could yield information on the
antigens which are important during infection and hopefully in
immunity.
Another approach would be to produce monoclonal antibodies
(Kohler and Milstein, 1975) to P.haemolytica antigens and to use
these as probes for detecting and analysing the surface
antigens. Apicella et al (1981) have applied the monoclonal
antibody technique to the analysis of N.gonorrhoeae and
N.meningitidis LPS antigens and shown the presence of a shared
determinant on these molecules. Monoclonal antibodies raised
against P.haemolytica antigens could be utilised in a number of
ways such as the identification of antigens when combined with
the Western blotting technique (Virji et a_l, 1983), location of
antigens on the cell surface on electron microscopy,
incorporation onto an immunosorbent column for the removal of
the antigen from a complex mixture of antigens (Momoi et al,
1980) and perhaps even the passive protection of mice to
determine any protection endowed by the antibody.
Protection against challenge by P.haemolytica A2 was not
demonstrated consistently in mice given inactivated vaccine but
with mice surviving an LD5g dose of A2 there appeared to be
solid immunity. This suggests that protection requires antigens
which are either particularly labile or not extractable and that
they can only be presented properly on live cells. If either is
true then the protection might best be effected by vaccination
with live bacteria. Wei and Carter (1978) have shown that
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streptomycin dependent mutants of P.multocida can be produced
and that they can stimulate immunity in mice and rabbits when
given as a vaccine. More recently Kucera et al (1983) have
reported that a strain of P.haemolytica Al, which had been grown
in media containing acriflavine was attenuated as measured by a
decrease in virulence for mice. This strain was used to
immunise cattle by intra muscular inoculation and shown to
protect the cattle against intratracheal challenge. It may be
possible to treat A2 strains in either of the two ways described
to produce vaccine strains.
Another possibility is that the cytotoxin associated with
P.haemolytica, which has been described in cattle strains by
Maheswaren et al (1980), is an important pathogenic effector
mechanism and immunity to this would be important in protection.
The cytotoxin is specifically active against the phagocytic
cells of ruminants but not for other cells in the ruminant or
the cells of other species which have been tested. (Sutherland
et al, 1983). Interestingly ultraviolet killed cells , LPS and
SSE of Al do not exhibit cytotoxic activity so it is not thought
that the toxin is a cell surface component but that it has to be
elaborated by living cells. This cytotoxin is only present in
the supernatant fluid of growing cultures or detected when
living cells are .present . A. Sutherland (personal
communication) has demonstrated that the toxin can be
neutralised by convalescent sheep sera and by sera raised
against live cells and must therefore be produced in vivo.
Immunization against this toxin may offer the host a defence
against one of the bacterium's earliest effects, that of killing
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the phagocytic macrophages in the lung. Again this would be
produced by a live vaccine strain. The apparent specificity of
the toxin for the phagocytic cells of ruminants may be connected
with limited range of species in which P.haemolytica is
naturally pathogenic.
The ELISA methods which were developed in this work could be
further improved if the serotype antigen found in the PWE was
purified as suggested above. The absorption studies (Section
3.1) showed that a large proportion of the serotype specific
activity resided in the PWE antigens. However, the observation
that SPF lambs, even before vaccination, had antibody that
reacted with A9 PWE suggests that the sensitivity of the test
may detect the presence of antigens in P.haemolyitca which are
present in other bacterial species. Although it may be due to an
individual antigen it could be the result of shared determinants
present on the LPS, as is the case between Vibrio cholerae and
E. coli, Salmonella and Citrobacter species (Winkle et a_l, 1972).
It would be difficult to remove the cross-reacting
determinant in these cases.
The serotype specific ELISA could be applied to the
measurement of antibodies against a single serotype in serum
from conventional animals vaccinated with a multivalent
pasteurella vaccine or in the sera of sheep undergoing infection
with a P.haemolytica strain. Although this is also possible with
the IHA the ELISA has the combined attributes of its sensitivity
and the capability of measuring different classes of antibody.
This is of particular importance in the lung where immunity to
P.haemolytica is thought to be important. Smith et al (1975)
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showed that IgA was the major immunoglobulin in the ovine lung
and it would seem important to establish the class and role of
pulmonary antibodies to P.haemolytica in the immune animal as
this would allow the development of vaccines designed to
specifically stimulate the correct type of response.
The ELISA technique using very small volumes (lOul) of mouse
blood was highly sensative for measuring antibody titres to
P.haemolytica in mouse sera. This could extend the usefulness
of the mouse model for P.haemolytica infection (Evans and Wells,
1979a) by affording a screening procedure for potential vaccine
components such as the A1 PWE which was shown to stimulate
antibodies against itself (Section 3) . With this ELISA it
would also be possible to measure the minimum dose of antigen
required to stimulate an antibody response and to correlate
antibody titre with a protective dose. This in turn may lead to
the same procedure in sheep where evaluation of the protective
capability of a vaccine could be carried out by measurement of
an antibody response and not by the challenge of the animal.
This has been used for the determination of immunity against
N.meningitidis (Goldschneider et a_l, 1969) where bactericidal
antibodies are measured.
The examination of IHA negative isolates was stimulated by
the large increase in the prevalence of these strains between
1978 and 1982 from 5% to 11% (Thompson et a_l, 1977; Fraser et
al, 1983 ) and by a report (Frank, 1980) that distict serotpyes
had been identified among a group of IHA negative strains
recovered from cattle. The demonstration of 10 serogroups within
31 strains from the MRI collection using CCIE indicates the
213
potentially large number of serogroups which may exist.
Although an immunological study was carried out on the serogroup
specific antigens the chemical analysis of these antigens
remains to be done. This may give some information on an
important difference between these strains and IHA positive
strains; for example why they do not react in the IHA test. The
binding of the IHA antigen is a reversible phenomenon (personal
observation) indicating a specific receptor or binding site on
the RBC membrane. The serogroup antigen of the IHA-negative
strains may lack a reacting group for the receptor or binding
site or be a completely different antigen from the IHA positive
serotype antigen.
The results obtained in the examination of pathogenicity of
these strains do not clarify their possible role in the
aetiology of pasteurellosis. As only two strains were tested
there is insufficient evidence to state that all IHA negative
strains are not pathogenic but other IHA negative strains should
be examined in the experimental SPF lamb model.
CCIE is a convenient method for serotyping IHA negative
strains and if the strains can be monitored, using this method,
in the field then a proper assessment of the role of these
strains in disease can be made.
The serogroups were numbered with Roman numerals to
differentiate them from IHA positive strains. This should help
avoid confusion if more IHA positive serotypes are discovered as
these can be given numbers consecutive to those existing already
and be easily identified as IHA positive serotypes. The
standardisation of the nomenclature is important and to this end
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it may be sensible to have one or two laboratories which will
perform the serology and designate new serotypes or serogroups
as they come to light.
To conclude, the major points arising from this work are:
mice can be protected against challenge by P♦haemolytica Al and
A6 with a carbohydrate antigen which is probably LPS; this
antigen can be used in a serotype specific micro ELISA; mice
cannot be consistently protected against P.haemolytica A2
challenge with extracts of the cells surface of the bacterium,
but solid protection was shown after challenge with an of
A2; and IHA negative strains of P.haemolytica can be serogrouped
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THE USE OF ELISA TO DETECT ANTIBODIES TO PASTEURELLA HAEMOLYTICA A2
AND MYCOPLASMA OVIPNEUMONIAE IN SHEEP WITH EXPERIMENTAL CHRONIC
PNEUMONIA
W. Donachie and G. E. Jones
Moredun Research Institute, 408 Gilmerton Road, Edinburgh EH17 7JH.
ABSTRACT
Ten untreated sheep and 18 sheep in which chronic pneumonia had
been experimentally reproduced were monitored for serum antibodies to
Pasteurella haemolytica serotype A2 and Mycoplasma ovipneumoniae by
ELISA tests. The pasteurella test utilised a phenol water extract, of P.
haemolytica A2 cells as antigen: for the mycoplasma test whole M.
ovipneumoniae cells solubilised in a carbonate:bicarbonate buffer were
used.
A rise in antibody titre in the infected animals was detected at 2
weeks post inoculation (wpi) and a peak in mean titres at 8 wpi for P.
haemolytica and 14 wpi for M. ovipneumoniae. Titres to both organisms
declined slowly thereafter till termination of the experiment at 24.5
wpi.
An indirect haemagglutination (IHA) test for P. haemolytica
serotype A2 antibodies demonstrated a similar pattern of antibody rise
and decline, but at considerably lower titres than provided by the ELISA
test.
It was concluded that the ELISA tests for both P. haemolytica and
M. ovipneumoniae were sensitive and have potential application in the
detection of antibody responses in ovine respiratory disease.
INTRODUCTION
Chronic ovine (atypical) pneumonia is a disease of lambs up to 1
year old (Stamp and Nisbet, 1963). Mycoplasma ovipneumoniae and
Pasteurella haemolytica A biotypes are associated with the disease in
the field (Jones et al, 1979) and inoculation of pneumonic lesion
homogenates containing both organisms induces a proliferative exudative
(PE) pneumonia indistinguishable from the naturally occurring condition
(Jones et al, 1978). Clinical signs of atypical pneumonia are
f
frequently mild or inapparent, yet its effect on growth and production
may be severe (Jones et al, in preparation). It was thus considered
important to develop methods to assist the detection of atypical
pneumonia and to this end we have investigated the value of ELISA tests
for antibodies to both P. haemolytica and M. ovipneumoniae.
Burrells et al (1979) used an antigen prepared by sodium
salicylate extraction (SSE) of P. haemolytica cells and found their
ELISA much more sensitive than the standard indirect haemagglutination
(IHA) test (Biberstein et al, 1960) for the measurement of antibody to
P. haemolytica. Subsequently, however, the SSE antigen has been shown
to contain antigens common to all P. haemolytica serotypes resulting in
ELISA cross reactions (Burrells, unpublished observations). In this
paper we report ELISA results obtained with an antigen prepared by
phenol-water extraction of P. haemolytica biotype A, serotype 2 (A^).
Several different methods have been used to prepare mycoplasma
antigens for use in ELISA tests, including solubilization in carbonate:
bicarbonate buffer (Horowitz and Cassell, 1978), in sodium dodecyl
sulphate (Bruggman et al, 1977), and in Tween 20 followed by gel
filtration (Nicolet et al, 1981). Initial trials with M. ovipneumoniae
antigen suspensions treated according to the method of Bruggman et al
(1977) indicated that the antigen produced was sensitive but labile,
even after storage at -20°C (Jones, unpublished observations). Whole
cell suspensions treated according to the method of Horowitz and Cassell
(1978) were found to be stable if stored at -20°C; their performance
as ELISA antigens is described in this communication.
MATERIALS AND METHODS
Antigens
Mycoplasma: Preparation of washed, whole cell suspensions of
strain 956/2 of M. ovipneumoniae was as previously described (Jones et
al, 1976), except that the medium used was preincubated and shaken at
37°C for 2 days, then filtered through 0.22 pm average pore diameter
(a.p.d.) membrane filters (Millipore UK, Harrow, Middlesex) before use.
The cell suspensions were analysed for protein content by a semi-micro
Kjeldahl method then solubilized in a carbonate: bicarbonate buffer
(CBB) according to the method of Horowitz and Cassell (1978). Aliquots
of the suspension were stored at - 20°C until use, when they were
✓
diluted to provide 5 pg protein/ml.
Bacteria: P. haemolytica A^ cells were grown in nutrient: broth
(Oxoid No. 2) for 18 h at 37°C. Cells were harvested by
centrifugation at 4000 g for 30 minutes then washed twice in distilled
water. A phenol water extract: (PWE) was prepared using the method of
Westphal et al, (1952). Ten grammes wet weight of cells were
resuspended to 50 ml in distilled water and heated to 68°C. An equal
volume of 90% phenol at 68°C was added to the suspension and the
mixture kept at 68°C for 10 minutes with vigorous shaking. The
mixture was quickly cooled to 4°C on an ice bath then centrifuged at
9000 g for 30 minutes. The aqueous layer was removed, dialysed against
running water for 24 hours then concentrated twofold by rotary
evaporation before centrifugation at 100,000 g for 2 h. The deposit,
resuspended in 5 ml distilled water, was recentrifuged and the resultant
pellet taken up in 1 ml distilled water and lyop'nilised. A
concentration of 2 mg/ml in distilled water was used in the ELISA test.
Experimental design
Twenty eight lambs, approximately 10 weeks old, were obtained from a
flock in which levels of infection with potentially pathogenic
respiratory microorganisms had been found to be very low over 4 years of
sampling. Nasal swabs taken from the lambs on day 0 were free of
pasteurellae, mycoplasmas and viruses.
Eighteen lambs were inoculated intratracheally on day 0 with 6 ml
of a homogenate of pneumonic lung lesions obtained from the abattoir
(Jones et al, 1978). This homogenate contained 10^ colour changing
units (ecu) per 0.2 ml of M. ovipneumoniae and 2 x 10"^ colony forming
units (cfu) of P. haemolytica A2 with no isolation of other
microorganisms. The same animals were inoculated intranasally on day 7
with 1 ml of a culture of P. haemolytica A2 containing 4 x 10^ cfu/ml.
The remaining 10 control lambs were untreated throughout. All control
lambs and 6 infected lambs were slaughtered at 15.5 wpi; the surviving
8 infected lambs were slaughtered at 24.5 wpi, when they had reached the
same mean liveweig'nt as the controls.
Sera
Standard M. ovipneumoniae anti serum:
A vaccine incorporating an aluminium hydroxide adsorbed suspension
of strain 956/2 mixed in'equal proportions with Bayol and Arlacel (Jones
1978) was administered subcutaneously twice with a 2 week interval to
two 3-week old gnotobiotic lambs. The lambs were killed and bled out 7
days after the second vaccination. The sera from both animals were
pooled and stored in aliquots at - 20°C until used at dilutions
between 1/2000 and 1/256,000.
Standard P. haemolytica anti-serum:
Sera from sheep shown 10 have antibody to P. haemolytica A2 in a
previous experiment were pooled and stored in aliquots at -20°C until
used at dilutions between 1/2000 and 1/256,000.
Serology
IHA test: this was carried out as described'by Fraser et al (in
press).
ELISA tests: the methods used were based on that described by Engvall
and Perlman (1972). The tests consisted of 5 steps with 3 washes of
0.05% Tween 20 in phosphate buffered saline pH 7.4 (PBS/Tween) after
each step and 200 pi volumes of reagents, at pre-determined optimal
dilutions, were used throughout.
For P. haemolytica the steps were: I. Micro ELISA plates (M192A
Dynatech Laboratories Ltd., - Billinghurst, Sussex) were coated with
PWE antigen diluted 1/200 in carbonate bicarbonate buffer pH 9.6. The
plates were incubated at 37°C for 24 hr then held at 4°C for 7
day s.
II. Standard or test sera were added to all wells except those in
column 1 to which diluent was added. Test sera were diluted 1/2000 in
PBS/Tween + 0.02% sodium azide before use. The standard serum was made
up in 8 two fold dilutions between 1/2000 and 1/256,000. Each sample
(test and different dilutions of standard) was tested in duplicate and
the plates incubated at room temperature (RT) for 3 h.
III. Pig IgG anti-s'neep IgG conjugated with alkaline phosphatase was
added to each well and incubated for 3 h at RT.
IV. Substrate (p-nitrophenyl phosphate, Sigma Chemical Co. Poole,
Dorset; 1 mg/ml) was added to each well and incubated at RT for 18 h.
V. 3 M NaOH was added to stop the reaction. The results were recorded
as optical densities at a wavelength of 405 run using an
automatic multichannel spectrophotometer ("Titertek Multiskan",Flow
Laboratories, Irvine, Ayrshire).
The steps for M. o\fipneumoniae were as follows:
1. The antigen was added to each well and incubated at RT overnight.
II. The standard and test sera were dispensed as for the P.
haemolytica ELISA but the plates were incubated for 4 hours at 37°C.
III. Conjugate (as above) was added to all wells and incubated
overnight at RT.
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Calculation of results
1. The absorbance figures (A) were converted to log10 values.
2. The log A values of the standard serum dilutions were plotted
against the log^g values of these dilutions to provide a standard
graph.
3. The titre of the standard serum was taken to be that dilution which
would give an absorbance value of 0.1 (log 1.0) as negative control sera
from SPF and gnotobiotic lambs were never found to exceed this value.
4. The titres of the test sera are calculated from the formula
titre of test Reciprocal of dilution of
serum = test serum (2000) x titre of standard
Reciprocal of dilution of serum
standard serum which would
give the same A value as the
test serum (read from graph)
RESULTS
ELISA. The calculated mean serum antibody titres against P. haemolytica
and M. ovipneumoniae for infected and control animals are shown in
Figures 1 and 2 respectively. Mean antibody titres against P.
haemolytica in the infected group peaked at 8 wpi (1/27,500) while
antibody titres against M. ovipneumoniae peaked at 14 wpi (1/21,480).
Antibodies against P. haemolytica A2 declined quickly after peaking
while those against M. ovipneumoniae persisted at a high level until 24
wpi. The control animals, in both tests, showed no significant rise in
mean antibody titre over the duration of the experiment.
IHA - The mean serum antibody titres of the infected group obtained in
the IHA test plotted against time are shown in Figure 3. Antibody
detected in this test increased quickly to a titre of 1/48 at 4 wpi and
declined sharply thereafter. The mean serum antibody titres of the
controls remained almost constant (at 1 in 2) throughout the
experiment.
Figure 3. Mean serum antibody titre (log ) against P.
haemolytica as detected by IHA for infected group (+) and control
group ( □ ). Arrow indicates time of first killing at 15.5 wpi.
Necropsy - The principal pathological and microbiological findings are
shown in Table 1. PE pneumonia was detected in all infected animals but
not in any control animal. Lungs from all infected animals and 3
controls yielded M. ovipneumoniae; P. haemolytica was recovered from the
lungs of 2 infected animals killed at 15.5 wpi.
Table 1. Principal pathological and microbiological findings in
infected and control groups at necropsy.
No. positive for
Group No. in No. with .PE M. ovipneumoniae P. haemolytica
group pneumonia
Infected 14 14 14 2
Control 90 3 0
DISCUSSION
Sheep in which pneumonia had been experimentally reproduced with
suspensions containing P. haemolytica and M. ovipneumoniae showed rises
in antibody titre to these two organisms by ELISA tests. Group mean
titres to the bacterium rose more quickly than those to the mycoplasma,
peaking at 8 weeks for the former and 14 weeks for the latter. Reasons
for this difference are uncertain but may involve a greater invasiveness
or antigenicity of the bacterium compared with the mycoplasma. One
possibility, that the response to P. haemolytica was anamnestic and that
to M. ovipneumoniae was primary, is a less likely explanation since low
levels of antibody to both organisms appeared to be present in pre-
inoculation sera, suggesting prior exposure of the animals to the two
agents. Whatever the cause, the ELISA test for P. haemolytica would
seem to be more useful diagnostically in the early phases of PE
pneumonia. The relatively rapid decline in titres to P. haemolytica
compared with M. ovipneumoniae probably reflects the early elimination
of the bacterium and the lengthy persistence of the mycoplasma in
lesions of PE pneumonia (Gilmour et al, in press), suggesting that the
ELISA test for M. ovipneumoniae antibodies may be more useful
diagnostically in the subacute phase of the disease.
None of the 9 control sheep showed significant rises in antibody
titre to pasteurella or mycoplasma above the levels present at the start
of the experiment, despite the isolation of M. ovipneumoniae from the
lungs of 3 sheep at slaughter. This finding corroborates earlier
observations (Jones, unpublished observations) that simple pulmonary
colonisation with M. ovipneumoniae is insufficient to induce
seroconversion, and that lung consolidation is necessary before
significant rises in antibody are detected.
Phenol-water extracts of serotypes of P. haemolytica have been
shown to contain the serotype specific antigen for that serotype
(Donachie, unpublished observations). This extract contains
lipopolysaccharide (Wilkinson, 1977) and as P. haemolytica serotypes
may share antigenic determinants in this component this may decrease the
specificity of the ELISA test and contribute to the "background" level
of antibody detected. Difficulty in binding polysaccharide antigens to
polystyrene has been noted previously (Barret et al, 1980). This
problem was overcome in these studies by incorporation of a prolonged
binding step (Dahlberg et al, 1980) of 24 h incubation at 37°C
followed by 7 days at 4°C-
The IHA test was less sensitive than the ELISA, but demonstrated
maximum titres at an earlier stage, suggesting that a different antibody
was assayed. The IHA test measures only antibodies to those antigens
which have affinity for erythrocyte membrane sites while all antigens
binding to the well are available for antibody-antigen reactions in the
ELISA test.
The ELISA test for M. ovipneumoniae antibodies used whole cell
antigen solubilized in CBB and proved extremely sensitive in these
studies. However, this antigen has been found to give positive results
with hyperimmune sera to a variety of mycoplasma species (Jones,
unpublished observations) and it may prove necessary to develop a more
specific antigen for future use.
In conclusion it would seem that the ELISA has potential for
serodiagnosis of pneumonia, as the combination of high serum antibody
titres to both I>. haemolytica and M. ovipneumoniae which are easily
detected by the assay, are correlated with consolidated lesions.
However a more specific antigen for both assays would give greater
confidence in the test and make it a more powerful diagnostic tool.
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ABSTRACT
Donachie, W., Burrells, C. and Dawson, A. McL., 1983. Specificity of the enzyme-linked
immunosorbent assay (ELISA) for antibodies in the sera of specific pathogen-free
lambs vaccinated with Pasteurella haemolytica antigens. Vet. Microbiol, 8: 199—205.
Pooled serum from specific pathogen-free (SPF) lambs vaccinated with sodium salicyl¬
ate extracted (SSE) antigens of Pasteurella haemolytica serotype A1 was shown to con¬
tain antibody to other A serotype SSE antigens when tested by the enzyme-linked immu¬
nosorbent assay (ELISA). Specific antibody to serotype A1 SSE antigens was demon¬
strated by absorption of the serum pool with heterologous serotype SSE antigens.
The type-specific antigens of serotypes A1 and A9 were prepared by phenol—water
extraction (PWE) of their respective SSE antigens. The PWE antigens were examined in
a sandwich ELISA where rabbit IgG anti-P. haemolytica A1 cells or A9 cells was used as
a coating layer to bind PWE antigens. The specificity of these antigens was demonstrated
by marked reduction of reactivity between serum from SPF lambs vaccinated with SSE
of serotypes A1 or A9.
INTRODUCTION
Strains of Pasteurella haemolytica, the causative organism of ovine pas-
teurellosis, can be grouped into two biotypes (Smith, 1961) and 15 sero¬
types (Fraser et al., 1982a). Biotype T strains are associated with systemic
pasteurellosis in older sheep while biotype A strains are responsible for septi¬
caemia in young lambs and pneumonia in all ages of sheep. A recent survey
by Fraser et al. (1982b) has shown that serotypes Al, A2, A6, A7 and A9
comprise 80% of the total number of biotype A strains submitted for exami¬
nation.
The 15 serotypes of Pasteurella haemolytica are identified by an indirect
haemagglutination (IHA) test (Biberstein et al., 1960). However, using the
more sensitive indirect enzyme-linked immunosorbent assay (ELISA) for
measurement of antibody to P. haemolytica (Burrells et al., 1979) the sera
of mice and rabbits immunized with sodium salicylate extracted (SSE) anti-
0378-1135/83/$03.00 © 1983 Elsevier Science Publishers B.V.
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gens of individual serotypes exhibited considerable cross reactivity (Burrells
et al., 1983). In addition, sera from ewes and lambs injected with a trivalent
P. haemolytica vaccine containing serotype Al, A2 and A6 SSE antigens
when tested by ELISA reacted not only to vaccine components, but also to
antigens of serotype All (N.J.L. Gilmour and C. Burrells, 19XX, unpublish¬
ed observations). These observations suggest the existence within the A bio-
type of common group antigens not demonstrable by IHA.
This communication reports the demonstration of Al serotype specificity
by absorption of immune serum and the development of a modified ELISA
for determining serum antibody to serotype-specific, phenol—water ex¬
tracted antigens. The "sandwich" ELISA method described here used rabbit
IgG anti-P. haemolytica serotypes Al or A9 cells as a coating layer to bind
type-specific antigens. This should allow the measurement by ELISA of the
antibody response to individual serotypes of P. haemolytica in sheep vacci¬
nated with multivalent P. haemolytica vaccines.
MATERIALS AND METHODS
Antigens
Sodium salicylate extracted (SSE) antigens of P. haemolytica were pre¬
pared as previously described (Wells et al., 1979a) and the bacterial cells re¬
maining after sodium salicylate treatment were retained for use as absorbing
antigen. Phenol—water extracted (PWE) antigens were prepared from Al and
A9 SSE by the hot phenol—water method (Westphal et al., 1952).
Antisera
Aliquots of a previously prepared pool of specific pathogen-free (SPF)
lamb anti-Al serum (Wells et al., 1979b) were absorbed (Table I) at 37°C
for 2 h then held at 4° C overnight. Resulting precipitates were removed by
centrifugation at 1200 g for 20 min and the supernates retained for testing.
Individual antisera were obtained from 3 SPF lambs vaccinated with Al
SSE, using the method of Wells et al. (1979b), and from 3 lambs similarly
vaccinated with A9 SSE. Control serum was obtained from 2 unvaccinated
SPF lambs.
Hyperimmune rabbit sera against Al and A9 cells, indentified by IHA,
were prepared by repeated injections of formalin-killed cells. Immunoglob¬
ulin G (IgG) fractions of these sera were prepared by fractionation on pro¬
tein A-Sepharose CL-4B (Pharmacia (Great Britain) Ltd. Hounslow,
Middlesex) (Goding, 1976) followed by dialysis against phosphate buffered
saline (PBS).




































Enzyme-linked immunosorbent assays (ELISA)
Absorbed SPF lamb antiserum to type A1 was examined by an indirect
ELISA technique as previously described (Burrells et al., 1979) with the
exception that optical densities were determined using a "Titertek Mul-
tiskan" multichannel spectrophotometer (Flow Laboratories, Irvine,
Ayrshire). Doubling dilutions of the abosrbed serum in diluent (PBS/Tween
20) were added in 300-pl volumes to triplicate wells of 96-well microtitre
plates (Gibco Biocult, Paisley, Renfrewshire), previously sensitised with
P. haemolytica Al SSE, and also to wells similarly sensitised with another
biotype SSE (All). Results were recorded as optical densities at a wave¬
length of 405 nm (OD405 ).
PWE antigens were examined with SPF lamb sera in a "sandwich" ELISA
based on that described by Burrells et al. (1979) as PWE antigens did not
bind directly to microtitre plate wells.
The test consisted of six steps with three PBS/Tween 20 washes between
each of the first five (300 pi volumes of reagents at previously determined
optimum dilutions were used). (1) Microtitre wells were coated with the IgG
fraction of the rabbit antisera diluted in 0.05 M carbonate/bicarbonate
buffer pH 9.6, by incubating at 4°C for 18 h. (2) Al and A9 PWE (4.0 pg
ml -1 ) were added to wells precoated with homologous IgG antibody and in¬
cubated for 1 h at 37°C. (3) SPF lamb sera, diluted in PBS/Tween 20 were
then added to appropriate wells and allowed to stand for 3 h at room temp¬
erature (RT). (4) Alkaline phosphatase conjugated pig IgG anti-sheep IgG
(Burrells et al., 1979) diluted in PBS/Tween 20 was added to every well and
allowed to stand at RT for 3 h. (5) Enzyme substrate (p-nitrophenyl phos¬
phate, (Sigma Chemical Co., Poole, Dorset.) 1 mg ml"1 in 10% di-
ethanolamine buffer) was added to every well and left at RT for 1 h. (6) En-
zymic degradation was stopped by adding 50 pi of 2 M NaOH to each well
and the OD405 for each was recorded.
RESULTS
The various absorption procedures performed on SPF antiserum to type
Al are shown in Table I. The OD405 of each dilution of unabsorbed serum
in reaction with Al SSE and All SSE are given in Figs. 1 and 2, respective¬
ly. Although Al specificity might be demonstrated by the difference in
OD405 at dilutions beyond 1/240 (e.g., the OD405 at 1/480 with Al SSE =
2.1, whilst with All SSE the OD405 = 1.1), cross-reaction with All SSE up
to a dilution of 1/7680 was detected. Absorption with Al cells which had
been extracted with sodium salicylate did not reduce the OD405 at any
point, and in the case of Al SSE, slightly but consistently enhanced the
reaction (Fig. 1).
When the SPF anti-Al serum was absorbed with the SSE antigens of all




RECIPROCAL OF SERUM DILUTION
Fig. 1. Optical densities at 405 nm (OD40S) of dilutions of SPF anti-Al serum after
ELISA reactions with A1 SSE antigen of P. haemolytica. Replicate aliquots of serum
were unabsorbed (o)I absorbed with sodium salicylate treated A1 cells (•) absorbed with
SSE of other serotypes (■) or abosrbed with SSE antigens plus sodium salicylate treated
A1 cells (□).
Fig. 2. Optical densities at 405 nm (OD40S) of dilutions of SPF anti-Al serum after
ELISA reactions with All SSE antigen of P. haemolytica. Replicate aliquots of serum
were unabsorbed (o) or absorbed with sodium salicylate treated A1 cells (•). (No OD4l)5
was obtained when serum was absorbed with SSEs of other serotypes or SSE antigens +
sodium salicylate treated A1 cells).
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out SSE treated A1 cells, a marked reduction of OD40s was observed with
the homologous antigen (Fig. 1).
Type specificity for A1 was indicated by the fact that at all dilutions the
same absorbed serum gave negative OD405 values with All antigen.
Table II shows the results obtained when SPF lamb sera to A1 and A9
were tested against homologous and heterologous PWE antigens. Individual
homologous values were all greater than 0.69 whilst heterologous values were
less than 0.23. Paired sera from the two unvaccinated lambs remained nega¬
tive to A1 PWE, but showed some reaction to A9 PWE. This reaction was
also seen in the pre-vaccination sera of vaccinated lambs.
TABLE II
OD405 values obtained from the reaction of antisera to type A1 or A9 with homologous
and heterologous phenol—water extracted antigens
SPF Vaccine A1 PWE A9 PWE
lamb no.
Pre-vaccination Post-vaccination Pre-vacc. Post-vacc.
1 ) 0 1.065 0.097 0.122
2 A1 SSE V 0 1.087 0.132 0.225
3 i 0 0.691 0.126 0.154
4 ) 0 0.025 0.096 1.140
5 A9SSE > 0 0 0.117 0.865
6 ) 0 0.030 0.084 0.696
7 Not vaccinated 1 0 0 0.086 0.151
8 0 0 0.117 0.130
DISCUSSION
Pooled sera from SPF lambs immunised with P. haemolytica serotype A1
SSE were shown to cross-react with SSE of serotype All. Absorption with
pooled SSE antigens from all the other available serotypes left antibody
which reacted specifically with type A1 SSE. The observed cross-reactivity
has also been described in mouse and rabbit serum (Burrells et al., 1983). It
is interesting that sodium salicylate-treated Al cells failed to reduce the
OD4os when used to absorb antiserum to Al SSE. This indicates that little,
if any, of the antigens extracted by sodium salicylate remain on the cells
after treatment.
PWE antigens of P. haemolytica SSE contain serotype-specific antigens
which are detectable by the IHA test and are polysaccharide in composition
(W. Donachie, 1980, unpublished observations). Antibodies to PWE anti¬
gens of serotypes Al and A9 were measured by the modified ELISA.
Although some pre-vaccination background reaction to A9 PWE, but not Al
PWE, was present in sera from both vaccinated ana control lambs the lowest
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3D4o5 in a homologous system (lamb 3 serum = 0.691) was more than three
times greater than the highest heterologous OD405 (lamb 2 serum = 0.225).
rhis was the criterion of specificity used by Russell et al. (1980) to measure
antibody to pneumococcal polysaccharides. A "sandwich" ELISA was used,
as coating layers of antiserum or IgG have previously been shown to bind
oneumococcal polysaccharides efficiently and with reproducible results
^Russell et al., 1980; Barret et al., 1980).
On the basis of these results with two P. haemolytica serotypes it is possi-
ale to determine the level of antibody to a single serotype. Further work is
aeing carried out to test the applicability of this "sandwich" ELISA to the
:ather serotypes as the specificity would allow quantitative assessment of the
antibody response to individual components in multivalent P. haemolytica
/accines.
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